TNF
Synonyms
Tumor Necrosis Factor (TNF Superfamily, Member 2), Tumor Necrosis Factor Ligand 1F, Tumor Necrosis Factor-Alpha, TNF Superfamily, Member 2, TNF, Macrophage-Derived, TNF, Monocyte-Derived, APC1 Protein, TNLG1F, DIF, ICD1, Tumor necrosis factor, NTF, TNF-a, TNF-alpha, ICD2, N-terminal fragment, TNF, Tumor necrosis factor ligand superfamily member 2, Cachectin, TNFSF2, TNFA
Description
Tumor necrosis factor α is a cell signaling protein (cytokine) involved in systemic inflammation and is one of the cytokines that make up the acute phase reaction. It is produced chiefly by activated macrophages, although it can be produced by many other cell types such as T helper cells, natural killer cells, neutrophils, mast cells, eosinophils, and neurons.TNF is a member of the TNF superfamily, consisting of various transmembrane proteins with a homologous TNF domain.Cytokine that binds to TNFRSF1A/TNFR1 and TNFRSF1B/TNFBR. It is mainly secreted by macrophages and can induce cell death of certain tumor cell lines. It is potent pyrogen causing fever by direct action or by stimulation of interleukin-1 secretion and is implicated in the induction of cachexia, Under certain conditions it can stimulate cell proliferation and induce cell differentiation. Impairs regulatory T-cells (Treg) function in individuals with rheumatoid arthritis via FOXP3 dephosphorylation. Upregulates the expression of protein phosphatase 1 (PP1), which dephosphorylates the key 'Ser-418' residue of FOXP3, thereby inactivating FOXP3 and rendering Treg cells functionally defective . Key mediator of cell death in the anticancer action of BCG-stimulated neutrophils in combination with DIABLO/SMAC mimetic in the RT4v6 bladder cancer cell line . Induces insulin resistance in adipocytes via inhibition of insulin-induced IRS1 tyrosine phosphorylation and insulin-induced glucose uptake. Induces GKAP42 protein degradation in adipocytes which is partially responsible for TNF-induced insulin resistance. Plays a role in angiogenesis by inducing VEGF production synergistically with IL1B and IL6 .The TNF intracellular domain (ICD) form induces IL12 production in dendritic cells.
KO Status
F2 (-/-)
Drug Information
Launched drugs: 46
Drugs in clinical trials: 63
Latest Research Phase: Approved
Drug Name
Code
Phase
Company
Indications
Clinical Trials
Luminol sodium
MP-1032
Approved
Selvim, Metrio
Immune System Diseases, Psoriasis
NCT Number
NCT03706209
NCT02908347
Intervention Type
Drug
Drug
Indications
Psoriasis
Psoriasis; Plaque Psoriasis
Study Phase
Phase 2
Phase 2
Recruitment Status
Completed
Completed
Etanercept biosimilar (Mochida)
LBEC-0101
Approved
Mochida Pharmaceutical Co Ltd
Arthritis, Rheumatoid, Arthritis, Juvenile
Infliximab
TA-650
Approved
Janssen Global Services Llc
Giant Cell Arteritis, Spondylitis, Ankylosing, Arthritis, Rheumatoid, Sarcoidosis, Pediatric Crohn's disease, Mucocutaneous Lymph Node Syndrome, Psoriasis, Pediatric ulcerative colitis, Colitis, Ulcerative, Arthritis, Psoriatic, Parapsoriasis, Uveitis, Pulmonary Disease, Chronic Obstructive, Crohn Disease, Behcet Syndrome
NCT Number
NCT04646187
NCT02517684
NCT01793831
NCT00216177
NCT01802593
NCT00542152
NCT01072058
NCT03004443
NCT00432432
NCT00132691
NCT02770794
NCT00851565
NCT02453776
NCT00507403
NCT00246064
NCT01308255
NCT02878161
NCT00463580
NCT01602302
NCT01295151
NCT02177071
NCT04775732
NCT00688636
NCT00779935
NCT00636142
NCT01638715
NCT01604629
NCT01346826
NCT01144143
NCT01181765
NCT01752790
NCT00779012
NCT00794898
NCT01408810
NCT00778869
NCT01880307
NCT00133315
NCT02242474
NCT00726804
NCT00936143
NCT02566889
NCT00686894
NCT03679546
NCT02714634
NCT01000441
NCT02770040
NCT04530877
NCT00574470
NCT00896168
NCT01548768
NCT02353780
NCT00462072
NCT01804166
NCT01442025
NCT01793519
NCT01282528
NCT03937609
NCT04150770
NCT00764725
NCT02132234
NCT00396747
NCT03006393
NCT00432406
NCT00589628
NCT00908089
NCT02829424
NCT02412085
NCT00714493
NCT02425852
NCT00752622
NCT01817426
NCT01148901
NCT00554710
NCT02994836
NCT00686595
NCT02743390
NCT00629772
NCT00443651
NCT00096655
NCT03596645
NCT00691028
NCT02332356
NCT02779114
NCT00040885
NCT00317538
NCT00236028
NCT03065244
NCT03112603
NCT01680159
NCT02096861
NCT00051623
NCT01551290
NCT03478111
NCT00207662
NCT00254982
NCT00527072
NCT02298062
NCT00132899
NCT00984568
NCT03147248
NCT00207675
NCT01217086
NCT00207701
NCT01661257
NCT04535518
NCT00336492
NCT00686686
NCT01580670
NCT00207766
NCT01724268
NCT01423591
NCT00844805
NCT00394589
NCT02771457
NCT00106834
NCT00094458
NCT00385086
NCT01936181
NCT00073437
NCT00095147
NCT01190839
NCT00202852
NCT02505568
NCT00056264
NCT00004941
NCT01596335
NCT03088293
NCT04610476
NCT01177800
NCT00036387
NCT01571219
NCT00796250
NCT00036374
NCT03162432
NCT00036439
NCT01548014
NCT00571337
NCT01585155
NCT01962974
NCT01559142
NCT00760435
NCT00251641
NCT00367237
NCT00833053
NCT00106847
NCT04593940
NCT00237484
NCT00202865
NCT00505947
NCT00521924
NCT00732875
NCT01532570
NCT03704610
NCT00269841
NCT00358670
NCT00537316
NCT02136069
NCT03371095
NCT00269867
NCT00687401
NCT00805766
NCT00439283
NCT00368264
NCT00269854
NCT02532738
NCT00521963
NCT00443222
NCT00591201
NCT00244179
NCT02457585
NCT01216631
NCT00029042
NCT00244192
NCT02403232
NCT04114188
NCT00006292
NCT00278083
NCT00060502
NCT00076726
NCT01355614
NCT00604864
NCT00523354
NCT00033891
NCT00512278
NCT03269695
NCT01313520
NCT00687362
NCT00753103
NCT04425538
NCT04305145
NCT00514982
NCT00823641
NCT00207714
NCT00074074
NCT04438382
NCT03684278
NCT01485055
NCT00175266
NCT02363738
NCT00372723
NCT00283712
NCT00112749
NCT02251041
NCT00304954
NCT00230529
NCT02495077
NCT04564001
NCT02763761
NCT00201799
NCT00795574
NCT01256489
NCT00325078
NCT02620618
NCT01846026
NCT00111917
NCT02126020
NCT00959725
NCT02638701
NCT00958906
NCT03293784
NCT01844804
NCT02987686
NCT00228839
NCT02359903
NCT00075075
NCT00271570
NCT02883452
NCT01567358
NCT01571206
NCT01261286
NCT01971814
NCT04779892
NCT03446976
NCT01220518
NCT00583232
NCT00695682
NCT01886443
NCT03819296
NCT02356445
NCT02057016
NCT04734678
NCT01438151
NCT00755937
NCT01286545
NCT02060318
NCT04725422
NCT03818516
NCT01245361
NCT00725543
NCT01915537
NCT03062865
NCT00748826
NCT00724243
NCT00561548
NCT02675153
NCT00676988
NCT03331393
NCT01613963
NCT00553176
NCT03393247
NCT01356758
NCT00901550
NCT00988832
NCT01881464
NCT04655729
NCT01605188
NCT03043677
NCT02075697
NCT03445624
NCT01706692
NCT01610947
NCT01657513
NCT02619552
NCT00955123
NCT03358693
NCT01543594
NCT03056924
NCT03775824
NCT03006198
NCT00380796
NCT02522169
NCT02134054
NCT01436019
NCT02922192
NCT00819663
NCT01592292
NCT03325582
NCT02088944
NCT01605175
NCT00606346
NCT00749398
NCT03397108
NCT00725621
NCT00307593
NCT00760669
NCT03370601
NCT00224562
NCT00658827
NCT01981473
NCT00723905
NCT02322008
NCT01299545
NCT04156425
NCT02330458
NCT00724529
NCT00818272
NCT00818168
NCT02073526
NCT01402661
NCT03496831
NCT00213564
NCT00705471
NCT02868398
NCT02852850
NCT01361542
NCT01233583
NCT01083563
NCT00237419
NCT03108326
NCT01137838
NCT00273390
NCT02847884
NCT01850121
NCT04378621
NCT00724672
NCT01787786
NCT00741793
NCT02707341
NCT01266785
NCT01630850
NCT02332460
NCT01812954
NCT03192878
NCT03765450
NCT00252369
NCT00791557
NCT00725296
NCT02293681
NCT00724958
NCT00661284
NCT03340519
NCT00207688
NCT02438410
NCT01753245
NCT02694588
NCT00261976
NCT00779675
NCT02376478
NCT01349920
NCT00727298
NCT01338740
NCT03681652
NCT01848028
NCT02711202
NCT03308357
NCT01692899
NCT00897312
NCT01490528
NCT00508547
NCT01666535
NCT02693340
NCT01971970
NCT00745329
NCT00948610
NCT03209232
NCT03729674
NCT00840957
NCT02027727
NCT00639821
NCT01685918
NCT03452501
NCT00586807
NCT02557308
NCT01759017
NCT01625650
NCT03266471
NCT01617018
NCT00741104
NCT02799615
NCT01691014
NCT04131504
NCT00705289
NCT02453607
NCT02728934
NCT00705484
NCT00725452
NCT01219257
NCT00705614
NCT04761952
NCT02998398
NCT02170714
NCT03016260
Intervention Type
Biological
Other, Drug
Procedure
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Procedure
Drug
Drug
Drug
Drug, Dietary Supplement
Biological, Drug
Drug
Drug
Biological, Drug
Drug
Biological
Drug
Biological
Biological
Drug
Drug
Drug
Drug
Biological
Drug
Biological
Biological
Drug
Biological
Drug
Drug
Drug
Drug
Drug
Drug
Procedure, Drug
Drug
Drug
Drug
Drug
Biological, Dietary Supplement
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological
Drug
Drug
Biological, Drug
Drug
Drug
Other, Drug
Drug
Drug
Drug
Drug
Drug
Biological
Drug
Biological
Other, Drug
Drug
Drug
Biological, Drug
Biological
Other, Biological
Drug
Drug
Drug
Drug
Drug
Drug
Other, Drug
Other, Biological, Drug
Drug
Drug
Drug
Drug
Drug
Biological
Drug
Drug
Drug
Drug
Biological
Biological
Drug
Drug
Biological, Drug
Biological
Drug
Drug
Drug
Drug
Drug
Biological
Biological
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other, Biological, Drug
Drug
Drug
Drug
Drug
Biological, Drug
Other, Biological, Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological
Biological, Drug
Drug
Drug
Drug
Dietary Supplement
Drug
Drug
Biological
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological
Drug
Biological, Drug
Biological
Drug
Drug
Drug
Biological
Biological, Drug
Other, Drug
Drug
Drug
Biological
Drug
Drug
Drug
Drug
Other, Biological, Drug
Biological
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Procedure, Device
Drug
Drug
Procedure, Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological
Procedure, Biological, Drug
Drug
Drug
Drug
Drug
Drug
Biological
Other, Biological, Drug
Other, Drug
Drug
Procedure, Drug
Other, Drug
Drug
Other, Drug
Other, Biological
Drug
Other, Drug
Drug
Biological, Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other, Drug
Drug
Drug
Drug
Drug
Combination Product
Biological
Drug
Drug
Drug
Drug
Biological, Drug
Biological
Biological
Biological
Drug
Drug
Drug
Biological
Drug
Drug
Drug
Drug
Procedure, Other, Biological, Drug
Other
Drug
Drug
Other
Drug
Drug
Other
Drug
Biological
Drug
Other
Biological
Drug
Procedure
Drug
Other
Drug
Other
Drug
Drug
Drug
Biological
Drug, Device
Drug
Biological
Drug
Biological, Drug
Drug
Drug
Drug
Drug
Biological
Drug
Drug
Drug
Drug
Drug
Drug
Biological, Drug
Biological
Biological
Drug
Drug
Drug
Drug
Other
Other
Biological
Drug, Dietary Supplement
Procedure
Biological
Biological
Biological
Drug
Drug
Drug
Biological
Drug
Drug
Drug
Biological
Drug
Biological
Drug
Other, Drug
Drug
Drug
Procedure, Biological
Drug
Drug
Drug
Procedure, Drug
Drug
Biological
Drug
Biological
Device
Drug
Drug
Drug
Biological
Other, Drug
Drug
Biological
Drug
Drug
Drug
Diagnostic Test
Other, Biological, Drug
Biological
Biological
Biological
Other
Drug
Drug
Drug
Biological
Other
Drug
Other
Diagnostic Test, Other
Drug
Drug
Other
Drug
Biological
Drug
Biological
Biological, Drug
Biological
Biological
Biological
Drug
Other
Other
Biological
Indications
Crohn's Disease
Crohn's Diseases; Inflammatory Bowel Disease
Rheumatoid Arthritis
Crohn's Disease
Ulcerative Colitis; Steroid Refractory
Arthritis, Rheumatoid; Spondylitis, Ankylosing
Depression
Ankylosing Spondylitis
Uveitis
Arthritis, Rheumatoid
Crohn's Disease
Inflammatory Bowel Disease
Ankylosing Spondylitis
Arthritis, Rheumatoid
Rheumatoid Arthritis
Rheumatoid Arthritis
Depression
Rheumatoid Arthritis
Rheumatoid Arthritis
Crohn's Disease
Crohn Disease; Ulcerative Colitis
Crohn's Disease
Spondylitis, Ankylosing
Obesity; Insulin Resistance; Metabolic Syndrome
Rheumatoid Arthritis
Spondylarthropathies
Crohn's Disease; Ulcerative Colitis
Osteoarthritis of the Knee
Crohn's Disease
Pediatric Crohn's Disease
Spondylitis, Ankylosing
Arthritis, Rheumatoid
Ulcerative Colitis
Spondylitis, Ankylosing
Crohn's Disease
Spondylarthropathies; Ankylosing Spondylitis; Psoriatic Arthritis
Rheumatoid Arthritis
SPONDYLOARTHRITIS
Spondylitis
Inflammatory Bowel Diseases
Spondylitis, Ankylosing; SpA
Ulcerative Colitis
Rheumatoid Arthritis; Insufficient Response to Methotrexate.
Rheumatoid Arthritis
Ulcerative Colitis
Crohn's Disease; Exclusive Enteral Nutrition; Infliximab; Mucosal Healing
Graft vs Host Disease
Arthritis, Rheumatoid
Rheumatoid Arthritis
Rheumatoid Arthritis (RA)
Rheumatoid Arthritis; Psoriatic Arthritis; Psoriasis; Crohn's Disease
Hepatosplenic T-Cell Lymphoma
Crohn's Disease
Rheumatoid Arthritis
Rheumatoid Arthritis; Ultrasonography; Infliximab
Colitis, Ulcerative
Uveitis; Infliximab
Rheumatoid Arthritis
Rheumatoid Arthritis; Psoriatic Arthritis; Ankylosing Spondylitis; Hypertension
Rheumatoid Arthritis
Depression
Psoriatic Arthritis
Chronic Uveitis
Rheumatoid Arthritis
Psoriasis
Colitis, Ulcerative
Rheumatoid Arthritis
Ulcerative Colitis
Crohn's Disease
Crohn Disease
Ankylosing Spondylitis
Crohn's Disease
Crohn's Disease; Inflammatory Bowel Disease; Ulcerative Colitis
Psoriasis
Hypertension
Palmoplantar Psoriasis
Rheumatoid Arthritis
Ulcerative Colitis
Colitis, Ulcerative
Rheumatoid Arthritis
Crohn Disease
Rheumatoid Arthritis
Anorexia; Cachexia; Fatigue; Lung Cancer
Rheumatoid Arthritis
Rheumatoid Arthritis
Mucocutaneous Lymph Node Syndrome
Graft-versus-host Disease (GVHD)
Plaque Psoriasis; Psoriatic Arthritis; Pustular Psoriasis (Excluding a Localized); Psoriatic Erythroderma
Crohn's Disease
Arthritis, Psoriatic
Ulcerative Colitis
Rheumatoid Arthritis
Crohn Disease
Psoriasis
Psoriasis
Kawasaki Disease
Crohn's Disease
Colitis, Ulcerative
Rheumatoid Arthritis
Crohn Disease
Rheumatoid Arthritis
Ankylosing Spondylitis
Crohn's Disease
Kawasaki Disease
Ulcerative Colitis
Psoriasis
Pediatric Crohn's Disease
Crohn Disease
RHEUMATOID ARTHRITIS
Polymyalgia Rheumatica
Ankylosing Spondylitis; Axial Spondyloarthritis
Rheumatoid Arthritis
Inflammatory Bowel Disease
Psoriasis
Crohn Disease
Post Operative Sciatica by Lumbar Spinal Fibrosis
Rheumatoid Arthritis
Sarcoidosis
Rheumatoid Arthritis
Crohn's Disease
Arthritis, Rheumatoid
Behcet Disease
Chronic Obstructive Pulmonary Disease; COPD
Crohn's Disease
Kawasaki Disease Refractory to Initial Therapy With Intravenous Immunoglobulin
Idiopathic Refractory Scleritis
Psoriatic Arthritis; Withdrawal; Reduction
Psoriasis
Arthritis, Rheumatoid
Rheumatoid Arthritis
Crohn's Disease
Rheumatoid Arthritis, Juvenile
IBD; Ulcerative Colitis; Crohn Disease
Ulcerative Colitis
Crohn's Disease
Crohn Disease
Pediatric Ulcerative Colitis
Arthritis, Rheumatoid
Crohn Disease
Kawasaki Disease
Psoriasis
Arthritis, Psoriatic
Psoriasis
Psoriasis; Parapsoriasis
Covid19
Hepatitis C, Chronic
Spondylitis, Ankylosing
Diabetic Macular Edema; Visual Acuity; Diabetic Retinopathy
Rheumatoid Arthritis
Arthritis, Rheumatoid
Behcet's Disease; Behcet Syndrome; Neuro-Behcet's Disease
Extrathoracic Sarcoidosis
Crohn Disease
Psoriasis
Ulcerative Colitis
Ulcerative Colitis
Behcet's Disease; Vasculitis
Rheumatoid Arthritis
Psoriasis
Crohn's Disease
Ankylosing Spondylitis
Lupus Erythematosus, Systemic; Lupus Nephritis
Crohn Disease
Crohn's Disease
Arthritis
Refractory Myositis
Spondylarthropathies
Reactive Arthritis
Takayasu's Arteritis
Spondylarthropathies
Juvenile Rheumatoid Arthritis
COPD; Cachexia
Perianal Fistula; Crohn Disease
Renal Transplant Rejection
Rheumatoid Arthritis
Asthma
Cachexia; Pancreatic Neoplasms
Giant Cell Arteritis
Crohn's Disease
Endometriosis
Esophagitis
Dermatomyositis; Polymyositis
Hepatitis C
Ulcerative Colitis
Arthritis, Rheumatoid
Psoriasis
Wegener's Granulomatosis; Renal Limited Vasculitis; Microscopic Polyangiitis
COVID-19
Melanoma Stage III; Melanoma Stage IV; Side Effect of Drug; Colitis
Hermanski-Pudlak Syndrome; Colitis; Cytokines; Lymphocytes; Drug Evaluation
HTLV-I-associated Myelopathy
Rheumatoid Arthritis
Myelodysplastic Syndromes
Hematopoietic and Lymphoid Cell Neoplasm; Malignant Solid Neoplasm; Steroid-Refractory Pneumonitis
Acute Pancreatitis
Graft Versus Host Disease; Steroid Refractory GVHD; Acute GVH Disease
Type 1 Diabetes
Bipolar Depression
Toxic Epidermal Necrolysis
Pemphigus
Breast Cancer; Fatigue
Reperfusion Injury
Age-Related Macular Degeneration; Choroidal Neovascularization
Psoriasis
Kidney Transplant
Takayasu Arteritis
Renal Cell Carcinoma; Melanoma; Lung Cancer
Graft-Versus-Host Disease
Hidradenitis Suppurativa
Stevens-Johnson Syndrome; Corneal Blindness
Chronic Granulomatous Disease; Crohn'S-like IBD; Inflammatory Bowel Disease (IBD)
Behçet's Disease; Uveitis
Ulcerative Colitis
Berylliosis; Beryllium Disease
Stevens-Johnson Syndrome; Toxic Epidermal Necrolysis (Lyell) Syndrome; Mucous Membrane Pemphigoid
Diabetic Macular Edema
Aneurysm; Stroke; Vasculitis; Tumor Necrosis Factor-alpha
Uveitic Macular Edema; Intraocular Inflammation
Melanoma
Healthy
Sterile Corneal Melt
Graft vs Host Disease
Ankylosing Spondylitis
Scleritis
Kawasaki Disease
Crohn's Disease; Ulcerative Colitis (Part 2 Only)
Rheumatoid Arthritis
Ankylosing Spondylitis
Crohn's Disease
Ulcerative Colitis (UC); Inflammatory Bowel Disease
Rheumatoid Arthritis
Health, Subjective
Ankylosing Spondylitis
Crohn's Disease; Protein Metabolism; Energy Metabolism
Diabetic Retinopathy; Macular Degeneration
Reperfusion Injury
Clinical Stage 0 Cutaneous Melanoma AJCC v8; Clinical Stage I Cutaneous Melanoma AJCC v8; Clinical Stage IA Cutaneous Melanoma AJCC v8; Clinical Stage IB Cutaneous Melanoma AJCC v8; Clinical Stage II Cutaneous Melanoma AJCC v8; Clinical Stage IIA Cutaneous Melanoma AJCC v8; Clinical Stage IIB Cutaneous Melanoma AJCC v8; Clinical Stage IIC Cutaneous Melanoma AJCC v8; Clinical Stage III Cutaneous Melanoma AJCC v8; Clinical Stage IV Cutaneous Melanoma AJCC v8; Colitis; Diarrhea; Malignant Genitourinary System Neoplasm; Pathologic Stage 0 Cutaneous Melanoma AJCC v8; Pathologic Stage I Cutaneous Melanoma AJCC v8; Pathologic Stage IA Cutaneous Melanoma AJCC v8; Pathologic Stage IB Cutaneous Melanoma AJCC v8; Pathologic Stage II Cutaneous Melanoma AJCC v8; Pathologic Stage IIA Cutaneous Melanoma AJCC v8; Pathologic Stage IIB Cutaneous Melanoma AJCC v8; Pathologic Stage IIC Cutaneous Melanoma AJCC v8; Pathologic Stage III Cutaneous Melanoma AJCC v8; Pathologic Stage IIIA Cutaneous Melanoma AJCC v8; Pathologic Stage IIIB Cutaneous Melanoma AJCC v8; Pathologic Stage IIIC Cutaneous Melanoma AJCC v8; Pathologic Stage IIID Cutaneous Melanoma AJCC v8; Pathologic Stage IV Cutaneous Melanoma AJCC v8
Sarcoidosis
Crohn's Disease; Ulcerative Colitis
Covid19; Cytokine Storm; Corona Virus Infection
Crohn's Disease
Crohn's Disease
Ankylosing Spondylitis
Crohn Disease
Chronic Nonbacterial Osteomyelitis; Chronic Recurrent Multifocal Osteomyelitis
Schizophrenia
Undifferentiated Arthritis
Spondylitis, Ankylosing
Rheumatoid Arthritis(RA)
RheumatoId Arthritis
Arthritis, Rheumatoid
Rheumatoid Arthritis
Crohn Disease
Crohn's Diseases
Crohn's Disease
Rheumatoid Arthritis
Uveitis; Scleritis
Crohn's Disease
Crohn Disease
Psoriasis; Atopic Dermatitis; Atherosclerosis
Rheumatoid Arthritis
Crohn's Disease
Crohn's Disease
Crohn Disease
Inflammatory Bowel Disease
Inflammatory Bowel Disease
Psoriasis
Inflammatory Bowel Diseases
Psoriasis
Spondyloarthritis
Psoriasis
Crohn's Disease; IBD
Inflammatory Bowel Diseases
Atopic Dermatitis; Psoriasis
Rheumatoid Arthritis
Inflammatory Bowel Diseases
Rheumatoid Arthritis
Arthritis, Rheumatoid; Spondylitis, Ankylosing; Arthritis, Psoriatic; Colitis, Ulcerative
COPD; Pulmonary Disease, Chronic Obstructive
Pediatric Crohns Disease
Inflammatory Bowel Disease
Juvenile Idiopathic Arthritis
Rheumatoid Arthritis; Inflammatory Bowel Disease; Psoriasis; Psoriatic Arthritis; Ankylosing Spondylitis
Crohn's Disease
Rheumatoid Arthritis
Perianal Fistula
Serological C Reactive Protein or Erythrocyte Sedimentation Rate
Inflammatory Bowel Disease
Crohn's Disease; Ulcerative Colitis; Indeterminate Colitis; Inflammatory Bowel Diseases
Psoriasis
Crohn's Disease; Ulcerative Colitis; Healthy Controls
Rheumatoid Arthritis
Wegener's Granulomatosis; Churg-Strauss Syndrome; Microscopic Polyangiitis
Spondylitis, Ankylosing; Arthritis, Rheumatoid; Psoriasis; Arthritis, Psoriatic
Inflammatory Bowel Diseases
Rheumatoid Arthritis; Crohn's Disease; Ankylosing Spondylitis; Psoriasis
Inflammatory Bowel Disease
Rheumatoid Arthritis
Crohn Disease; Arthritis, Rheumatoid
Crohn's Disease; Ulcerative Colitis; Inflammatory Bowel Disease
Rheumatoid Arthritis
Major Depressive Disorder
Inflammatory Bowel Disease; Crohn's Disease
Crohn's Disease; Ankylosing Spondylitis
Crohn's Disease
Spondylitis, Ankylosing
Inflammatory Bowel Disease; Crohn's Disease; Ulcerative Colitis
Rheumatoid Arthritis
Rheumatoid Arthritis; Spondyloarthritis; Psoriatic Arthritis
Rheumatoid Arthritis
Crohn Disease
Ulcerative Colitis
Ulcerative Colitis
Ankylosing Spondylitis
Psoriasis
Rheumatoid Arthritis
Ankylosing Spondylitis
Crohn Disease
Rheumatoid Arthritis
Uveitis
Inflammatory Bowel Disease; Crohn's Disease
Ankylosing Spondylitis
Rheumatoid Arthritis; Pain; Fatigue; Cognitive Decline; Depression; Brain Diseases; Hand Rheumatism
Rheumatoid Arthritis
Crohn's Disease; Ulcerative Colitis
Arthritis, Rheumatoid; Spondyloarthritis, Axial; Arthritis, Psoriatic
Psoriasis
Crohn's Disease
Diabetes Mellitus, Type 1
Chronic Inflammatory Disease
Psoriasis
Takayasu Arteritis
Ulcerative Colitis
Crohn's Disease
Pyoderma Gangrenosum; Crohn's Disease; Ulcerative Colitis; Inflammatory Bowel Disease
Arthritis, Psoriatic
Spondylitis, Ankylosing
Crohn's Disease
Rheumatoid Arthritis
Crohn Disease
Ulcerative Colitis
Colitis, Ulcerative; Inflammatory Bowel Disease; IBD
Psoriasis Vulgaris; Metabolic Syndrome
IBD
Arthritis, Rheumatoid; Crohn Disease; Psoriasis
Psoriasis
Psoriasis; Inflammatory Bowel Diseases
Crohn Disease
Arthritis, Rheumatoid; Spondylitis, Ankylosing; Arthritis, Psoriatic; Psoriasis; Crohn's Disease
Crohn's Disease
Crohn Disease
Psoriasis; Psoriatic-arthritis
Kidney Transplantation
Inflammatory Bowel Diseases
Rheumatoid Arthritis
Melanoma
Pediatric Inflammatory Bowel Disease
Inflammatory Bowel Disease
Inflammatory Bowel Disease
Inflammatory Bowel Diseases
Crohn's Disease; Ulcerative Colitis
Rheumatoid Arthritis
Ulcerative Colitis
Rheumatoid Arthritis; Ankylosing Spondylitis; Ulcerative Colitis; Crohn's Disease
Rheumatoid Arthritis
Inflammatory Bowel Diseases
Inflammatory Bowel Diseases
Rheumatoid Arthritis
Inflammatory Bowel Diseases; Crohn Disease; Fistulizing Crohn's Disease; Ulcerative Colitis
Ulcerative Colitis; Protein Metabolism; Energy Expenditure
Ankylosing Spondylitis
Crohn's Disease
Rheumatoid Arthritis
Inflammatory Bowel Diseases
Psoriasis
Rheumatoid Arthritis
Colitis, Ulcerative; Bowel Diseases, Inflammatory
Rheumatoid Arthritis (RA)
Crohn's Disease; IBD
Rheumatoid Arthritis
Inflammatory Bowel Disease; Crohn's Disease
Arthritis, Rheumatoid
Ulcerative Colitis
Psoriasis
Spondyloarthritis; Ultrasonography
Crohn's Disease
Inflammatory Bowel Diseases; Crohn Disease; Polyunsaturated Acid Lipidosis
Rheumatoid Arthritis; Spondyloarthritis; Crohn's Disease; Uveitis
Pediatric Acute Severe Colitis
RheumatoId Arthritis
Study Phase
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Early Phase 1
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Recruitment Status
Recruiting
Active, not recruiting
Recruiting
Unknown status
Terminated
Completed
Unknown status
Recruiting
Completed
Completed
Completed
Unknown status
Completed
Completed
Completed
Completed
Unknown status
Completed
Terminated
Completed
Active, not recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Withdrawn
Completed
Completed
Completed
Completed
Terminated
Completed
Unknown status
Terminated
Completed
Terminated
Terminated
Recruiting
Unknown status
Unknown status
Recruiting
Not yet recruiting
Completed
Completed
Completed
Terminated
Completed
Completed
Completed
Recruiting
Unknown status
Recruiting
Active, not recruiting
Completed
Unknown status
Completed
Completed
Completed
Completed
Unknown status
Recruiting
Unknown status
Completed
Recruiting
Terminated
Unknown status
Withdrawn
Completed
Active, not recruiting
Completed
Completed
Completed
Completed
Completed
Recruiting
Completed
Recruiting
Unknown status
Completed
Completed
Completed
Recruiting
Active, not recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Terminated
Completed
Completed
Completed
Completed
Completed
Withdrawn
Completed
Completed
Completed
Completed
Unknown status
Unknown status
Completed
Terminated
Withdrawn
Completed
Completed
Completed
Completed
Completed
Completed
Terminated
Completed
Completed
Completed
Completed
Completed
Recruiting
Not yet recruiting
Completed
Completed
Completed
Terminated
Completed
Recruiting
Completed
Unknown status
Completed
Completed
Terminated
Unknown status
Completed
Completed
Completed
Terminated
Completed
Recruiting
Completed
Completed
Terminated
Terminated
Completed
Completed
Recruiting
Completed
Terminated
Terminated
Completed
Not yet recruiting
Completed
Completed
Completed
Completed
Terminated
Completed
Unknown status
Withdrawn
Completed
Completed
Unknown status
Unknown status
Terminated
Terminated
Completed
Unknown status
Completed
Completed
Completed
Completed
Terminated
Completed
Completed
Completed
Completed
Completed
Terminated
Completed
Completed
Completed
Completed
Recruiting
Withdrawn
Terminated
Completed
Completed
Recruiting
Suspended
Terminated
Completed
Unknown status
Withdrawn
Completed
Terminated
Completed
Completed
Completed
Active, not recruiting
Not yet recruiting
Withdrawn
Completed
Completed
Withdrawn
Terminated
Completed
Withdrawn
Terminated
Withdrawn
Unknown status
Recruiting
Withdrawn
Recruiting
Completed
Recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Unknown status
Completed
Not yet recruiting
Unknown status
Completed
Recruiting
Terminated
Terminated
Unknown status
Completed
Recruiting
Recruiting
Completed
Completed
Unknown status
Recruiting
Completed
Completed
Terminated
Recruiting
Completed
Active, not recruiting
Unknown status
Completed
Unknown status
Completed
Completed
Completed
Unknown status
Recruiting
Completed
Completed
Recruiting
Recruiting
Recruiting
Completed
Unknown status
Completed
Completed
Recruiting
Recruiting
Completed
Completed
Completed
Completed
Unknown status
Active, not recruiting
Unknown status
Unknown status
Completed
Completed
Unknown status
Unknown status
Completed
Active, not recruiting
Completed
Recruiting
Completed
Completed
Completed
Terminated
Unknown status
Completed
Completed
Completed
Completed
Terminated
Not yet recruiting
Unknown status
Completed
Completed
Completed
Completed
Enrolling by invitation
Completed
Completed
Terminated
Completed
Unknown status
Completed
Completed
Terminated
Unknown status
Recruiting
Completed
Completed
Completed
Completed
Not yet recruiting
Withdrawn
Withdrawn
Completed
Enrolling by invitation
Withdrawn
Recruiting
Active, not recruiting
Completed
Unknown status
Recruiting
Terminated
Completed
Completed
Terminated
Completed
Completed
Recruiting
Completed
Completed
Unknown status
Unknown status
Completed
Completed
Completed
Completed
Completed
Unknown status
Recruiting
Recruiting
Completed
Unknown status
Completed
Terminated
Unknown status
Recruiting
Completed
Unknown status
Completed
Unknown status
Completed
Recruiting
Recruiting
Completed
Unknown status
Completed
Unknown status
Completed
Terminated
Recruiting
Terminated
Completed
Active, not recruiting
Recruiting
Completed
Completed
Terminated
Recruiting
Completed
Unknown status
Completed
Completed
Completed
Completed
Completed
Not yet recruiting
Unknown status
Completed
Terminated
Etanercept biosimilar (AryoGen Biopharma)
Approved
Aryogen Biopharma
Spondylitis, Ankylosing, Arthritis, Rheumatoid, Arthritis, Juvenile, Psoriasis, Arthritis, Psoriatic
Etanercept biosimilar (Shanghai CP Guojian Pharmaceutical)
301S
Approved
Shanghai Cp Guojian Pharmaceutical Co Ltd, Cipla Gmbh
Arthritis, Rheumatoid, Spondylitis, Ankylosing, Psoriasis
NCT Number
NCT02960035
NCT02364479
NCT03411798
NCT01394913
NCT04345458
NCT03589833
Intervention Type
Drug
Drug
Drug
Drug
Drug
Drug
Indications
Spondyloarthropathy
Spondyloarthritis
Ankylosing Spondylitis
Rheumatoid Arthritis
Ankylosing Spondylitis
Arthritis, Rheumatoid
Study Phase
Phase 4
Phase 4
Phase 4
Phase 3
Phase 3
Phase 2
Recruitment Status
Completed
Completed
Completed
Withdrawn
Completed
Unknown status
Infliximab (dyyb)
CT-P13
Approved
Celltrion
Spondylitis, Ankylosing, Arthritis, Rheumatoid, Psoriasis, Arthritis, Psoriatic, Colitis, Ulcerative, Urologic Neoplasms, Crohn Disease
NCT Number
NCT02452151
NCT02148640
NCT03707535
NCT02096861
NCT01217086
NCT03945019
NCT03147248
NCT04205643
NCT04438382
NCT02883452
NCT01220518
NCT01571206
NCT03729674
NCT02539368
NCT03801928
NCT03016260
NCT02605642
NCT03681652
NCT04378621
Intervention Type
Drug
Drug
Biological
Biological
Drug
Other, Biological
Biological
Other, Biological
Other, Biological, Drug
Biological
Drug
Biological
Drug
Drug
Drug
Biological
Drug
Drug
Other, Drug
Indications
Colitis, Ulcerative; Crohn's Disease
Rheumatoid Arthritis; Spondyloarthritis; Psoriatic Arthritis; Ulcerative Colitis; Crohn's Disease; Psoriasis Chronic
Rheumatoid Arthritis
Crohn's Disease
Rheumatoid Arthritis
Crohn's Disease
Rheumatoid Arthritis
Ulcerative Colitis
Hematopoietic and Lymphoid Cell Neoplasm; Malignant Solid Neoplasm; Steroid-Refractory Pneumonitis
Crohn's Disease; Ulcerative Colitis (Part 2 Only)
Ankylosing Spondylitis
Ankylosing Spondylitis
Rheumatoid Arthritis; Ankylosing Spondylitis; Ulcerative Colitis; Crohn's Disease
Inflammatory Bowel Diseases; Ulcerative Colitis; Crohn's Disease
Inflammatory Bowel Disease (IBD); Crohn's Disease (CD); Ulcerative Colitis (UC)
RheumatoId Arthritis
Rheumatoid Diseases; Rheumatoid Arthritis; Ankylosing Spondylitis; Psoriatic Arthritis
Crohn Disease
Rheumatoid Arthritis; Pain; Fatigue; Cognitive Decline; Depression; Brain Diseases; Hand Rheumatism
Study Phase
Phase 4
Phase 4
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 2
Phase 1
Phase 1
Phase 1
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Recruitment Status
Unknown status
Completed
Active, not recruiting
Completed
Completed
Recruiting
Completed
Recruiting
Recruiting
Completed
Completed
Completed
Recruiting
Completed
Completed
Terminated
Completed
Recruiting
Not yet recruiting
Etanercept biosimilar (Hanwha Chemical)
HD-203, MK-8953
Approved
Hanwha Chemical
Spondylitis, Ankylosing, Arthritis, Rheumatoid, Psoriasis, Arthritis, Psoriatic
NCT Number
NCT01270997
NCT01431404
NCT01894412
NCT01044836
Intervention Type
Biological
Biological
Biological
Biological
Indications
Rheumatoid Arthritis
Healthy
Healthy
Healthy
Study Phase
Phase 3
Phase 1
Phase 1
Phase 1
Recruitment Status
Completed
Completed
Completed
Completed
Adalimumab biosimilar (Bio-Thera Solutions)
BAT-1406
Approved
Bio-Thera Solutions Ltd
Spondylitis, Ankylosing, Arthritis, Rheumatoid, Psoriasis, Uveitis, Crohn Disease
NCT Number
NCT04135508
Intervention Type
Drug
Indications
Ankylosing Spondylitis
Study Phase
Phase 3
Recruitment Status
Completed
Infliximab biosimilar (Bionovis/The Instituto Vital Brazil)
Approved
Bionovis, The Instituto Vital Brazil
Arthritis, Rheumatoid, Spondylitis, Ankylosing, Psoriasis, Arthritis, Psoriatic, Colitis, Ulcerative, Crohn Disease
NCT Number
NCT00902811
Intervention Type
Drug
Indications
Uncomplicated Falciparum Malaria
Study Phase
Phase 4
Recruitment Status
Unknown status
Adalimumab biosimilar (Innovent Biologics)
IBI-303
Approved
Innovent Biologics(Suzhou) Co Ltd
Arthritis, Rheumatoid, Spondylitis, Ankylosing, Psoriasis
NCT Number
NCT02893254
Intervention Type
Drug
Indications
AS
Study Phase
Phase 3
Recruitment Status
Completed
Adalimumab biosimilar (Shanghai Henlius Biotech)
HLX-03
Approved
Shanghai Henlius Biotech Co Ltd
Arthritis, Rheumatoid, Spondylitis, Ankylosing, Psoriasis, Plaque psoriasis
NCT Number
NCT03316781
NCT03357939
Intervention Type
Drug
Drug
Indications
Plaque Psoriasis
Immune System Disorder
Study Phase
Phase 3
Phase 1
Recruitment Status
Unknown status
Completed
Adalimumab biosimilar (Samsung Bioepis)
SB-5
Approved
Samsung Bioepis
Spondylitis, Ankylosing, Arthritis, Rheumatoid, Arthritis, Juvenile, Psoriasis, Arthritis, Psoriatic, Colitis, Ulcerative, Hidradenitis Suppurativa, Uveitis, Crohn Disease
NCT Number
NCT04045782
NCT02167139
NCT02565810
NCT02326233
NCT02144714
NCT04089514
NCT04378621
Intervention Type
Drug
Drug
Drug
Biological
Biological
Drug
Other, Drug
Indications
Inflammatory Bowel Diseases
Rheumatoid Arthritis
Rheumatoid Arthritis
Healthy
Healthy
Arthritis, Rheumatoid (RA); Axial Spondyloarthritis (axSpA); Arthritis, Psoriatic (PsA); Crohn's Disease (CD); Colitis, Ulcerative (UC)
Rheumatoid Arthritis; Pain; Fatigue; Cognitive Decline; Depression; Brain Diseases; Hand Rheumatism
Study Phase
Phase 4
Phase 3
Phase 2
Phase 1
Phase 1
N/A
N/A
Recruitment Status
Recruiting
Completed
Completed
Completed
Completed
Active, not recruiting
Not yet recruiting
Adalimumab biosimilar (Hisun Pharma)
HS-016
Approved
Zhejiang Hisun Pharmaceutical Co Ltd
Spondylitis, Ankylosing, Arthritis, Rheumatoid
Adalimumab biosimilar (Celltrion)
CT-P17
Approved
Celltrion
Spondylitis, Ankylosing, Arthritis, Rheumatoid, Arthritis, Juvenile, Psoriasis, Arthritis, Psoriatic, Colitis, Ulcerative, Uveitis, Hidradenitis Suppurativa, Crohn Disease
NCT Number
NCT04171414
NCT04295356
NCT03970824
Intervention Type
Biological
Biological
Biological
Indications
Rheumatoid Arthritis
Healthy
Healthy
Study Phase
Phase 3
Phase 1
Phase 1
Recruitment Status
Recruiting
Completed
Completed
Adalimumab biosimilar (Zydus Cadila)
Approved
Zydus Cadila
Spondylitis, Ankylosing, Arthritis, Rheumatoid, Arthritis, Juvenile, Arthritis, Psoriatic
Infliximab biosimilar (Amgen)
ABP-710
Approved
Amgen Inc
Arthritis, Rheumatoid, Pediatric Crohn's disease, Spondylitis, Ankylosing, Pediatric ulcerative colitis, Colitis, Ulcerative, Arthritis, Psoriatic, Crohn Disease
NCT Number
NCT02937701
NCT04305145
Intervention Type
Biological
Drug
Indications
Arthritis, Rheumatoid
Melanoma Stage III; Melanoma Stage IV; Side Effect of Drug; Colitis
Study Phase
Phase 3
Phase 2
Recruitment Status
Completed
Recruiting
Adalimumab biosimilar (Biocad)
BCD-057
Approved
Biocad
Psoriasis
NCT Number
NCT02762955
NCT02395055
Intervention Type
Biological
Drug
Indications
Psoriasis
Healthy
Study Phase
Phase 3
Phase 1
Recruitment Status
Unknown status
Completed
Etanercept biosimilar (Shanghai Celgen)
Approved
Shanghai Celgen Bio-Pharmaceutical Co Ltd
Psoriasis
Adalimumab biosimilar (Reliance Life Sciences)
R-TPR-021
Approved
Reliance Life Sciences
Arthritis, Rheumatoid, Spondylitis, Ankylosing, Psoriasis, Colitis, Ulcerative, Arthritis, Psoriatic
Thalidomide
K-17, NSC-66847, NSC-527179
Approved
Celgene Corp
HIV Infections, Spondylitis, Ankylosing, Myelodysplastic Syndromes, Multiple Myeloma, Erythema Nodosum, HIV Wasting Syndrome, Leprosy, Lepromatous, Carcinoma, Hepatocellular
NCT Number
NCT00652041
NCT03122431
NCT02778893
NCT02844309
NCT02844361
NCT00314665
NCT02858804
NCT01640639
NCT00390247
NCT04612582
NCT02401971
NCT01664975
NCT02559154
NCT01638078
NCT01249690
NCT03777930
NCT00432458
NCT00083876
NCT02248428
NCT00367185
NCT00049673
NCT00644306
NCT00028886
NCT00720538
NCT01134484
NCT00602511
NCT01554852
NCT00734877
NCT00910897
NCT03318835
NCT00787436
NCT00461747
NCT00050843
NCT01858571
NCT00217438
NCT00305552
NCT00452569
NCT00507416
NCT00005834
NCT00038233
NCT02748772
NCT00075829
NCT00892346
NCT00061919
NCT00232934
NCT00083915
NCT01659658
NCT00005966
NCT00633542
NCT00215943
NCT00057564
NCT00921531
NCT02707484
NCT00222053
NCT00600028
NCT00934154
NCT00111319
NCT00097981
NCT00004635
NCT00256776
NCT00098475
NCT00004859
NCT01070862
NCT00529633
NCT00572169
NCT00083551
NCT00033254
NCT00207805
NCT01532856
NCT00041080
NCT00225290
NCT00033332
NCT00218855
NCT03016000
NCT00416897
NCT00111748
NCT01539083
NCT01971658
NCT02203253
NCT00443235
NCT00573391
NCT03402295
NCT02085655
NCT01063179
NCT03221166
NCT00728078
NCT02532738
NCT01438450
NCT02387086
NCT00205751
NCT00038090
NCT00657488
NCT04453345
NCT01094340
NCT00934739
NCT04273581
NCT00006226
NCT00310076
NCT00015990
NCT00079092
NCT02447679
NCT00162760
NCT00319865
NCT00140452
NCT00531453
NCT00389935
NCT00165230
NCT00072345
NCT00039468
NCT00165451
NCT00961467
NCT00015912
NCT00006016
NCT00505635
NCT03069326
NCT02879526
NCT00064337
NCT00523848
NCT00000790
NCT01341262
NCT00226980
NCT00112879
NCT00053287
NCT00142116
NCT03004287
NCT00003894
NCT00016224
NCT00521482
NCT00112502
NCT00053300
NCT00089544
NCT00179881
NCT00001599
NCT02501291
NCT00276705
NCT01779167
NCT00121563
NCT03341494
NCT00450008
NCT00025285
NCT00025506
NCT00004088
NCT00958854
NCT00026520
NCT00054158
NCT00027664
NCT00083707
NCT00777998
NCT00083005
NCT00400517
NCT00953615
NCT00723658
NCT00445900
NCT00004276
NCT03140943
NCT03393273
NCT00072163
NCT00538824
NCT00089167
NCT00577668
NCT00026416
NCT03896737
NCT01356290
NCT03184844
NCT00519688
NCT00238329
NCT00231140
NCT00379353
NCT02995707
NCT00964496
NCT00276744
NCT00281827
NCT00274820
NCT00349115
NCT02586038
NCT00538733
NCT00026533
NCT02410694
NCT00577512
NCT00083408
NCT02733380
NCT00019539
NCT00004876
NCT01328236
NCT00047879
NCT00670631
NCT01055301
NCT00053001
NCT01485224
NCT00083538
NCT03608501
NCT04352205
NCT00193544
NCT04680195
NCT00458705
NCT00287872
NCT00469703
NCT04120519
NCT00003850
NCT02301949
NCT00027638
NCT03208413
NCT00025519
NCT00307294
NCT04273529
NCT00193102
NCT00182663
NCT00209014
NCT00089609
NCT00030550
NCT00083577
NCT01756989
NCT02128230
NCT03043105
NCT01527032
NCT00038181
NCT02201043
NCT00046826
NCT00015821
NCT00151281
NCT00124813
NCT00058487
NCT00357500
NCT00049361
NCT01548573
NCT00378755
NCT02891811
NCT00033709
NCT01891019
NCT00006358
NCT00284505
NCT00025220
NCT00040937
NCT00856804
NCT00358020
NCT00792142
NCT00384800
NCT01526694
NCT00001524
NCT00083382
NCT00008242
NCT00124579
NCT00251511
NCT02966522
NCT00017316
NCT00025467
NCT00098865
NCT03273452
NCT00320476
NCT00450801
NCT00022581
NCT00263484
NCT00222105
NCT00869232
NCT00019747
NCT00049374
NCT02507336
NCT00053430
NCT01274403
NCT00438841
NCT03062800
NCT00455910
NCT00001680
NCT00201357
NCT00001446
NCT00083681
NCT00003754
NCT03335098
NCT00227682
NCT00104988
NCT01551641
NCT00090870
NCT00083694
NCT00412542
NCT00009984
NCT00002127
NCT00020046
NCT02424851
NCT00747123
NCT00250796
NCT00047294
NCT02022033
NCT00075023
NCT00083902
NCT01632150
NCT00113932
NCT00006006
NCT00373646
NCT00081939
NCT00006198
NCT00769587
NCT01125176
NCT04382300
NCT01775553
NCT00890188
NCT00047281
NCT00006200
NCT02754960
NCT00006890
NCT00114192
NCT00301405
NCT02649101
NCT01976195
NCT01849783
NCT00022607
NCT00165217
NCT01114048
NCT00019123
NCT00871013
NCT00006005
NCT03980002
NCT00966693
NCT01057225
NCT00155272
NCT00971126
NCT01061866
NCT00096018
NCT02145715
NCT01242267
NCT00406978
NCT00277017
NCT00081757
NCT02545907
NCT00005815
NCT00038246
NCT01420432
NCT00052416
NCT01028781
NCT00251797
NCT00014443
NCT00000812
NCT01998971
NCT00083460
NCT02870036
NCT00527657
NCT01937442
NCT00002104
NCT01661400
NCT02467647
NCT00062127
NCT00418132
NCT00258245
NCT00049296
NCT01537861
NCT02956538
NCT01697839
NCT00899080
NCT02998827
NCT00023530
NCT00577096
NCT01924624
NCT03089411
NCT00002157
NCT00004450
NCT01268774
NCT00907452
NCT03601871
NCT00002392
NCT03723083
NCT00002174
NCT01927718
NCT02293681
Intervention Type
Drug
Drug
Drug
Drug
Other
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other, Drug
Drug
Drug
Drug
Drug
Drug
Drug
Procedure, Biological, Drug
Drug
Procedure, Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Procedure, Drug, Genetic
Drug
Drug
Drug
Biological, Drug
Drug
Drug
Procedure, Drug, Behavioral
Procedure
Drug
Drug
Drug
Drug
Biological, Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other, Drug
Drug
Other, Drug
Radiation, Drug
Drug
Other, Drug
Drug
Drug
Procedure, Radiation, Drug
Procedure
Drug
Other, Drug
Drug
Drug
Drug
Other, Drug
Procedure, Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other, Biological, Drug
Other, Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other, Drug
Procedure, Drug
Other, Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other, Biological, Drug
Other, Drug
Drug
Drug
Drug
Procedure, Biological, Drug
Drug
Drug
Drug
Drug
Procedure, Drug
Drug
Drug
Procedure, Drug
Drug
Drug
Drug
Drug
Procedure, Drug
Procedure, Other, Radiation, Biological, Drug
Procedure, Drug
Drug
Drug
Procedure, Drug
Drug
Drug
Drug
Drug
Drug
Other, Drug
Procedure, Biological, Drug
Other, Drug
Biological, Drug
Drug
Biological, Drug
Drug
Procedure
Drug
Procedure, Biological, Drug
Drug
Procedure, Biological, Drug
Other, Procedure, Drug
Drug
Drug
Drug
Drug
Drug
Biological, Drug
Drug
Procedure, Biological, Drug
Drug
Drug
Drug
Drug
Biological, Drug
Drug
Drug
Drug
Drug
Procedure, Biological, Drug
Procedure, Drug
Drug, Dietary Supplement
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological, Drug
Combination Product
Other, Procedure, Drug, Genetic
Biological, Drug
Drug
Drug
Drug
Biological, Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other, Drug
Drug
Drug
Procedure, Biological, Radiation, Drug
Drug
Drug
Drug
Drug
Drug
Other, Biological, Drug, Genetic
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other, Drug
Drug
Drug
Drug
Drug
Radiation, Drug
Procedure, Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other, Drug
Procedure, Biological, Drug
Drug
Drug
Other, Procedure, Drug, Genetic
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other, Drug
Drug
Drug
Drug
Drug
Other, Drug
Drug
Drug
Drug
Procedure, Other, Drug
Biological, Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug, Dietary Supplement
Drug
Other, Drug
Biological, Drug
Drug
Procedure, Drug
Drug
Drug
Drug
Drug
Biological
Drug
Procedure, Drug
Drug
Drug
Drug
Biological
Procedure
Biological, Drug
Drug
Drug
Procedure, Drug
Drug
Biological, Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Procedure, Drug
Biological, Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other, Drug
Drug
Drug, Dietary Supplement
Drug
Drug
Drug
Other, Genetic
Other, Drug
Procedure, Drug
Biological, Drug, Behavioral
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug, Behavioral
Drug
Indications
Multiple Myeloma
Systemic Lupus Erythematosus (SLE); Juvenile SLE; Cutaneous Lupus
NSCLC
Waldenström Macroglobulinemia
Waldenström Macroglobulinemia
Uveitis
Mantle Cell Lymphoma
Congestive Heart Failure
Peritoneal Dialysis; Malnutrition
Immunoglobulin Light-Chain Amyloidosis
Gastric Cancer
Peripheral T-cell Lymphoma
Multiple Myeloma
Coronary Artery Disease
Multiple Myeloma
Cancer, Therapy-Related
Multiple Myeloma and Plasma Cell Neoplasm
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma and Plasma Cell Neoplasm
Newly Diagnosed, Multiple Myeloma
Multiple Myeloma and Plasma Cell Neoplasm
Inflammatory Bowel Diseases; Crohn's Disease; Ulcerative Colitis
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Thalidomide
Gastrointestinal Hemorrhage; Portal Hypertension
Multiple Myeloma
Myelodysplastic Syndromes
Malignant Childhood Neoplasm
Refractory Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma
Sarcoidosis
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Colorectal Neoplasms
Multiple Myeloma
Multiple Myeloma
Lung Cancer
Multiple Myeloma
Multiple Myeloma
Relapsed or Refractory Systemic Light Chain Amyloidosis
Kidney Cancer
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Hepatocellular Carcinoma
Gastrointestinal Vascular Malformation
Multiple Myeloma
Idiopathic Pulmonary Fibrosis; Cough
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Prostate Cancer
Multiple Myeloma
DS Stage I Plasma Cell Myeloma; DS Stage II Plasma Cell Myeloma; DS Stage III Plasma Cell Myeloma
Lung Cancer
Multiple Myeloma de Novo Treatment
Hypoalbuminemia
Multiple Myeloma
Multiple Myeloma
Tumors Metastatic to Brain
Multiple Myeloma
Multiple Myeloma
Fallopian Tube Cancer; Primary Peritoneal Cavity Cancer; Recurrent Ovarian Epithelial Cancer; Stage III Ovarian Epithelial Cancer; Stage IV Ovarian Epithelial Cancer
Carcinoma, Hepatocellular
Multiple Myeloma and Plasma Cell Neoplasm
Multiple Myeloma
Lymphoma, Large B-Cell, Diffuse
Multiple Myeloma and Plasma Cell Neoplasm; Renal Failure
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Neoplasms
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma; Effects of Chemotherapy
Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type
Multiple Myeloma
Crohn Disease
Hepatocellular Carcinoma; Liver Cancer
Crohn's Disease
Hepatocellular Carcinoma
NSCLC
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
T-LGL Leukemia; Clpd-Nk
Alzheimer's Disease
Oral Cavity Cancer
COVID-19 Thalidomide
B-cell Chronic Lymphocytic Leukemia; Refractory Chronic Lymphocytic Leukemia
Carcinoma of the Appendix; Colorectal Cancer
Chronic Myelomonocytic Leukemia; de Novo Myelodysplastic Syndromes; Previously Treated Myelodysplastic Syndromes; Refractory Anemia; Refractory Anemia With Excess Blasts; Refractory Anemia With Excess Blasts in Transformation; Refractory Anemia With Ringed Sideroblasts; Secondary Myelodysplastic Syndromes
Brain and Central Nervous System Tumors
Adult Hepatocellular Carcinoma; Recurrent Hepatocellular Carcinoma; Adverse Reaction to Drug; Vascular Endothelial Growth Factor Overexpression
Idiopathic Pulmonary Fibrosis (IPF)
Multiple Myeloma
Amyotrophic Lateral Sclerosis; ALS
Multiple Myeloma
Arteriovenous Malformation; Hereditary Hemorrhagic Telangiectasia; Hematochezia; Melena
Neuroendocrine Tumor
Intraocular Melanoma; Melanoma (Skin)
Brain and Central Nervous System Tumors
Neoplasms
Multiple Myeloma
Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma
Adult Primary Hepatocellular Carcinoma; Advanced Adult Primary Liver Cancer; Localized Unresectable Adult Primary Liver Cancer
Melanoma
Myelofibrosis
Relapse/Refratory Peripheral T Cell Lymphoma
Multiple Myeloma; Plasma Cell Myeloma
Multiple Myeloma and Plasma Cell Neoplasm
HIV Infections; Stomatitis, Aphthous
Multiple Myeloma
Kidney Neoplasms
Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma; Refractory Plasma Cell Neoplasm
Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
Waldenstrom's Macroglobulinemia; Lymphoplasmacytic Lymphoma
Multiple Myeloma
Graft Versus Host Disease; Unspecified Adult Solid Tumor, Protocol Specific; Unspecified Childhood Solid Tumor, Protocol Specific
Ovarian Cancer
Glioblastoma
Brain and Central Nervous System Tumors
Lung Cancer
Recurrent Adult Soft Tissue Sarcoma; Stage I Adult Soft Tissue Sarcoma AJCC v7; Stage II Adult Soft Tissue Sarcoma AJCC v7; Stage III Adult Soft Tissue Sarcoma AJCC v7
Brain Stem Neoplasms, Primary; Neoplasms, Brain Stem
Sjogren's Syndrome; Xerostomia
Crohn's Disease
Liver Cancer
Waldenstrom Macroglobulinemia
Pain
NSCLC Stage IV; Chemotherapy Effect
Prostatic Neoplasms
Lung Cancer
Recurrent Uterine Corpus Sarcoma; Uterine Carcinosarcoma
Multiple Myeloma and Plasma Cell Neoplasm
Lymphoma
Melanoma (Skin)
Multiple Myeloma and Plasma Cell Neoplasm
Kidney Cancer
Waldenstrom Macroglobulinemia
Multiple Myeloma
Prostate Cancer
Prostate Cancer
Primary Sclerosing Cholangitis
Lymphoma
Chronic Myeloproliferative Disorders; Secondary Myelofibrosis
HIV Infections; Mycobacterium Infections; Tuberculosis
Relapsed and/or Refractory Multiple Myeloma
Multiple Myeloma
Recurrent Melanoma; Stage IV Melanoma; Tumors Metastatic to Brain
Multiple Myeloma
Multiple Myeloma and Plasma Cell Neoplasm
Multiple Myeloma
Sarcoma
Multiple Myeloma
Medulloblastoma Recurrent; Ependymoma Recurrent; ATRT Recurrent
Thalassemia
Hepatocellular Carcinoma
Intraocular Melanoma; Melanoma (Skin)
Amyotrophic Lateral Sclerosis (ALS)
Advanced Cancers
Thalassemia
Obscure Gastrointestinal Bleeding; Angiodysplasia; Gastric Antral Vascular Ectasia; Thalidomide
Pancreatic Cancer
Lung Cancer
Chronic Myeloproliferative Disorders; Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Head and Neck Cancer
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Diffuse Large B-cell Lymphoma
Stage IV Renal Cell Cancer; Recurrent Renal Cell Cancer
Ovarian Cancer
Plasma Cell Leukemia; Multiple Myeloma
Glioma
Multiple Myeloma
Multiple Myeloma; Plasma Cell Myeloma
Anemia; Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms
Hereditary Hemorrhagic Telangiectasia; Epistaxis
Multiple Myeloma
Multiple Myeloma
Plasma Cell Myeloma; Renal Failure
Multiple Myeloma
Chronic Radiation Proctitis
Multiple Myeloma and Plasma Cell Neoplasm
Multiple Myeloma
Chronic Pancreatitis
Langerhans Cell Histiocytosis
Head and Neck Cancer
Gastrointestinal Bleeding of Unknown Origin; Gastrointestinal Vascular Malformation; Thalidomide Efficiency
Gastrointestinal Carcinoid Tumor; Islet Cell Tumor; Lung Cancer; Neoplastic Syndrome
Radiation Injuries
Kidney Cancer
Prostate Cancer
COVID-19 Thalidomide
Breast Cancer
Refractory Multiple Myeloma; Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma
B-Cell Lymphoma; Hodgkin's Disease
Prostatic Neoplasms
Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms
Multiple Myeloma
Brainstem Glioma
Multiple Myeloma
Multicentric Castleman Disease
Amyloidosis
Prostate Cancer
Ankylosing Spondylitis
Prostate Cancer
Primary Myelofibrosis
Non-Hodgkin's Lymphoma
Multiple Myeloma
Liver Cancer
Central Nervous System Tumor, Pediatric; Leukemia; Lymphoma; Neuroblastoma; Sarcoma; Unspecified Childhood Solid Tumor, Protocol Specific
Brain and Central Nervous System Tumors; Unspecified Adult Solid Tumor, Protocol Specific
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Sarcoma
Psoriasis, Plaque-type
Brain and Central Nervous System Tumors
Arachnoiditis
Recurrent Uterine Corpus Sarcoma; Uterine Corpus Leiomyosarcoma
Multiple Myeloma
Hepatitis C
Multiple Myeloma
Multiple Myeloma and Plasma Cell Neoplasm; Neurotoxicity
Carcinoma, Hepatocellular
Multiple Myeloma
Acquired Immunodeficiency Syndrome; Burning Mouth Syndrome; HIV Infection
Multiple Myeloma
Multiple Myeloma and Plasma Cell Neoplasm
Multiple Myeloma
Myelodysplastic Syndrome
Cardiac Amyloidosis
Melanoma (Skin)
Endometrial Adenoacanthoma; Endometrial Adenocarcinoma; Endometrial Adenosquamous Cell Carcinoma; Endometrial Clear Cell Carcinoma; Endometrial Papillary Serous Carcinoma; Recurrent Endometrial Carcinoma
Central Nervous System Tumor, Pediatric; Neuroblastoma
Angioimmunoblastic T-cell Lymphoma
Multiple Myeloma
Lymphoma
Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Small Lymphocytic Lymphoma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Colorectal Cancer
Multiple Myeloma and Plasma Cell Neoplasm
Mantle Cell Lymphoma; Non-Hodgkin's Lymphoma
HIV Infections
Multiple Myeloma
Multiple Myeloma and Plasma Cell Neoplasm
Advanced Nsclc
Myelodysplastic Syndromes
Discoid Lupus Erythematosus
Hormone-refractory Prostate Cancer
Prostatic Neoplasm
Multiple Myeloma
Unspecified Childhood Solid Tumor, Protocol Specific
Waldenstrom Macroglobulinemia; Lymphoplasmacytic Lymphoma
Multiple Myeloma and Plasma Cell Neoplasm
Melanoma (Skin)
Esophageal Cancer
Kidney Cancer
Leukemia
Glioblastoma Multiforme; Glioma
Recurrent Small Lymphocytic Lymphoma; Refractory Chronic Lymphocytic Leukemia
HIV Infections; HIV Wasting Syndrome
Stage IV Prostate Cancer; Adenocarcinoma of the Prostate; Recurrent Prostate Cancer
Multiple Myeloma; Chronic Kidney Disease
Multiple Myeloma
Liver; Cancer
Brain and Central Nervous System Tumors
Pancreatic Cancer
Graft-versus-Host Disease; Stomatitis
Multiple Myeloma
Relapsed and/or Refractory Multiple Myeloma
Multiple Myeloma
Liver Cancer
MALT Lymphoma
Multiple Myeloma
Liver Cancer
Non Neoplastic Condition; Precancerous Condition
Chronic Lymphocytic Leukemia
Non-small-cell Lung Cancer
Relapse Multiple Myeloma; Refractory Multiple Myeloma
Colon Cancer
Brain and Central Nervous System Tumors
Melanoma
Gastrointestinal Hemorrhage; Vascular Malformation
Multiple Myeloma and Plasma Cell Neoplasm
Lung Cancer
Chronic Prostatitis; Pelvic Pain
Metastatic Breast Cancer
Immune Thrombocytopenia
Extramedullary Plasmacytoma; Isolated Plasmacytoma of Bone; Light Chain Deposition Disease; Primary Systemic Amyloidosis; Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma
Multiple Myeloma and Plasma Cell Neoplasm
Colorectal Adenocarcinoma
Multiple Myeloma
Sarcoma
Myeloma
Endometrial Cancer; Sarcoma
Chronic Lymphocytic Leukemia
Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma
Multiple Myeloma; Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma
Hepatocellular Carcinoma
Hepatocellular Carcinoma
Refractory Epilepsy
Leukemia
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Kidney; Cancer
Multiple Myeloma
Amyloidosis
Intraocular Melanoma; Melanoma (Skin)
Prostate Cancer
Ankylosing Spondylitis
Leukemia; Lymphoma
Endometriosis
Brain and Nervous System; Cancer
Brain and Central Nervous System Tumors
HIV Infections
Multiple Myeloma
Multiple Myeloma
Advanced Solid Tumor; Advanced/Metastatic Colorectal Cancer
Brain Neoplasms; Melanoma
Multiple Myeloma
Mycobacterium Avium-Intracellulare Infection; HIV Infections; Tuberculosis, Mycobacterium Infection
Glioma; Neuroectodermal Tumors, Primitive; Wilms Tumor; Rhabdomyosarcoma; Sarcoma, Ewing; Osteosarcoma; Retinoblastoma
Multiple Myeloma
Unspecified Adult Solid Tumor, Protocol Specific
Scleroderma, Systemic
Multiple Myeloma and Plasma Cell Neoplasm
Cancer
Multiple Myeloma
Crohn Disease
Multiple Myeloma; Peripheral Neuropathy
Multiple Myeloma and Plasma Cell Neoplasm
Crohn Disease
Bone Marrow Transplantation; Blood Disease; Hematopoietic Stem Cell Transplantation; Leukemia; Multiple Myeloma; Myelodysplastic Syndromes; Graft vs Host Disease
Multiple Myeloma
Hepatocellular Carcinoma; Recurrence
Myeloma Multiple
HIV Infections; HIV Wasting Syndrome
Adrenoleukodystrophy
Multiple Myeloma
Myeloma
Chemotherapy-induced Nausea and Vomiting
HIV Infections
Dermatologic; Other
HIV Infections
Myeloma
Spondylitis, Ankylosing
Study Phase
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Early Phase 1
Early Phase 1
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Recruitment Status
Completed
Recruiting
Unknown status
Unknown status
Unknown status
Terminated
Unknown status
Unknown status
Withdrawn
Recruiting
Unknown status
Completed
Unknown status
Unknown status
Unknown status
Not yet recruiting
Completed
Completed
Unknown status
Completed
Completed
Terminated
Unknown status
Completed
Unknown status
Completed
Active, not recruiting
Active, not recruiting
Unknown status
Unknown status
Withdrawn
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Terminated
Completed
Unknown status
Completed
Suspended
Completed
Completed
Completed
Active, not recruiting
Completed
Completed
Terminated
Completed
Unknown status
Recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Terminated
Active, not recruiting
Terminated
Completed
Terminated
Active, not recruiting
Completed
Completed
Completed
Unknown status
Completed
Terminated
Completed
Completed
Recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Terminated
Completed
Recruiting
Completed
Terminated
Unknown status
Unknown status
Unknown status
Unknown status
Completed
Completed
Completed
Recruiting
Unknown status
Terminated
Not yet recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Unknown status
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Terminated
Completed
Terminated
Recruiting
Recruiting
Completed
Completed
Completed
Completed
Completed
Withdrawn
Completed
Completed
Active, not recruiting
Completed
Completed
Unknown status
Completed
Completed
Terminated
Completed
Completed
Completed
Unknown status
Terminated
Completed
Recruiting
Terminated
Completed
Completed
Completed
Unknown status
Completed
Completed
Unknown status
Completed
Unknown status
Completed
Completed
Terminated
Withdrawn
Completed
Completed
Recruiting
Withdrawn
Completed
Terminated
Completed
Withdrawn
Unknown status
Recruiting
Recruiting
Unknown status
Completed
Completed
Terminated
Completed
Unknown status
Completed
Terminated
Terminated
Completed
Unknown status
Active, not recruiting
Active, not recruiting
Completed
Completed
Completed
Completed
Recruiting
Completed
Completed
Unknown status
Completed
Completed
Withdrawn
Completed
Completed
Completed
Withdrawn
Recruiting
Completed
Not yet recruiting
Completed
Completed
Terminated
Recruiting
Completed
Withdrawn
Completed
Recruiting
Withdrawn
Completed
Not yet recruiting
Terminated
Completed
Terminated
Completed
Completed
Completed
Completed
Active, not recruiting
Active, not recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Unknown status
Completed
Completed
Completed
Terminated
Unknown status
Recruiting
Unknown status
Completed
Completed
Completed
Completed
Completed
Unknown status
Completed
Completed
Unknown status
Completed
Completed
Completed
Completed
Terminated
Terminated
Unknown status
Completed
Completed
Completed
Unknown status
Completed
Completed
Completed
Completed
Completed
Active, not recruiting
Terminated
Completed
Active, not recruiting
Completed
Completed
Unknown status
Recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Recruiting
Terminated
Completed
Unknown status
Terminated
Completed
Completed
Terminated
Completed
Completed
Completed
Completed
Completed
Completed
Active, not recruiting
Terminated
Completed
Completed
Completed
Completed
Completed
Completed
Unknown status
Completed
Active, not recruiting
Recruiting
Completed
Unknown status
Completed
Unknown status
Withdrawn
Completed
Completed
Terminated
Unknown status
Withdrawn
Terminated
Completed
Completed
Unknown status
Completed
Active, not recruiting
Completed
Recruiting
Completed
Completed
Unknown status
Terminated
Completed
Completed
Unknown status
Completed
Completed
Completed
Completed
Unknown status
Completed
Completed
Unknown status
Completed
Terminated
Completed
Unknown status
Completed
Active, not recruiting
Completed
Recruiting
Completed
Completed
Completed
Recruiting
Unknown status
Completed
Terminated
Completed
Completed
Terminated
Unknown status
Completed
Completed
Unknown status
Completed
Completed
Unknown status
Unknown status
Completed
Completed
Completed
Completed
Recruiting
Completed
No longer available
Completed
Terminated
Terminated
Adalimumab-afzb
PF-06410293
Approved
Pfizer Pharmaceuticals Ltd (China)
Arthritis, Rheumatoid, Spondylitis, Ankylosing, Arthritis, Juvenile, Psoriasis, Arthritis, Psoriatic, Colitis, Ulcerative, Hidradenitis Suppurativa, Uveitis, Crohn Disease
NCT Number
NCT04230213
NCT02480153
NCT02237729
NCT02572245
NCT01870986
Intervention Type
Drug
Biological
Biological
Device
Biological
Indications
Rheumatoid Arthritis
Rheumatoid Arthritis
Healthy Subjects
Healthy Subjects
Healthy
Study Phase
Phase 3
Phase 3
Phase 1
Phase 1
Phase 1
Recruitment Status
Recruiting
Completed
Completed
Completed
Completed
Golimumab
rTNV148B, CNTO-148
Approved
Janssen Global Services Llc
Diabetes Mellitus, Type 1, Spondylitis, Ankylosing, Arthritis, Rheumatoid, Colitis, Ulcerative, Arthritis, Psoriatic, Asthma
NCT Number
NCT01548768
NCT01295151
NCT01212653
NCT03733925
NCT01604629
NCT02318667
NCT01804166
NCT02186886
NCT02425865
NCT02758782
NCT01668004
NCT02687724
NCT01602302
NCT02155335
NCT03124121
NCT03253796
NCT01718951
NCT03669029
NCT02092285
NCT02242474
NCT01871649
NCT04108468
NCT03596645
NCT02181673
NCT01004432
NCT02438787
NCT02065713
NCT00265083
NCT02186873
NCT04610476
NCT00488631
NCT00264537
NCT02277444
NCT00771251
NCT00973479
NCT00727987
NCT00264550
NCT01453725
NCT01426815
NCT02437162
NCT01863771
NCT03270501
NCT01230827
NCT01248793
NCT00487539
NCT02456363
NCT04729296
NCT00207740
NCT02846545
NCT01217814
NCT01988961
NCT01715896
NCT02862574
NCT00955279
NCT04218565
NCT03182166
NCT01526174
NCT01900574
NCT01288157
NCT03298542
NCT03632759
NCT01081717
NCT03955861
NCT02841176
NCT03043677
NCT04378621
NCT03729349
NCT04200833
NCT02414984
NCT02011386
NCT03016260
NCT01610947
NCT01313858
NCT03945903
NCT04531423
NCT03496831
NCT03775824
NCT04188249
NCT04725422
Intervention Type
Drug
Biological, Drug
Other, Drug
Drug
Drug
Biological
Drug
Drug
Drug
Biological, Drug
Biological
Drug
Drug
Drug
Drug
Other, Biological
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological
Drug
Drug
Biological
Biological, Drug
Drug
Drug
Other, Drug
Drug
Drug
Biological
Drug
Drug
Other, Drug
Drug
Drug
Drug
Biological
Biological, Drug
Drug
Drug
Biological
Drug
Biological
Biological
Drug
Drug
Biological
Diagnostic Test, Biological, Drug
Drug
Drug
Drug
Drug
Drug
Other, Biological, Drug
Biological
Other, Biological
Biological
Other, Drug
Biological
Drug
Biological
Drug
Biological
Drug
Drug
Drug
Other, Drug
Drug
Drug
Drug
Drug
Indications
Rheumatoid Arthritis
Rheumatoid Arthritis
Ankylosing Spondylitis(AS)
Spondylitis, Ankylosing; Arthritis, Psoriatic
Spondylarthropathies
Colitis, Ulcerative
Hepatosplenic T-Cell Lymphoma
Ulcerative Colitis
ULCERATIVE COLITIS
Ankylosing Spondylitis
Ankylosing Spondylitis
Colitis
Rheumatoid Arthritis
Ulcerative Colitis
Ulcerative Colitis
Spondyloarthritis
Spondyloarthropathy
Colitis, Ulcerative
Ulcerative Colitis
Rheumatoid Arthritis
Psoriatic Arthritis
Psoriatic Arthritis
Colitis, Ulcerative
Arthritis, Psoriatic
Arthritis; Arthritis, Rheumatoid; Autoimmune Diseases
Axial Spondyloarthritis
Psoriatic Arthritis
Spondylitis, Ankylosing
Ankylosing Spondylitis
Psoriatic Arthritis; Withdrawal; Reduction
Colitis, Ulcerative
Rheumatoid Arthritis
Arthritis, Juvenile
Rheumatoid Arthritis
Arthritis, Rheumatoid
Rheumatoid Arthritis
Rheumatoid Arthritis
Spondylitis, Ankylosing
Peripheral Spondylarthritis
Axial Spondyloarthritis
Colitis, Ulcerative
Axial Spondyloarthritis
Juvenile Idiopathic Arthritis
Ankylosing Spondylitis
Colitis, Ulcerative
Ankylosing Spondylitis
Diabetes Mellitus, Type 1
Asthma
Diabetes Mellitus, Type 1
Rheumatoid Arthritis
Colitis, Ulcerative
Rheumatoid Arthritis
Rheumatoid Arthritis
Sarcoidosis
Behcet Syndrome; Uveitis
Ulcerative Colitis
Autoimmune Inner Ear Disease
Colitis, Ulcerative
Healthy Adult Chinese Males
Pre-Symptomatic Type 1 Diabetes
Type 1 Diabetes Mellitus
Rheumatoid Arthritis; Arthritis, Psoriatic; Ankylosing Spondylitis
Psoriatic Arthritis; Psoriasis; Enthesitis
Psoriatic Arthritis
Inflammatory Bowel Disease
Rheumatoid Arthritis; Pain; Fatigue; Cognitive Decline; Depression; Brain Diseases; Hand Rheumatism
Arthritis, Rheumatoid
JIA Associated Uveitis
Rheumatoid Arthritis
Axial Spondyloarthritis
RheumatoId Arthritis
Spondyloarthritis
Arthritis, Rheumatoid; Arthritis, Psoriatic; Spondylitis, Ankylosing
Diabetes Mellitus, Type 1
Major Depressive Disorder
Rheumatoid Arthritis; Spondyloarthritis; Psoriatic Arthritis
Rheumatoid Arthritis
Arthritis, Rheumatoid
Chronic Nonbacterial Osteomyelitis; Chronic Recurrent Multifocal Osteomyelitis
Study Phase
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 2/Phase 3
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 1/Phase 2
Phase 1
Phase 1
Phase 1
Early Phase 1
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Recruitment Status
Completed
Completed
Completed
Recruiting
Completed
Completed
Completed
Unknown status
Active, not recruiting
Completed
Completed
Unknown status
Terminated
Completed
Completed
Active, not recruiting
Completed
Unknown status
Completed
Unknown status
Completed
Recruiting
Recruiting
Completed
Completed
Terminated
Completed
Completed
Completed
Not yet recruiting
Completed
Completed
Active, not recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Terminated
Completed
Recruiting
Terminated
Completed
Completed
Unknown status
Not yet recruiting
Completed
Completed
Terminated
Completed
Completed
Terminated
Completed
Recruiting
Recruiting
Terminated
Active, not recruiting
Completed
Completed
Recruiting
Completed
Recruiting
Terminated
Completed
Not yet recruiting
Recruiting
Active, not recruiting
Terminated
Completed
Terminated
Completed
Completed
Available
Not yet recruiting
Completed
Completed
Recruiting
Recruiting
Infliximab-qbtx
GP-1111, PF-6438179, PF-06438179
Approved
Pfizer Pharmaceuticals Ltd (China)
Arthritis, Rheumatoid, Spondylitis, Ankylosing, Psoriasis, Arthritis, Psoriatic, Colitis, Ulcerative, Crohn Disease
NCT Number
NCT02222493
NCT04305145
NCT01844804
NCT03884439
NCT03885089
NCT03885037
Intervention Type
Biological
Drug
Biological
Drug
Drug
Drug
Indications
Rheumatoid Arthritis
Melanoma Stage III; Melanoma Stage IV; Side Effect of Drug; Colitis
Healthy
Crohn's Disease; Ulcerative Colitis
Psoriasis Vulgaris; Psoriasis Arthropathica; Pustular Psoriasis; Erythrodermic Psoriasis
Rheumatoid Arthritis
Study Phase
Phase 3
Phase 2
Phase 1
N/A
N/A
N/A
Recruitment Status
Completed
Recruiting
Completed
Recruiting
Recruiting
Recruiting
Infliximab biosimilar (Nichiiko Pharmaceutical/Aprogen)
GS-071, NI-071
Approved
Nichi-Iko Pharmaceutical, Aprogen
Arthritis, Rheumatoid, Psoriasis, Arthritis, Psoriatic, Colitis, Ulcerative, Crohn Disease
NCT Number
NCT02990806
NCT01927263
NCT01567358
NCT01931189
Intervention Type
Biological
Biological
Biological
Biological
Indications
Rheumatoid Arthritis (RA)
Rheumatoid Arthritis
Rheumatoid Arthritis
Healthy
Study Phase
Phase 3
Phase 3
Phase 1
Phase 1
Recruitment Status
Completed
Completed
Completed
Completed
Etanercept biosimilar (Intas Biopharmaceuticals)
Approved
Intas Biopharmaceuticals
Spondylitis, Ankylosing, Arthritis, Rheumatoid, Arthritis, Juvenile, Psoriasis, Arthritis, Psoriatic
Adalimumab biosimilar (Amgen)
ABP-501
Approved
Amgen Inc
Arthritis, Rheumatoid, Spondylitis, Ankylosing, Arthritis, Juvenile, Psoriasis, Arthritis, Psoriatic, Colitis, Ulcerative, Hidradenitis Suppurativa, Crohn Disease
NCT Number
NCT04131322
NCT01970475
NCT01970488
NCT02114931
NCT04378621
Intervention Type
Drug
Biological
Biological
Biological
Other, Drug
Indications
Crohn Disease; Ulcerative Colitis
Arthritis, Rheumatoid
Psoriasis
Arthritis, Rheumatoid
Rheumatoid Arthritis; Pain; Fatigue; Cognitive Decline; Depression; Brain Diseases; Hand Rheumatism
Study Phase
Phase 4
Phase 3
Phase 3
Phase 3
N/A
Recruitment Status
Terminated
Completed
Completed
Completed
Not yet recruiting
Adalimumab biosimilar (Fujifilm Kyowa Kirin Biologics/Mylan)
FKB-327
Approved
Fujifilm Kyowa Kirin Biologics Co Ltd
Arthritis, Rheumatoid, Spondylitis, Ankylosing, Colitis, Ulcerative, Arthritis, Psoriatic, Uveitis, Hidradenitis Suppurativa, Crohn Disease
NCT Number
NCT02260791
NCT02405780
Intervention Type
Drug
Drug
Indications
Arthritis, Rheumatoid
Arthritis, Rheumatoid
Study Phase
Phase 3
Phase 3
Recruitment Status
Completed
Completed
Etanercept biosimilar (Mylan)
YLB-113
Approved
Mylan Nv, Rubin Ltd
Arthritis, Rheumatoid, Spondylarthropathies, Spondylitis, Ankylosing, Arthritis, Juvenile, Psoriasis, Arthritis, Psoriatic
Adalimumab-adbm
BI-695501
Approved
C.H. Boehringer Sohn Ag & Co. Kg
Spondylitis, Ankylosing, Arthritis, Rheumatoid, Arthritis, Juvenile, Psoriasis, Colitis, Ulcerative, Arthritis, Psoriatic, Uveitis, Hidradenitis Suppurativa, Crohn Disease
NCT Number
NCT02871635
NCT02640612
NCT02850965
NCT03210259
NCT02137226
NCT02636907
NCT02606903
NCT02899338
NCT02045979
NCT01505491
Intervention Type
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Indications
Crohn Disease
Arthritis, Rheumatoid
Psoriasis
Psoriasis
Arthritis, Rheumatoid
Arthritis, Rheumatoid
Healthy
Healthy
Healthy
Healthy
Study Phase
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 2
Phase 1
Phase 1
Phase 1
Phase 1
Recruitment Status
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Etanercept biosimilar (Amega Biotech)
Approved
Amega Biotech
Arthritis, Rheumatoid
NCT Number
NCT03332719
NCT03403140
Intervention Type
Biological, Drug
Drug
Indications
Rheumatoid Arthritis
Rheumatoid Arthritis
Study Phase
Phase 3
Phase 3
Recruitment Status
Completed
Unknown status
Adalimumab biosimilar (Sandoz)
GP-2017
Approved
Sandoz
Arthritis, Rheumatoid, Spondylitis, Ankylosing, Arthritis, Juvenile, Psoriasis, Colitis, Ulcerative, Arthritis, Psoriatic, Hidradenitis Suppurativa, Uveitis, Plaque psoriasis, Crohn Disease
NCT Number
NCT03259074
NCT02016105
NCT02744755
Intervention Type
Biological
Drug
Biological
Indications
Ankylosing Spondylitis
Plaque Type Psoriasis
Rheumatoid Arthritis
Study Phase
Phase 3
Phase 3
Phase 3
Recruitment Status
Active, not recruiting
Completed
Completed
Etanercept biosimilar (Hisun-Pfizer Pharmaceuticals)
Approved
Hisun-Pfizer
Spondylitis, Ankylosing, Arthritis, Rheumatoid, Psoriasis, Arthritis, Psoriatic
NCT Number
NCT04077957
NCT03636984
Intervention Type
Drug
Drug
Indications
Ankylosing Spondylitis; Spondyloarthritis
Rheumatoid Arthritis; Ankylosing Spondylitis
Study Phase
Phase 4
N/A
Recruitment Status
Not yet recruiting
Not yet recruiting
Adalimumab biosimilar (Mylan/Biocon)
BMO-2, MYL-1401-A
Approved
Biocon
Spondylitis, Ankylosing, Arthritis, Rheumatoid, Arthritis, Juvenile, Psoriasis, Arthritis, Psoriatic, Colitis, Ulcerative, Crohn Disease, Plaque psoriasis
NCT Number
NCT02714322
NCT02472912
Intervention Type
Biological
Biological
Indications
Psoriasis; Arthritis, Psoriatic
Healthy Volunteers
Study Phase
Phase 3
Phase 1
Recruitment Status
Completed
Completed
Lenalidomide
IMID-5013, CDC-5013, CDC-501, ENMD-0997, CC-5013, IMiD-3
Approved
Celgene Corp
Lymphoma, B-Cell, Marginal Zone, Leukemia, Myeloid, Lymphoma, T-Cell, Peripheral, Hematologic Diseases, Solid tumours, HIV Infections, Lymphoma, B-Cell, Anemia, Paraproteinemias, Lymphoma, Large B-Cell, Diffuse, Leukemia-Lymphoma, Adult T-Cell, Myelodysplastic Syndromes, Blood Protein Disorders, Smoldering Multiple Myeloma, Multiple Myeloma, Lymphoma, Mantle-Cell, Prostatic Neoplasms, Lymphoma, Follicular, Radiculopathy, Reflex Sympathetic Dystrophy, Lymphoma, Non-Hodgkin, Lymphoma, T-Cell, Leukemia, Myeloid, Acute, Thrombocytopenia, Waldenstrom Macroglobulinemia, Melanoma, Neoplasm Metastasis, Leukemia, Lymphocytic, Chronic, B-Cell, Complex Regional Pain Syndromes, Crohn Disease, Carcinoma, Non-Small-Cell Lung
NCT Number
NCT04217967
NCT01408199
NCT01731886
NCT03829371
NCT04152577
NCT01198054
NCT04038411
NCT03416374
NCT04040491
NCT04348006
NCT03908138
NCT03934684
NCT04361643
NCT03173092
NCT04224493
NCT04270409
NCT01109004
NCT04298372
NCT00551928
NCT04404283
NCT01996865
NCT01476787
NCT04566328
NCT00424047
NCT00910910
NCT00056160
NCT01621672
NCT03729804
NCT01243944
NCT00689936
NCT04751877
NCT02215980
NCT04490707
NCT01093196
NCT00988208
NCT04071457
NCT00057616
NCT02406144
NCT00405756
NCT00928486
NCT03952091
NCT00602641
NCT00111319
NCT02252172
NCT01208766
NCT03319667
NCT03859427
NCT01564537
NCT01080391
NCT00480363
NCT03720041
NCT00522392
NCT00622336
NCT00093028
NCT00114101
NCT00572169
NCT01863550
NCT01850524
NCT04288765
NCT01659658
NCT01554852
NCT02112175
NCT02354313
NCT00064038
NCT02285062
NCT00843882
NCT02076009
NCT02516423
NCT04483739
NCT02579863
NCT01243476
NCT01530594
NCT01239797
NCT01891643
NCT00166452
NCT00430365
NCT01091831
NCT02322320
NCT04712097
NCT03901963
NCT03652064
NCT01650701
NCT01865110
NCT00098475
NCT02155634
NCT03710603
NCT01208662
NCT01335399
NCT01938001
NCT01098656
NCT03993912
NCT04084626
NCT01169337
NCT01021423
NCT02495922
NCT03948035
NCT01029262
NCT01191060
NCT02128061
NCT01916252
NCT02544308
NCT00774345
NCT03651128
NCT00179647
NCT03937635
NCT03617731
NCT00478777
NCT01122472
NCT00644228
NCT01685814
NCT00420849
NCT02659293
NCT00891384
NCT02575144
NCT00179621
NCT04680052
NCT04096066
NCT03941860
NCT04287660
NCT02516696
NCT03428373
NCT00120120
NCT00055562
NCT01197560
NCT02419118
NCT02145598
NCT00413036
NCT00968331
NCT02415413
NCT02399085
NCT01351896
NCT04497961
NCT04717700
NCT02441686
NCT00977132
NCT02917941
NCT02874742
NCT00907348
NCT01133743
NCT01545804
NCT02921893
NCT00044018
NCT00538824
NCT01307592
NCT00885508
NCT01401322
NCT04775550
NCT00899431
NCT04737889
NCT02126553
NCT00410605
NCT00874978
NCT00860457
NCT00067743
NCT00378209
NCT00883623
NCT02532257
NCT01501370
NCT01402284
NCT00996931
NCT00783367
NCT01816971
NCT03118466
NCT00540644
NCT00837031
NCT00628238
NCT03949062
NCT01282047
NCT02955823
NCT01858558
NCT00833534
NCT01446133
NCT02041325
NCT03412565
NCT02969837
NCT00287287
NCT01316523
NCT00751296
NCT02916771
NCT00064974
NCT03333746
NCT01611259
NCT00460031
NCT01775553
NCT02928419
NCT01919086
NCT03697356
NCT02880228
NCT01274533
NCT01379274
NCT02471820
NCT04025593
NCT01794039
NCT01245673
NCT03490344
NCT00717756
NCT01216683
NCT02128230
NCT01639898
NCT04223661
NCT02331368
NCT01160484
NCT01729338
NCT00609869
NCT04481815
NCT02765854
NCT02633137
NCT02802943
NCT01121757
NCT00322985
NCT01647165
NCT00925821
NCT02371590
NCT01123356
NCT04518982
NCT02294357
NCT01450215
NCT02619682
NCT03730740
NCT02460276
NCT00540007
NCT03495960
NCT01572480
NCT00424229
NCT01724177
NCT00902915
NCT01481194
NCT02472691
NCT02272803
NCT00546897
NCT00535873
NCT00065156
NCT00179738
NCT01160107
NCT01373294
NCT04052880
NCT01380106
NCT03019640
NCT00564889
NCT01415752
NCT03252600
NCT01442714
NCT01301820
NCT01497496
NCT02420860
NCT03012880
NCT01132989
NCT01772420
NCT02720510
NCT00109772
NCT01651039
NCT04329130
NCT02897830
NCT01496976
NCT00963105
NCT00567229
NCT01522976
NCT01723839
NCT00179686
NCT01264315
NCT00974233
NCT04174196
NCT01241786
NCT03837873
NCT04480099
NCT03556332
NCT00654186
NCT02086552
NCT04129710
NCT04063189
NCT01358734
NCT03605056
NCT03815279
NCT01548573
NCT01419795
NCT04140162
NCT02203643
NCT01463670
NCT01032291
NCT03746223
NCT01706666
NCT02279394
NCT01600053
NCT02903381
NCT01271283
NCT00786851
NCT02206503
NCT02906332
NCT04268498
NCT00466921
NCT02719613
NCT01237249
NCT02986451
NCT03500445
NCT00065351
NCT02219178
NCT03212807
NCT00087672
NCT00179673
NCT03809780
NCT02253316
NCT01053806
NCT03232307
NCT01553786
NCT00044382
NCT00096044
NCT00227591
NCT00807599
NCT01553357
NCT01816620
NCT03673826
NCT01054144
NCT04151667
NCT03409432
NCT00305812
NCT02060656
NCT03314636
NCT00109005
NCT00482911
NCT01698801
NCT02005289
NCT00908232
NCT04352205
NCT03544281
NCT01460940
NCT00737529
NCT00742560
NCT03004287
NCT01737177
NCT02538198
NCT00403169
NCT00695786
NCT01553149
NCT03733691
NCT01702831
NCT02728102
NCT00847639
NCT02225275
NCT00360672
NCT00971685
NCT00744536
NCT04460248
NCT01036399
NCT00482261
NCT01782963
NCT04094142
NCT00799513
NCT04231370
NCT03184194
NCT00720850
NCT04792502
NCT03188172
NCT04782687
NCT00445484
NCT02232516
NCT00445692
NCT03376477
NCT01307605
NCT00418665
NCT00840827
NCT01081431
NCT00096525
NCT03003520
NCT01743859
NCT01215344
NCT00843310
NCT00352794
NCT03376672
NCT01349569
NCT01718743
NCT01754857
NCT02309515
NCT00875667
NCT01718379
NCT01194791
NCT03054532
NCT00675441
NCT02193698
NCT02353468
NCT03367143
NCT01222195
NCT00602459
NCT00607581
NCT00617591
NCT00942578
NCT04627753
NCT01116193
NCT00867308
NCT04430894
NCT03290950
NCT01375140
NCT01593410
NCT04009109
NCT00478959
NCT01206205
NCT00074282
NCT01465230
NCT00957385
NCT02871219
NCT02538965
NCT00142168
NCT00772915
NCT00923663
NCT01939327
NCT02159365
NCT03477539
NCT02348528
NCT00759603
NCT03641456
NCT01088373
NCT01472562
NCT04032626
NCT02843074
NCT00165477
NCT01924169
NCT04622579
NCT03411031
NCT01178814
NCT01701076
NCT04277845
NCT01729091
NCT00238238
NCT02405364
NCT00848328
NCT01919619
NCT01559935
NCT00602836
NCT00632359
NCT01127542
NCT01830478
NCT00166413
NCT00779922
NCT01556035
NCT01011894
NCT04544059
NCT01936532
NCT03031483
NCT01374217
NCT00151203
NCT01270932
NCT01556477
NCT00439231
NCT01675141
NCT00446433
NCT04635189
NCT02188368
NCT01393756
NCT00961467
NCT03104842
NCT03000634
NCT03168100
NCT00179660
NCT03289299
NCT00665652
NCT00765245
NCT04002401
NCT01754870
NCT01342692
NCT00784927
NCT01133275
NCT03959358
NCT01199575
NCT03715309
NCT01125176
NCT00553644
NCT00538733
NCT00691704
NCT02446457
NCT00679367
NCT02371577
NCT00619684
NCT04065789
NCT00812968
NCT02375555
NCT00478218
NCT01246076
NCT00684242
NCT01145495
NCT00051116
NCT01617213
NCT01055301
NCT01856192
NCT00474188
NCT03669445
NCT00655668
NCT03863184
NCT01673308
NCT03224507
NCT00091260
NCT03606577
NCT02636322
NCT00761449
NCT03785184
NCT04404088
NCT03413800
NCT01518465
NCT03891355
NCT00352365
NCT01779167
NCT04214626
NCT01269203
NCT01459211
NCT02523040
NCT01002755
NCT00267059
NCT03269669
NCT02389517
NCT01956695
NCT01133665
NCT01460420
NCT04539236
NCT01010243
NCT01049945
NCT00306813
NCT01003769
NCT01166035
NCT01019174
NCT02038153
NCT01582776
NCT03100877
NCT01142232
NCT02343042
NCT01029054
NCT01241734
NCT02589145
NCT01355705
NCT01002703
NCT01583283
NCT00975806
NCT00378105
NCT02937571
NCT00910858
NCT02077959
NCT02077166
NCT01155583
NCT00179712
NCT02875067
NCT01502085
NCT03015792
NCT01788189
NCT00670358
NCT01421186
NCT01038635
NCT01881789
NCT00352001
NCT02911142
NCT00939510
NCT02802163
NCT02983097
NCT01180569
NCT01348919
NCT00972842
NCT00294632
NCT01484626
NCT04120350
NCT01558167
NCT03011814
NCT01547260
NCT01297764
NCT00179725
NCT02631577
NCT01208051
NCT00179751
NCT01744912
NCT02281279
NCT01342172
NCT02963610
NCT02340936
NCT00829647
NCT02057640
NCT01615029
NCT02213913
NCT01079936
NCT01995669
NCT00987493
NCT02389543
NCT01057121
NCT01060384
NCT00724568
NCT00831766
NCT02561273
NCT01111903
NCT00966693
NCT03191981
NCT00903630
NCT01075321
NCT01755975
NCT04796857
NCT02898259
NCT02302469
NCT01368757
NCT00727415
NCT04257448
NCT01638936
NCT02142049
NCT00699842
NCT01246557
NCT00396045
NCT00890929
NCT02529852
NCT02206425
NCT02265510
NCT01383928
NCT04663347
NCT01054196
NCT04432714
NCT01531998
NCT01555281
NCT00536341
NCT01703364
NCT00963534
NCT01686386
NCT00790842
NCT00112827
NCT02685826
NCT04446962
NCT00738829
NCT00621400
NCT00507442
NCT01668719
NCT01403246
NCT00778752
NCT02733042
NCT03980171
NCT02180711
NCT03015896
NCT00348595
NCT00901615
NCT00477750
NCT02341014
NCT00633594
NCT01076543
NCT01303965
NCT01352338
NCT00915408
NCT04607772
NCT00981708
NCT02628405
NCT01412307
NCT01704781
NCT01217957
NCT01127386
NCT04423926
NCT01035463
NCT02075021
NCT01016600
NCT01575860
NCT01093183
NCT01246622
NCT03373305
NCT04578600
NCT02481934
NCT00398515
NCT00603447
NCT04661007
NCT01750983
NCT01645930
NCT02954406
NCT01217203
NCT00466895
NCT01712828
NCT01400685
NCT00828802
NCT01711671
NCT01953692
NCT01254578
NCT01185262
NCT03591744
NCT00543114
NCT00100880
NCT00036894
NCT00502112
NCT00091624
NCT04134936
NCT01241292
NCT01985477
NCT01169298
NCT00687674
NCT02030483
NCT01429025
NCT00179608
NCT04246086
NCT03506802
NCT01629082
NCT02446236
NCT02280525
NCT01207921
NCT01433965
NCT02573896
NCT01729104
NCT04722146
NCT02255162
NCT03283046
NCT01359657
NCT03702725
NCT01965353
NCT02018523
NCT02160015
NCT03302728
NCT04091126
NCT02370888
NCT02036502
NCT00560391
NCT00735930
NCT00923234
NCT02705638
NCT02568553
NCT01711554
NCT01045928
NCT01378091
NCT02655458
NCT03359460
NCT00532675
NCT02200848
NCT01155505
NCT01126450
NCT00642954
NCT00415116
NCT03558750
NCT01440582
NCT01838434
NCT01202890
NCT00253344
NCT04609046
NCT01750762
NCT00729638
NCT00933426
NCT02492750
NCT03208218
NCT01562405
NCT03984097
NCT02426723
NCT00839059
NCT01042704
NCT01200004
NCT02992522
NCT02721043
NCT01732861
NCT01619761
NCT01034592
NCT02312102
NCT04436107
NCT00153933
NCT00495872
NCT04196491
NCT02335983
NCT03223610
NCT00864942
NCT03703167
NCT00525447
NCT03070327
NCT01604031
NCT03150316
NCT02521714
NCT00046735
NCT02886065
NCT00671801
NCT03113695
NCT04635683
NCT02600897
NCT03701711
NCT00415064
NCT03015922
NCT01886859
NCT03110822
NCT00991562
NCT01116154
NCT01954784
NCT01955499
NCT04272775
NCT00698776
NCT01348503
NCT02431208
NCT01766583
NCT00580242
NCT02086604
NCT01681537
NCT01718899
NCT01542918
NCT00179699
NCT01062152
NCT00840931
NCT01088048
NCT04447716
NCT03050450
NCT01393964
NCT03031730
NCT01998971
NCT01254617
NCT01038388
NCT01005979
NCT01421927
NCT04301076
NCT00555100
NCT03523975
NCT01352962
NCT02334865
NCT01373229
NCT00884546
NCT01904643
NCT04447027
NCT01183663
NCT01132586
NCT00729118
NCT00412581
NCT01829568
NCT01615042
NCT00419250
NCT00031941
NCT01749969
NCT00104962
NCT02918331
NCT02513186
NCT04326296
NCT04519476
NCT02697344
NCT01578954
NCT01218555
NCT01644799
NCT04739813
NCT01742793
NCT01222754
NCT01056679
NCT01537861
NCT01861340
NCT00704691
NCT00434239
NCT04049864
NCT02537808
NCT02856438
NCT04109872
NCT00633945
NCT04432402
NCT00911105
NCT02528838
NCT01827137
NCT04036448
NCT01649791
NCT01927718
NCT01752075
NCT03433001
NCT03715296
NCT02922543
NCT02608515
NCT02341781
NCT02733224
NCT01347944
NCT02921802
NCT02741544
NCT01268774
NCT00890552
NCT04319601
NCT02368301
NCT03106324
NCT01081028
NCT00792077
NCT02921815
NCT03001804
NCT02279654
NCT02556905
NCT02863458
NCT02525250
NCT00899080
NCT02387879
NCT00907452
NCT04435743
NCT01430546
NCT03903406
NCT01947309
NCT02075996
NCT03065790
NCT02666209
NCT02692339
NCT03098589
NCT03647124
NCT02164955
Intervention Type
Drug
Drug
Procedure, Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug, Combination Product
Drug
Drug
Drug
Drug
Other, Drug
Drug
Drug
Other, Biological, Drug
Drug
Drug
Drug
Drug
Drug
Other, Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other, Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Procedure
Drug
Drug
Drug
Drug
Procedure, Other, Drug
Drug
Other, Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other, Drug
Drug
Other, Biological, Drug
Drug
Drug
Drug
Biological, Drug
Other, Drug
Drug
Biological, Drug
Biological, Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other, Drug
Drug
Drug
Procedure, Drug
Biological, Drug
Drug
Drug
Drug
Drug
Other, Drug
Other, Drug
Drug
Other, Drug
Other, Drug
Drug
Drug
Drug
Other, Drug
Drug
Biological, Drug
Drug
Other, Biological, Drug
Drug
Drug
Drug
Other, Drug
Biological, Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other, Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other, Biological, Drug
Drug, Behavioral
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other, Drug
Drug
Drug
Biological, Drug
Drug
Drug
Drug
Procedure, Drug
Drug
Other, Drug
Biological, Drug
Drug
Drug
Drug
Drug
Drug
Other, Biological, Drug
Drug
Drug
Drug
Drug
Procedure, Other, Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological, Drug
Biological, Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other, Biological, Drug
Drug
Drug
Drug
Other, Drug
Drug
Drug
Other, Biological, Drug
Drug
Drug
Drug
Drug
Drug
Other, Biological, Drug
Drug
Drug
Biological, Drug
Drug
Drug
Drug
Procedure, Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological, Drug
Drug
Drug
Drug
Procedure, Drug
Drug
Drug
Drug
Drug
Drug
Other, Drug
Drug
Drug
Drug
Radiation, Drug
Drug
Drug
Drug
Drug
Drug
Biological, Drug
Biological, Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Procedure, Biological, Drug
Drug
Biological, Drug
Other, Biological, Drug
Drug
Drug
Drug
Other, Biological, Drug
Other, Biological, Drug
Drug
Other, Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other, Biological, Drug, Genetic
Other, Drug
Drug
Drug
Drug
Drug
Radiation, Drug
Drug
Drug
Drug
Procedure, Drug
Drug
Other, Drug
Drug
Drug
Other, Drug
Drug
Drug
Procedure, Drug
Other, Biological, Drug
Drug
Drug
Drug
Drug
Drug
Other, Procedure, Drug
Drug
Drug
Drug
Other, Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological, Drug
Drug
Biological, Drug
Drug
Drug
Biological, Drug
Other, Drug
Procedure, Drug
Drug
Drug
Drug
Drug
Drug
Other, Drug
Drug
Drug
Drug, Device
Drug
Drug
Drug
Other, Biological, Drug
Drug
Biological, Drug
Drug
Drug
Drug
Biological, Drug
Procedure, Drug
Drug
Drug
Drug
Biological, Drug
Other, Drug
Drug
Drug
Procedure, Biological, Drug
Drug
Biological, Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological, Drug
Other, Drug
Drug
Other, Biological, Drug
Biological, Drug
Biological, Drug
Drug
Drug
Drug
Drug
Other, Drug
Drug
Drug
Drug
Drug
Biological, Drug
Other, Drug
Drug
Other, Biological, Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other, Biological, Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological, Drug
Drug
Drug
Biological, Drug
Drug
Drug
Drug
Drug
Drug
Drug
Procedure, Other, Biological, Drug
Drug
Drug
Drug
Drug
Biological, Drug
Drug
Procedure, Drug
Radiation, Drug
Biological, Drug
Drug
Drug
Drug
Drug
Drug
Procedure, Other, Biological, Drug
Biological, Drug
Drug
Biological, Drug
Biological, Drug
Drug
Biological, Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological, Drug
Drug
Drug
Biological, Drug
Drug
Drug
Drug
Drug
Biological, Drug
Other, Drug
Drug
Drug
Other, Biological, Drug
Drug
Drug
Drug
Drug
Drug
Procedure, Drug
Drug
Drug
Drug
Other, Biological, Drug
Drug
Drug
Other, Procedure, Drug, Genetic
Other, Biological, Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological, Drug
Drug
Drug
Biological, Drug
Drug
Other, Drug
Drug
Drug
Drug
Drug
Other, Drug
Drug
Drug
Biological, Drug
Drug
Biological, Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other, Drug
Drug
Drug
Other, Drug
Drug
Other, Procedure, Biological, Radiation, Drug
Drug
Drug
Drug
Drug
Procedure, Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other, Biological, Drug
Drug
Other, Drug
Drug
Biological, Drug
Drug
Other, Drug
Drug
Other, Biological, Drug, Genetic
Drug
Drug
Drug
Drug
Drug
Other, Biological, Drug
Drug
Procedure, Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other, Biological, Drug
Drug
Drug
Drug
Drug
Other, Drug
Drug
Drug
Other, Biological, Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other, Biological, Drug
Procedure, Drug
Other, Biological, Drug
Biological, Drug
Drug
Drug
Drug
Drug
Drug
Procedure, Other, Drug
Drug
Drug
Drug
Drug
Other, Drug, Genetic
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug, Dietary Supplement
Drug
Drug
Biological, Drug
Drug
Drug
Drug, Behavioral
Drug
Drug
Drug
Drug
Drug
Drug
Procedure, Radiation, Biological, Drug, Genetic
Drug
Drug
Biological, Drug
Drug
Drug
Other, Biological, Drug
Drug
Drug
Drug
Drug
Drug
Other, Biological, Drug
Drug
Drug
Drug
Drug
Drug
Other, Drug
Drug
Drug
Drug
Drug
Drug
Other, Biological, Drug
Other, Drug
Drug
Drug
Other, Drug
Drug
Procedure, Biological, Drug
Drug
Drug
Drug
Other, Drug
Drug
Other, Drug
Biological, Drug
Procedure, Drug
Other, Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological, Drug
Other, Drug
Drug
Biological, Drug
Drug
Procedure, Other, Drug
Drug
Drug
Drug
Drug
Biological
Drug
Drug
Drug
Drug
Biological, Drug
Drug
Drug
Procedure, Other, Biological, Radiation, Drug
Drug
Drug
Procedure, Drug
Drug
Drug
Biological, Drug
Drug
Drug
Drug, Genetic
Drug
Biological
Drug
Drug
Drug
Other, Biological, Drug
Drug
Drug
Drug
Biological, Drug
Drug
Other, Drug
Drug
Drug
Biological, Drug
Other, Biological, Drug
Other, Biological, Drug, Genetic
Drug
Other, Drug
Drug
Drug, Combination Product
Drug
Drug
Other, Biological, Drug, Genetic
Drug
Drug
Biological, Drug
Drug, Behavioral
Drug
Drug
Drug
Biological, Drug
Drug
Drug
Drug
Other, Biological, Drug
Drug
Drug
Drug
Drug
Drug
Other, Drug
Drug
Biological, Drug
Biological, Drug
Drug
Procedure, Other, Biological, Radiation, Drug
Drug
Drug
Drug
Drug
Drug
Biological, Drug
Drug
Drug
Drug
Drug
Drug
Biological, Drug
Biological, Drug
Drug
Drug
Drug
Biological, Drug
Drug
Drug
Biological, Drug
Drug
Drug
Drug
Biological, Drug
Drug
Drug
Drug
Other, Drug
Other, Procedure, Radiation, Drug
Other, Drug
Drug
Biological, Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological
Drug
Drug
Drug
Biological, Drug
Drug
Biological, Drug
Drug
Biological, Drug
Drug
Drug
Other, Biological, Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other, Biological, Drug
Drug
Drug
Drug
Drug
Drug
Other, Drug
Drug
Drug
Other, Biological, Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other, Drug
Drug
Drug
Drug
Biological, Drug
Drug
Radiation, Drug
Drug
Drug
Drug
Drug
Drug
Biological, Drug
Drug
Drug
Drug
Drug
Biological, Drug
Drug
Other, Procedure, Drug
Drug, Behavioral
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Procedure
Other, Genetic
Drug
Drug
Drug
Drug
Diagnostic Test
Drug
Drug
Drug
Drug
Drug
Indications
Multiple Myeloma
Cutaneous Lupus
Multiple Myeloma
Multiple Myeloma
Lymphoma, B-Cell
AML
NK/T Cell Lymphoma
Relapsed and/or Refractory Multiple Myeloma
Peripheral T-cell Lymphoma
Newly Diagnosed Multiple Myeloma
Hematologic Neoplasms; Multiple Myeloma; Efficacy; Safety
Relapsed Refractory Multiple Myeloma
COVID-19
Multiple Myeloma
Relapsed/Refractory Follicular Lymphoma
Plasma Cell Myeloma
Multiple Myeloma
Amyloidosis Cardiac
Multiple Myeloma; Newly Diagnosed Patients
Diffuse Large B-cell Lymphoma
Lymphoma, Non-Hodgkin
Follicular Lymphoma
Plasma Cell Myeloma; RISS Stage I Plasma Cell Myeloma; RISS Stage II Plasma Cell Myeloma
Multiple Myeloma
B-Cell Chronic Lymphocytic Leukemia
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Polycythemia Vera
Multiple Myeloma
Multiple Myeloma; Myeloma
Multiple Myeloma
Acute Myeloid Leukemia in Remission
Multiple Myeloma
Prostate Cancer
Multiple Myeloma
Melanoma; Neoplasm Metastasis
Multiple Myeloma
Newly Diagnosed Multiple Myeloma
Multiple Myeloma
Multiple Myeloma in Relapse; Refractory Multiple Myeloma
Plasma Cell Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Plasma Cell Myeloma
Relapsed or Refractory Multiple Myeloma
Relapsed Multiple Myeloma; Refractory Multiple Myeloma
Relapsed Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
DS Stage I Plasma Cell Myeloma; DS Stage II Plasma Cell Myeloma; DS Stage III Plasma Cell Myeloma; Refractory Plasma Cell Myeloma; Smoldering Plasma Cell Myeloma
Multiple Myeloma
Plasma Cell Myeloma
Multiple Myeloma
Multiple Myeloma
Relapsed or Refractory Systemic Light Chain Amyloidosis
Multiple Myeloma
Multiple Myeloma
MANTLE CELL LYMPHOMA
Multiple Myeloma; Plasma Cell Neoplasm
Lymphoma, Large B-Cell, Diffuse
Anemia; Chronic Myelomonocytic Leukemia; de Novo Myelodysplastic Syndrome; Myelodysplastic Syndrome
Multiple Myeloma
Solitary Osseous Plasmacytoma
Multiple Myeloma
Multiple Myeloma
Myelodysplastic Syndrome
Multiple Myeloma
Lymphoma; Multiple Myeloma
Newly Diagnosed, Previously Untreated Multiple Myeloma
Complex Regional Pain Syndrome, Type 1
Myeloma
Multiple Myeloma
Multiple Myeloma
Relapsed or Refractory Follicular Lymphoma
Multiple Myeloma
Multiple Myeloma
Follicular Lymphoma
Mantle Cell Lymphoma
DS Stage I Plasma Cell Myeloma; DS Stage II Plasma Cell Myeloma; DS Stage III Plasma Cell Myeloma
Multiple Myeloma; Neoplasms; Plasma Cells; Paraproteinemias; Blood Protein Disorders; Hematologic Diseases; Therapeutic Uses
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Lymphoma, Non-Hodgkin
Lymphoma
Multiple Myeloma
EBV Infection
Light Chain Deposition Disease; Smoldering Plasma Cell Myeloma
Mantle Cell Lymphoma; Non-Hodgkin's Lymphoma
Multiple Myeloma
Newly Diagnosed Multiple Myeloma
Anemia
Myeloma
Diffuse Large B Cell Lymphoma
Multiple Myeloma
Plasmacytoma
B-cell Chronic Lymphocytic Leukemia
Multiple Myeloma
Multiple Myeloma
Smoldering Plasma Cell Myeloma
Multiple Myeloma
Relapsed or Refractory Multiple Myeloma
Lymphoma; Diffuse Large B-cell Lymphoma
DS Stage I Plasma Cell Myeloma; DS Stage II Plasma Cell Myeloma; DS Stage III Plasma Cell Myeloma
Previously Untreated Symptomatic Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Myelodysplastic Syndromes
Follicular Lymphoma; Marginal Zone Lymphoma
Multiple Myeloma; New Diagnosis Tumor
Plasma Cell Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma in Relapse; Multiple Myeloma Progression; Multiple Myeloma Stage II; Multiple Myeloma Stage I; Multiple Myeloma With Failed Remission; Multiple Myeloma Stage III
Radiculopathy
Melanoma; Neoplasm Metastasis
Diffuse Large B-cell Lymphoma
Multiple Myeloma
Multiple Myeloma
Lymphoma, Non-Hodgkin's
Diffuse Large B-cell Lymphoma
Smoldering Multiple Myeloma
Diffuse Large B-cell Lymphoma
Ann Arbor Stage I Small Lymphocytic Lymphoma; Ann Arbor Stage II Small Lymphocytic Lymphoma; Chronic Lymphocytic Leukemia; Chronic Lymphocytic Leukemia With Unmutated Immunoglobulin Heavy Chain Variable-Region Gene; Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable-Region Gene; Stage 0 Chronic Lymphocytic Leukemia; Stage I Chronic Lymphocytic Leukemia; Stage II Chronic Lymphocytic Leukemia
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Myelodysplastic Syndrome MDS
Relapsed and/or Refractory Multiple Myeloma
Multiple Myeloma
Non Hodgkin Lymphoma; Follicular Lymphoma
Chronic Lymphocytic Leukemia
Liver Cancer
Plasmacytoma; POEMS Syndrome
Multiple Myeloma
Multiple Myeloma
Lymphoma
Myelodysplastic Syndrome; Chronic Myelomonocytic Leukemia; Acute Myeloid Leukemia
Leukemia; Relapsed Adult Acute Lymphocytic Leukemia
High-risk Smoldering Multiple Myeloma; Multiple Myeloma
Chronic Lymphocytic Leukemia
Primary Central Nervous System Lymphoma
Alkylating Agent-Related Acute Myeloid Leukemia; Secondary Acute Myeloid Leukemia
Multiple Myeloma in Relapse; Stage II Multiple Myeloma; Stage III Multiple Myeloma
Myelodysplastic Syndromes
Chronic Lymphocytic Leukemia
Complex Regional Pain Syndrome (RSD)
Multiple Myeloma
Primary Amyloidosis
Ann Arbor Stage II Follicular Lymphoma; Ann Arbor Stage II Marginal Zone Lymphoma; Ann Arbor Stage III Follicular Lymphoma; Ann Arbor Stage III Marginal Zone Lymphoma; Ann Arbor Stage IV Follicular Lymphoma; Ann Arbor Stage IV Marginal Zone Lymphoma; CD20 Positive; Grade 1 Follicular Lymphoma; Grade 2 Follicular Lymphoma; Grade 3a Follicular Lymphoma
Multiple Myeloma
Multiple Myeloma
Autism
Follicular Lymphoma; Marginal Zone B-Cell Lymphoma; MALT Lymphoma; Lymphoma of Mucosa-Associated Lymphoid Tissue; Lymphoma, Small Lymphocytic; Waldenstrom Macroglobulinemia; Mantle-Cell Lymphoma
Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma
AML
Multiple Myeloma
Metastatic Pancreatic Cancer
Chronic Lymphocytic Leukemia; CLL; Untreated; Front-line; First-Line; Initial Therapy
Diffuse Large B Cell Lymphoma
HIV Infection Associated Kaposi Disease
Diffuse Large B-cells Non-Hodgkin Lymphoma
Multiple Myeloma
Leukemia; Lymphoma
Leukemia; Lymphoma
Plasma Cell Disorder
Multiple Myeloma
Multiple Myeloma
Thyroid Neoplasms
Non Hodgkin's Lymphoma
Chronic Lymphocytic Leukaemia
Smoldering Multiple Myeloma
Myelodysplastic Syndromes
Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma
Lymphoma of the Mucosa Associated Lymphoid Tissue (MALT)
Prostate Cancer
Relapse Multiple Myeloma; Refractory Multiple Myeloma
Myelodysplastic Syndromes
Multiple Myeloma (MM)
Waldenström's Macroglobulinemia
Plasma Cell Myeloma
Adult T Cell Leukemia/Lymphoma
MDS
Multiple Myeloma
Diffuse Large B Cell Lymphoma
Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma
Myeloma
Multiple Myeloma
Liver Cancer
Lymphoma
Multiple Myeloma
POEMS Syndrome
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Lymphocytic Leukemia; Mantle Cell Lymphoma
PCNSL
Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma
Mantle Cell Lymphoma; Untreated
Leukemia, Chronic Lymphatic
Follicular Lymphoma; Marginal Zone Lymphoma
T-cell Lymphoma
Multiple Myeloma
Multiple Myeloma
Chronic Lymphocytic Leukemia
Chronic Lymphocytic Leukemia
CAEBV
Multiple Myeloma
Multiple Myeloma
Plasma Cell Myeloma; Transplant-Related Carcinoma
Relapsed and/or Refractory Non-Hodgkin T-cell Lymphoma
Relapsed/Refractory Mantle Cell Lymphoma
Hodgkin Disease
Primary Central Nervous System Lymphoma
Multiple Myeloma
Myelodysplastic Syndromes
Adult T-Cell Leukemia-Lymphoma
Multiple Myeloma Light Chain Induced Renal Insufficiency
Multiple Myeloma
Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Leukemia, Myelomonocytic, Chronic
Multiple Myeloma
Leukemia, Myeloid, Acute
Leukemia; CLL; Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma
Myelodysplastic Syndromes
Prostate Cancer
Multiple Myeloma
Bladder Cancer
Newly Diagnosed Multiple Myeloma
Multiple Myeloma
Mantle Cell Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Follicular Lymphoma; Recurrent Indolent Adult Non-Hodgkin Lymphoma; Refractory Diffuse Large B-Cell Lymphoma; Refractory Follicular Lymphoma; Refractory Indolent Adult Non-Hodgkin Lymphoma
Multiple Myeloma and Plasma Cell Neoplasm
Lymphoma; Neurotoxicity; Therapy-related Toxicity
Recurrent Primary Amyloidosis
Leukemia; Acute Myeloid Leukemia (AML); Myelodysplastic Syndromes (MDS)
Acute Myeloid Leukemia
Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma
Hematopoietic Cell Transplantation Recipient; Plasma Cell Myeloma
Plasma Cell Myeloma
Cutaneous T Cell Lymphoma
Adult Myelodysplastic Syndrome; Anemia; Chronic Myelomonocytic Leukemia
Multiple Myeloma
Complex Regional Pain Syndrome, Type I
Multiple Myeloma
Relapsed or Refractory Peripheral T-cell Lymphoma
Multiple Myeloma
Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma
Relapsed or Refractory Chronic Lymphocytic Leukemia
Multiple Myeloma and Plasma Cell Neoplasm
Chronic Myelomonocytic Leukemia; Chronic Myelomonocytic Leukemia-1; Chronic Myelomonocytic Leukemia-2; Myelodysplastic Syndrome; Myelodysplastic Syndrome With Excess Blasts; Myelodysplastic Syndrome With Excess Blasts-1; Myelodysplastic Syndrome With Excess Blasts-2
Chronic Lymphocytic Leukemia (CLL)
Non-Small Cell Lung Cancer
Multiple Myeloma
Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma
Plasmacytoma; Plasmacytoma of Bone; Multiple Myeloma
Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL)
Diffuse Large B Cell Lymphoma; High-grade B-cell Lymphoma; Transformed Lymphoma
Peripheral T-cell Lymphoma
Multiple Myeloma
Prostate Cancer
Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma
Recurrent/RefractoryPrimary Central Nervous System Lymphoma (PCNSL)
Multiple Myeloma in Relapse
Acute Myeloid Leukemia; Acute Myelogenous Leukemia
Multiple Myeloma
Multiple Myeloma; Smoldering Multiple Myeloma
Multiple Myeloma
Adult Nasal Type Extranodal NK/T-cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Cutaneous B-cell Non-Hodgkin Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Hepatosplenic T-cell Lymphoma; Intraocular Lymphoma; Nodal Marginal Zone B-cell Lymphoma; Noncutaneous Extranodal Lymphoma; Peripheral T-cell Lymphoma; Prolymphocytic Leukemia; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Adult T-cell Leukemia/Lymphoma; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Recurrent Small Lymphocytic Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Hairy Cell Leukemia; Small Intestine Lymphoma; Splenic Marginal Zone Lymphoma; T-cell Large Granular Lymphocyte Leukemia; Testicular Lymphoma; Waldenström Macroglobulinemia
Multiple Myeloma
MULTIPLE MYELOMA (MM)
Multiple Myeloma
Colorectal Cancer
Primary Intraocular Lymphoma
Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma
Smoldering Myeloma; Smoldering Multiple Myeloma
Chronic Lymphocytic Leukemia
Smoldering Multiple Myeloma
Chronic Lymphocytic Leukemia; Stage III Chronic Lymphocytic Leukemia; Stage IV Chronic Lymphocytic Leukemia
MANTLE CELL LYMPHOMA
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Lymphoma
Multiple Myeloma
Multiple Myeloma
Relapse/Refractory Multiple Myeloma
Myeloma; Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
EBV Related Non-Hodgkin's Lymphoma; Primary CNS Lymphoma; Primary Testicular Lymphoma
Myelofibrosis
Non-Hodgkins Lymphoma
Multiple Myeloma
Multiple Myeloma
Myelodysplastic Syndrome
CCND1 Positive; CD20-Positive Neoplastic Cells Present; Mantle Cell Lymphoma
T-cell Lymphoma
Myelodysplastic Syndrome
Leukemia
Essential Thrombocythemia; Polycythemia Vera; Primary Myelofibrosis
Multiple Myeloma
Primary Plasma Cell Leukemia
POEMS Syndrome
Smouldering Myeloma
Multiple Myeloma
Multiple Myeloma
Lymphomatoid Papulosis; Primary Cutaneous Anaplastic Large Cell Lymphoma; Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma; Recurrent T-Cell Non-Hodgkin Lymphoma; Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma; Stage I Cutaneous T-Cell Non-Hodgkin Lymphoma; Stage II Cutaneous T-Cell Non-Hodgkin Lymphoma; Stage III Cutaneous T-Cell Non-Hodgkin Lymphoma; Stage IV Cutaneous T-Cell Non-Hodgkin Lymphoma
Multiple Myeloma and Plasma Cell Neoplasm
Diffuse Large B-Cell Lymphoma
Myeloma
Melanoma
Intraocular Melanoma; Malignant Conjunctival Neoplasm
Multiple Myeloma
Contiguous Stage II Small Lymphocytic Lymphoma; Noncontiguous Stage II Small Lymphocytic Lymphoma; Prolymphocytic Leukemia; Recurrent Small Lymphocytic Lymphoma; Refractory Chronic Lymphocytic Leukemia; Stage I Chronic Lymphocytic Leukemia; Stage I Small Lymphocytic Lymphoma; Stage II Chronic Lymphocytic Leukemia; Stage III Chronic Lymphocytic Leukemia; Stage III Small Lymphocytic Lymphoma; Stage IV Chronic Lymphocytic Leukemia; Stage IV Small Lymphocytic Lymphoma
Multiple Myeloma
Plasma Cell Myeloma; Renal Failure
Adult Lymphocyte Depletion Hodgkin Lymphoma; Adult Lymphocyte Predominant Hodgkin Lymphoma; Adult Mixed Cellularity Hodgkin Lymphoma; Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma; Adult Nodular Sclerosis Hodgkin Lymphoma; Recurrent Adult Hodgkin Lymphoma
Mantle Cell Lymphoma
Hematologic Cancer
Multiple Myeloma
Mantle Cell Lymphoma
Plasma Cell Myeloma
Kidney Cancer
Ann Arbor Stage III Grade 1 Follicular Lymphoma; Ann Arbor Stage III Grade 2 Follicular Lymphoma; Ann Arbor Stage III Indolent Adult Non-Hodgkin Lymphoma; Ann Arbor Stage III Marginal Zone Lymphoma; Ann Arbor Stage III Small Lymphocytic Lymphoma; Ann Arbor Stage IV Grade 1 Follicular Lymphoma; Ann Arbor Stage IV Grade 2 Follicular Lymphoma; Ann Arbor Stage IV Indolent Adult Non-Hodgkin Lymphoma; Ann Arbor Stage IV Marginal Zone Lymphoma; Ann Arbor Stage IV Small Lymphocytic Lymphoma
Neurofibromatosis Type 1; Recurrent Childhood Pilocytic Astrocytoma; Recurrent Childhood Visual Pathway Glioma
Newly Diagnosed Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Recurrent Chronic Lymphocytic Leukemia; Recurrent Small Lymphocytic Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Small Lymphocytic Lymphoma
Acute Myelogenous Leukemia; Myelodysplastic Syndrome
POEMS Syndrome
Myelodysplastic Syndromes; Leukemia, Myelomonocytic, Chronic; Angiogenesis
Diffuse Large B Cell Lymphoma
Peripheral T-cell Lymphoma
Multiple Myeloma
Multiple Myeloma
Non-hodgkin Lymphoma,B Cell
Diffuse Large B-cell Lymphoma
NK/T Cell Lymphoma Nos
Myeloma
Myelodysplastic Syndromes; Acute Myelogenous Leukemia
Follicular Lymphoma; Marginal Zone Lymphoma; B-cell Lymphoma
Multiple Myeloma
Multiple Myeloma; Myeloma Multiple; Kahler Disease; Myeloma, Plasma Cell; Myeloma-Multiple; Myelomatosis; Plasma Cell Myeloma
Multiple Myeloma and Plasma Cell Neoplasm
Adult Nasal Type Extranodal NK/T-cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Hepatosplenic T-cell Lymphoma; Peripheral T-cell Lymphoma; Stage I Cutaneous T-cell Non-Hodgkin Lymphoma; Stage IA Mycosis Fungoides/Sezary Syndrome; Stage IB Mycosis Fungoides/Sezary Syndrome; Stage II Cutaneous T-cell Non-Hodgkin Lymphoma; Stage IIA Mycosis Fungoides/Sezary Syndrome; Stage IIB Mycosis Fungoides/Sezary Syndrome; Stage III Cutaneous T-cell Non-Hodgkin Lymphoma; Stage IIIA Mycosis Fungoides/Sezary Syndrome; Stage IIIB Mycosis Fungoides/Sezary Syndrome; Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma; Stage IVA Mycosis Fungoides/Sezary Syndrome; Stage IVB Mycosis Fungoides/Sezary Syndrome
DS Stage I Plasma Cell Myeloma; DS Stage II Plasma Cell Myeloma; DS Stage III Plasma Cell Myeloma; Refractory Plasma Cell Myeloma
Multiple Myeloma
Lymphoma
Myelodysplastic Syndromes; Thrombocytopenia
Myelodysplastic Syndrome
Myelodysplastic Syndromes
Kidney Cancer
Lymphoma, Large B-Cell, Diffuse
Acute Myeloid Leukemia
Multiple Myeloma
Multiple Myeloma
Myelofibrosis
Multiple Myeloma
Multiple Myeloma
Hematopoietic Cell Transplantation Recipient; Plasma Cell Myeloma
Lymphoid Leukemia; Small Lymphocytic Lymphoma; Lymphoma, Non-Hodgkin
Monoclonal B-Cell Lymphocytosis; Stage 0 Chronic Lymphocytic Leukemia; Stage I Chronic Lymphocytic Leukemia; Stage I Small Lymphocytic Lymphoma
Mantle Cell Lymphoma; Lymphoma, Mantle-Cell
Myelodysplastic Syndromes
Primary Systemic Amyloidosis
LYMPHOMA
Graft-versus-Host Disease
POEMS Syndrome
Refractory Plasma Cell Myeloma
Diffuse Large B-Cell Lymphoma Refractory
Leukemia
Stage I Chronic Lymphocytic Leukemia; Stage II Chronic Lymphocytic Leukemia; Stage III Chronic Lymphocytic Leukemia; Stage IV Chronic Lymphocytic Leukemia
Amyloidosis
Multiple Myeloma
Metastatic Prostate Cancer
Primary CNS Lymphoma
Leukemia, Lymphoid; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
Myelodysplastic Syndrome
Multiple Myeloma
Multiple Myeloma
Myeloproliferative Diseases
Multiple Myeloma
Myeloma, Multiple
Hodgkin Disease
Multiple Myeloma
Leukemia
Chronic Lymphocytic Leukemia
Acute Myeloid Leukemia
Ann Arbor Stage II Grade 1 Follicular Lymphoma; Ann Arbor Stage II Grade 2 Follicular Lymphoma; Ann Arbor Stage III Grade 1 Follicular Lymphoma; Ann Arbor Stage III Grade 2 Follicular Lymphoma; Ann Arbor Stage IV Grade 1 Follicular Lymphoma; Ann Arbor Stage IV Grade 2 Follicular Lymphoma; Bulky Disease; Fatigue; Fever; Grade 3a Follicular Lymphoma; Night Sweats; Splenomegaly; Weight Loss
Leukemia, Myeloid
Waldenstrom's Macroglobulinemia
Multiple Myeloma and Plasma Cell Neoplasm
MALT Lymphoma
Non-Hodgkin Lymphoma
Multiple Myeloma
Minimal Residual Disease; Plasma Cell Myeloma
Multiple Myeloma
Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma
Myeloma; Newly Diagnosed; High Risk
Myelodysplastic Syndromes
Mantle Cell Lymphoma
Cognitive Impairment, Mild; Cognitive Dysfunction; Amyloid Plaque; Neurodegeneration; Inflammation, Brain
Multiple Myeloma
Glioblastoma; Gliosarcoma; Malignant Gliomas
Hematologic Disorder
Diffuse Large B Cell Lymphoma; Age Over 80 Years
Multiple Myeloma
Myelodysplastic Syndrome
Multiple Myeloma
Multiple Myeloma
Plasma Cell Leukemia; Plasma Cell Myeloma
Lymphoma
Multiple Myeloma
Lymphoma
B-Cell Non-Hodgkin Lymphoma; Hematopoietic and Lymphoid Cell Neoplasm; Leukemia; Lymphoma; Plasma Cell Myeloma; T-Cell Non-Hodgkin Lymphoma
Multiple Myeloma
Leukemia; Lymphoma
Chronic Lymphocytic Leukemia
Chronic Lymphocytic Leukaemia
Indolent Non Hodgkin Lymphoma
Amyloidosis
Multiple Myeloma; Impaired Renal Function
Refractory Primary-cutaneous Large B-cell Lymphoma (Leg-type)
Chronic Lymphocytic Leukemia; Leukemia
Diffuse Large B Cell Lymphoma
Newly Diagnosed Multiple Myeloma
Mucosa Associated Lymphoid Tissue (MALT) Lymphoma
Multiple Myeloma
Multiple Myeloma
Renal Failure; Multiple Myeloma
Myelodysplastic Syndrome; Acute Myelogenous Leukemia
Chronic Lymphocytic Leukemia (CLL); Small Lymphocytic Lymphoma
Multiple Myeloma
Crohn's Disease
Multiple Myeloma
Multiple Myeloma
Follicular Lymphoma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Non-Hodgkins Lymphoma
Smoldering Multiple Myeloma
Neuropathy; Nonmalignant Monoclonal Gammopathy of Undetermined Significance (MGUS)
Lymphoma
Refractory Large B-cell Lymphoma
Chronic Lymphocytic Leukemia (CLL); Small Lymphocytic Lymphoma (SLL)
MDS
Lymphoma
Myelodysplastic Syndrome; MDS
Multiple Myeloma; Amyloidosis
Chronic Lymphocytic Leukemia; CLL
Follicular Lymphoma
Chronic Lymphocytic Leukemia
Recurrent Mantle Cell Lymphoma
Multiple Myeloma
Multiple Myeloma
Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3a Follicular Lymphoma
Multiple Myeloma
Chronic Lymphocytic Leukemia (CLL)
Refractory Multiple Myeloma; Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma
Myeloma Multiple; Myeloma, Plasma-Cell; Myeloma-Multiple; Plasma Cell Myeloma
Myelodysplastic Syndromes
Multiple Myeloma
Multiple Myeloma and Plasma Cell Neoplasm
Myelodysplastic Syndromes
Advanced Cancer; Pain
Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma; Ann Arbor Stage III Grade 1 Follicular Lymphoma; Ann Arbor Stage III Grade 2 Follicular Lymphoma; Ann Arbor Stage III Grade 3 Follicular Lymphoma; Ann Arbor Stage IV Grade 1 Follicular Lymphoma; Ann Arbor Stage IV Grade 2 Follicular Lymphoma; Ann Arbor Stage IV Grade 3 Follicular Lymphoma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma; Plasma Cell Myeloma
Ann Arbor Stage II Diffuse Large B-Cell Lymphoma; Ann Arbor Stage III Diffuse Large B-Cell Lymphoma; Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma
Diffuse Large B-cell Lymphoma
Multiple Myeloma
T-cell Non-Hodgkin's Lymphoma
Mantle Cell Lymphoma
Myelodysplastic Syndrome
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Diffuse Large B-Cell Lymphoma Unclassifiable
MDS; AML
Multiple Myeloma
Ann Arbor Stage III Grade 1 Follicular Lymphoma; Ann Arbor Stage III Grade 2 Follicular Lymphoma; Ann Arbor Stage III Grade 3 Follicular Lymphoma; Ann Arbor Stage IV Grade 1 Follicular Lymphoma; Ann Arbor Stage IV Grade 2 Follicular Lymphoma; Ann Arbor Stage IV Grade 3 Follicular Lymphoma; Grade 3a Follicular Lymphoma
Relapsed Hematologic Malignancy; Multiple Myeloma
Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma
Mantle Cell Lymphoma
Adult Acute Basophilic Leukemia; Adult Acute Eosinophilic Leukemia; Adult Acute Megakaryoblastic Leukemia (M7); Adult Acute Minimally Differentiated Myeloid Leukemia (M0); Adult Acute Monoblastic Leukemia (M5a); Adult Acute Monocytic Leukemia (M5b); Adult Acute Myeloblastic Leukemia With Maturation (M2); Adult Acute Myeloblastic Leukemia Without Maturation (M1); Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Adult Acute Myelomonocytic Leukemia (M4); Adult Erythroleukemia (M6a); Adult Pure Erythroid Leukemia (M6b); Secondary Acute Myeloid Leukemia; Untreated Adult Acute Myeloid Leukemia
Waldenstrom Macroglobulinemia
Diffuse Large B Cell Lymphoma
Multiple Myeloma
Chronic Lymphocytic Leukemia
Langerhans Cell Histiocytosis (LCH); Histiocytoses Erdheim-chester Disease; Histiocytic Sarcoma (HS)
Chronic Lymphocytic Leukemia; Fatigue; Fever; Hypogammaglobulinemia; Lymphadenopathy; Lymphocytosis; Night Sweats; Paraproteinemia; Small Lymphocytic Lymphoma; Thrombocytopenia
Chronic Lymphocytic Leukemia; Leukemia
Plasma Cell Myeloma; Residual Disease
Lymphoma; Relapse
Squamous Cell Carcinoma
Hematologic Malignancies; Multiple Myeloma
Myelodysplastic Syndromes
Multiple Myeloma
Refractory Multiple Myeloma
Relapse; Refractory Multiple Myeloma
Recurrent Chronic Lymphocytic Leukemia
Solid Tumors
Multiple Myeloma
Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome; Adult Acute Myeloid Leukemia in Remission
Follicular Lymphoma Patients (Phase IB); Follicular and Agressive (DLBCL&MCL) B-cell Lymphoma Patients (Phase II)
Plasma Cell Leukemia in Remission; Plasma Cell Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Diffuse Large B-cell Lymphoma.
Lymphoma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Renal Cell Carcinoma
Multiple Myeloma
Multiple Myeloma
Low- or Intermediate-1-risk Myelodysplastic Syndrome (MDS)
Multiple Myeloma
Relapsed Diffuse Large B-Cell Lymphoma; Refractory Diffuse Large B-Cell Lymphoma
Refractory Multiple Myeloma
Ovarian Cancer
Relapsed Hodgkin Lymphoma; Relapsed Non-Hodgkin Lymphoma
Multiple Myeloma
Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma
B-cell Lymphoma
Lymphoma
Multiple Myeloma
Leukemia
Multiple Myeloma
Leukemia; Myelodysplastic Syndromes
Primary Effusion Lymphoma; B-Cell Neoplasm
Prostate Cancer
Multiple Myeloma
Diffuse Large B-cell Lymphoma (DLBCL); Follicular Lymphoma Grade III (FL III°); Mantle Cell Lymphoma (MCL), Blastoid Variant; Burkitt Lymphoma (BL); Aggressive Marginal Zone Lymphoma (MZL)
Lymphoma; Follicular Lymphoma
Multiple Myeloma
Peripheral T-Cell Non-Hodgkin's Lymphoma
Lymphoma
Multiple Myeloma
Primary Central Nervous System Lymphoma
Chronic Lymphocytic Leukemia
Folliculotropic Mycosis Fungoides; Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma; Recurrent Mycosis Fungoides; Refractory Cutaneous T-Cell Non-Hodgkin Lymphoma; Refractory Mycosis Fungoides; Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified; Sezary Syndrome; Recurrent Mature T- and NK-Cell Non-Hodgkin Lymphoma
Pancreatic Carcinoma.
Multiple Myeloma
Ovarian Cancer
Lymphoma, Follicular
Refractory Differentiated Thyroid Gland Carcinoma; Refractory Thyroid Gland Follicular Carcinoma; Refractory Thyroid Gland Hurthle Cell Carcinoma; Refractory Thyroid Gland Papillary Carcinoma; Unresectable Thyroid Gland Carcinoma
Pancreatic Cancer
Non-Hodgkins Lymphoma; Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma; B-cell Lymphomas; Marginal Zone Lymphoma; Mantle Cell Lymphoma; Waldenstrom's Macroglobulinemia
B-cell Adult Acute Lymphoblastic Leukemia; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Intraocular Lymphoma; Nodal Marginal Zone B-cell Lymphoma; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Small Lymphocytic Lymphoma; Refractory Hairy Cell Leukemia; Small Intestine Lymphoma; Splenic Marginal Zone Lymphoma; Testicular Lymphoma; Waldenström Macroglobulinemia
Urinary Bladder Neoplasms
Relapsed or Refractory Solid Tumors; Nonsmall Cell Lung Cancer
Diffuse Large B-cell Lymphoma
Chronic Lymphocytic Leukemia; Leukemia
Multiple Myeloma; Kahler Disease; Plasma-Cell Myeloma; Myelomatosis
Multiple Myeloma
Adult Grade III Lymphomatoid Granulomatosis; B-cell Chronic Lymphocytic Leukemia; Contiguous Stage II Adult Diffuse Large Cell Lymphoma; Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma; Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma; Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma; Contiguous Stage II Grade 1 Follicular Lymphoma; Contiguous Stage II Grade 2 Follicular Lymphoma; Contiguous Stage II Grade 3 Follicular Lymphoma; Contiguous Stage II Mantle Cell Lymphoma; Contiguous Stage II Marginal Zone Lymphoma; Contiguous Stage II Small Lymphocytic Lymphoma; Cutaneous B-cell Non-Hodgkin Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Intraocular Lymphoma; Nodal Marginal Zone B-cell Lymphoma; Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma; Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma; Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma; Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma; Noncontiguous Stage II Grade 1 Follicular Lymphoma; Noncontiguous Stage II Grade 2 Follicular Lymphoma; Noncontiguous Stage II Grade 3 Follicular Lymphoma; Noncontiguous Stage II Mantle Cell Lymphoma; Noncontiguous Stage II Marginal Zone Lymphoma; Noncontiguous Stage II Small Lymphocytic Lymphoma; Progressive Hairy Cell Leukemia, Initial Treatment; Small Intestine Lymphoma; Splenic Marginal Zone Lymphoma; Stage 0 Chronic Lymphocytic Leukemia; Stage I Adult Diffuse Large Cell Lymphoma; Stage I Adult Diffuse Mixed Cell Lymphoma; Stage I Adult Diffuse Small Cleaved Cell Lymphoma; Stage I Adult Hodgkin Lymphoma; Stage I Adult Immunoblastic Large Cell Lymphoma; Stage I Chronic Lymphocytic Leukemia; Stage I Grade 1 Follicular Lymphoma; Stage I Grade 2 Follicular Lymphoma; Stage I Grade 3 Follicular Lymphoma; Stage I Mantle Cell Lymphoma; Stage I Marginal Zone Lymphoma; Stage I Small Lymphocytic Lymphoma; Stage II Adult Hodgkin Lymphoma; Stage II Chronic Lymphocytic Leukemia; Stage II Small Lymphocytic Lymphoma; Stage III Adult Diffuse Large Cell Lymphoma; Stage III Adult Diffuse Mixed Cell Lymphoma; Stage III Adult Diffuse Small Cleaved Cell Lymphoma; Stage III Adult Hodgkin Lymphoma; Stage III Adult Immunoblastic Large Cell Lymphoma; Stage III Chronic Lymphocytic Leukemia; Stage III Grade 1 Follicular Lymphoma; Stage III Grade 2 Follicular Lymphoma; Stage III Grade 3 Follicular Lymphoma; Stage III Mantle Cell Lymphoma; Stage III Marginal Zone Lymphoma; Stage III Small Lymphocytic Lymphoma; Stage IV Adult Diffuse Large Cell Lymphoma; Stage IV Adult Diffuse Mixed Cell Lymphoma; Stage IV Adult Diffuse Small Cleaved Cell Lymphoma; Stage IV Adult Hodgkin Lymphoma; Stage IV Adult Immunoblastic Large Cell Lymphoma; Stage IV Chronic Lymphocytic Leukemia; Stage IV Grade 1 Follicular Lymphoma; Stage IV Grade 2 Follicular Lymphoma; Stage IV Grade 3 Follicular Lymphoma; Stage IV Mantle Cell Lymphoma; Stage IV Marginal Zone Lymphoma; Stage IV Small Lymphocytic Lymphoma; Testicular Lymphoma; Untreated Hairy Cell Leukemia; Waldenström Macroglobulinemia
Myeloma; Stem Cell Transplantation
Grade 3a Follicular Lymphoma; Recurrent Follicular Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Small Lymphocytic Lymphoma; Refractory Follicular Lymphoma; Refractory Marginal Zone Lymphoma; Refractory Small Lymphocytic Lymphoma
Lymphoma
Multiple Myeloma
AIDS-Related Kaposi Sarcoma; Recurrent Kaposi Sarcoma
Non-Hodgkin's Lymphoma
Multiple Myeloma
Myelodysplastic Syndrome; Acute Myeloid Leukemia
Anaplastic Large Cell Lymphoma, ALK-Negative; Anaplastic Large Cell Lymphoma, ALK-Positive; Hepatosplenic T-Cell Lymphoma; Peripheral T-Cell Lymphoma, Not Otherwise Specified; Stage II Angioimmunoblastic T-cell Lymphoma; Stage II Enteropathy-Associated T-Cell Lymphoma; Stage III Angioimmunoblastic T-cell Lymphoma; Stage III Enteropathy-Associated T-Cell Lymphoma; Stage IV Angioimmunoblastic T-cell Lymphoma; Stage IV Enteropathy-Associated T-Cell Lymphoma
Ovarian Cancer Recurrent
Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma
Myeloma Multiple
Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
Adult Nasal Type Extranodal NK/T-cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Hepatosplenic T-cell Lymphoma; Nodal Marginal Zone B-cell Lymphoma; Peripheral T-cell Lymphoma; Post-transplant Lymphoproliferative Disorder; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult T-cell Leukemia/Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Splenic Marginal Zone Lymphoma; Waldenstrom Macroglobulinemia
Multiple Myeloma; Non-Hodgkin's Lymphoma
Non-GCB/ABC Diffuse Large B-Cell Lymphoma; High-grade B-cell Lymphoma; Follicular Lymphoma Grade IIIb; Transformed Lymphoma; EBV-Positive DLBCL, Nos; ALK-Positive Anaplastic Large Cell Lymphoma
B Cell Lymphoma; Lymphoma
Waldenstrom Macroglobulinemia
Chronic Myelomonocytic Leukemia
Chronic Lymphocytic Leukemia
Pancreas Cancer; Pancreatic Adenocarcinoma; Pancreatic Ductal Adenocarcinoma
Multiple Myeloma
Diffuse Large B Cell Lymphoma Relapsed; Diffuse Large B Cell Lymphoma Refractory
Myelodysplastic Syndrome; MDS; Low to Intermediate-1 MDS; Non-deletion 5q
Chronic Lymphatic Leukemia
Multiple Myeloma
Acute Myeloid Leukemia (AML); Adult Acute Myeloblastic Leukemia
Lymphoma
Multiple Myeloma
Solid Tumors; Advanced Malignancies; Metastatic Cancer
Multiple Myeloma
Diffuse Large B-Cell Lymphoma; Follicular Lymphoma
Multiple Myeloma
DLBCL; Untreated; MYC Gene Rearrangement
Myeloma
Multiple Myeloma
Chronic Lymphocytic Leukemia
CLL; Chronic Lymphocytic Leukemia
Mantle Cell Lymphoma
Multiple Myeloma
Multiple Myeloma; Plasma Cell Neoplasm
Refractory Multiple Myeloma; Smoldering Multiple Myeloma; Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma
Multiple Myeloma
Lymphoma, Large B-Cell, Diffuse; Central Nervous System Neoplasms, Primary
Leukemia, Lymphocytic, Chronic, B-Cell
Amyloidosis
Multiple Myeloma
DS Stage I Plasma Cell Myeloma; DS Stage II Plasma Cell Myeloma; DS Stage III Plasma Cell Myeloma
Chronic Lymphocytic Leukemia
Multiple Myeloma
Lymphoma; Leukemia, Lymphocytic, Chronic, B-Cell
Follicular Lymphoma
Non Hodgkin Lymphoma
Grade 3a Follicular Lymphoma; Recurrent Burkitt Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Follicular Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Lymphoplasmacytic Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Waldenstrom Macroglobulinemia; Refractory Burkitt Lymphoma; Refractory Diffuse Large B-Cell Lymphoma; Refractory Follicular Lymphoma; Refractory Lymphoplasmacytic Lymphoma; Refractory Mantle Cell Lymphoma
Prostate Cancer
Lymphoma, Large B-Cell, Diffuse; Follicular Lymphoma; Mantle Cell Lymphoma; Marginal Zone Lymphoma
Multiple Myeloma and Plasma Cell Neoplasm
T-cell Lymphomas; Relapsed or Refractory
Mantle Cell Lymphoma
AIDS-Related Hodgkin Lymphoma; Recurrent Adult Hodgkin Lymphoma; Recurrent Follicular Lymphoma; Recurrent Lymphoplasmacytic Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Non-Hodgkin Lymphoma; Recurrent T-Cell Non-Hodgkin Lymphoma; Waldenstrom Macroglobulinemia
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Amyloidosis
Recurrent B-Cell Non-Hodgkin Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma; Recurrent Transformed Non-Hodgkin Lymphoma; Refractory B-Cell Non-Hodgkin Lymphoma; Refractory Diffuse Large B-Cell Lymphoma; Refractory Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma; Refractory Transformed Non-Hodgkin Lymphoma
Recurrent Adult Hodgkin Lymphoma
HIV-1 Infection
Multiple Myeloma
Cancer Cachexia Syndrome
PTCL, NOS; AITL; ALK- ALCL; Phase III-IV ALK+ ALCL; EATL
Anaplastic Large Cell Lymphoma, ALK-Negative; Recurrent Anaplastic Large Cell Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Mature T- and NK-Cell Non-Hodgkin Lymphoma; Recurrent Non-Hodgkin Lymphoma; Recurrent Transformed Non-Hodgkin Lymphoma
Relapsed or Refractory Multiple Myeloma
Leukemia, Myeloid, Acute
Lymphoma
Adenocarcinoma of the Prostate; Hormone-resistant Prostate Cancer; Recurrent Prostate Cancer
Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(15;17)(q22;q12); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Recurrent Adult Acute Myeloid Leukemia
CD30-Positive Neoplastic Cells Present; Folliculotropic Mycosis Fungoides; Recurrent Mycosis Fungoides; Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma; Refractory Mycosis Fungoides; Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma; Sezary Syndrome
Indolent B-Cell Non-Hodgkin Lymphoma; Recurrent B-Cell Non-Hodgkin Lymphoma; Recurrent Chronic Lymphocytic Leukemia; Recurrent Mucosa-Associated Lymphoid Tissue Lymphoma; Recurrent Follicular Lymphoma; Recurrent Hairy Cell Leukemia; Recurrent Lymphoplasmacytic Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Refractory B-Cell Non-Hodgkin Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Mucosa-Associated Lymphoid Tissue Lymphoma; Refractory Follicular Lymphoma; Refractory Hairy Cell Leukemia; Refractory Lymphoplasmacytic Lymphoma; Refractory Mantle Cell Lymphoma; Refractory Marginal Zone Lymphoma; Recurrent Small Lymphocytic Lymphoma; Refractory Small Lymphocytic Lymphoma
Multiple Myeloma
Refractory Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma
Relapsed Multiple Myeloma
Non Hodgkins Lymphoma; Diffuse Large B-cell Lymphoma
Advanced Cancers
Multiple Myeloma
Lymphoma, Non-Hodgkin
Patients With Multiple Myeloma Experiencing a; First or Second Relapse
Acute Myeloid Leukemia; Acute Lymphoblastic Leukemia; Chronic Lymphocytic Leukemia
Healthy
Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma; B Chronic Lymphocytic Leukemia
Myelodysplastic Syndromes
Multiple Myeloma
Myelodysplastic Syndrome; Multiple Myeloma; Hodgkin Lymphoma; Non-Hodgkin Lymphoma; Diffuse Large B-Cell Lymphoma; Follicular Lymphoma; Primary Mediastinal B-Cell Lymphoma
Adult Acute Myeloid Leukemia in Remission; Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11; Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11; Adult Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1; Adult Acute Myeloid Leukemia With t(9;11)(p22.3;q23.3); MLLT3-KMT2A; Adult Acute Promyelocytic Leukemia With PML-RARA; Adult Grade III Lymphomatoid Granulomatosis; Adult Nasal Type Extranodal NK/T-Cell Lymphoma; Alkylating Agent-Related Acute Myeloid Leukemia; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-Cell Lymphoma; Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue; Hepatosplenic T-Cell Lymphoma; Intraocular Lymphoma; Lymphomatous Involvement of Non-Cutaneous Extranodal Site; Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma; Nodal Marginal Zone Lymphoma; Post-Transplant Lymphoproliferative Disorder; Primary Cutaneous B-Cell Non-Hodgkin Lymphoma; Prolymphocytic Leukemia; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Immunoblastic Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Adult T-Cell Leukemia/Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mycosis Fungoides and Sezary Syndrome; Recurrent Non-Hodgkin Lymphoma; Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma; Recurrent Small Lymphocytic Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Hairy Cell Leukemia; Richter Syndrome; Small Intestinal Lymphoma; Splenic Marginal Zone Lymphoma; T-Cell Large Granular Lymphocyte Leukemia; Testicular Lymphoma; Waldenstrom Macroglobulinemia
Chronic Lymphocytic Leukemia
Plasma Cell Leukemia
Chronic Lymphocytic Leukemia; Small Lymphocytic Leukemia
Childhood Atypical Teratoid/Rhabdoid Tumor; Childhood Central Nervous System Germ Cell Tumor; Childhood Choroid Plexus Tumor; Childhood Craniopharyngioma; Childhood Ependymoblastoma; Childhood Grade I Meningioma; Childhood Grade II Meningioma; Childhood Grade III Meningioma; Childhood High-grade Cerebellar Astrocytoma; Childhood High-grade Cerebral Astrocytoma; Childhood Infratentorial Ependymoma; Childhood Low-grade Cerebellar Astrocytoma; Childhood Low-grade Cerebral Astrocytoma; Childhood Medulloepithelioma; Childhood Mixed Glioma; Childhood Oligodendroglioma; Childhood Supratentorial Ependymoma; Recurrent Childhood Brain Tumor; Recurrent Childhood Cerebellar Astrocytoma; Recurrent Childhood Cerebral Astrocytoma; Recurrent Childhood Ependymoma; Recurrent Childhood Medulloblastoma; Recurrent Childhood Pineoblastoma; Recurrent Childhood Subependymal Giant Cell Astrocytoma; Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor; Recurrent Childhood Visual Pathway and Hypothalamic Glioma
Brain and Central Nervous System Tumors
Myelodysplastic Syndrome (MDS)
Multiple Myeloma
Diffuse Large B-cell Lymphoma
Multiple Myeloma
Myeloma
Adult T-cell Leukemia-Lymphoma; Peripheral T-cell Lymphoma
Multiple Myeloma and Plasma Cell Neoplasm
Multiple Myeloma
Refractory/Relapsed Indolent Non-Hodgkin Lymphoma
Malignant Melanoma
Follicular Lymphoma
HLA-A*0201 Positive Cells Present; NY-ESO-1 Positive Tumor Cells Present; Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma
Myeldysplastic Syndrome (MDS); Chronic Myelomonocytic Leukemia; Bone Marrow Diseases; Neutropenia; Acute Myeloid Leukemia (AML)
Mantle Cell Lymphoma
Leukemia
Hodgkin Disease
Acute Myeloid Leukemia; Myelodysplastic Syndrome
Neuroblastoma
Lymphoma
Multiple Myeloma
Acute Myeloid Leukemia (AML); Acute Myelocytic Leukemia; Acute Myelogenous Leukemia; Acute Granulocytic Leukemia; Acute Non-Lymphocytic Leukemia
Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic; Multiple Myeloma
Multiple Myeloma
Refractory Multiple Myeloma; Multiple Myeloma in Relapse; Multiple Myeloma
Multiple Myeloma in Relapse
Carcinoma, Non-Small-Cell Lung
Ann Arbor Stage III Small Lymphocytic Lymphoma; Ann Arbor Stage IV Small Lymphocytic Lymphoma; Recurrent Chronic Lymphocytic Leukemia; Recurrent Small Lymphocytic Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Small Lymphocytic Lymphoma; Stage III Chronic Lymphocytic Leukemia; Stage IV Chronic Lymphocytic Leukemia
Lymphoma, T-Cell, Cutaneous; Lymphoma, T-Cell, Peripheral; Hodgkin Lymphoma
Multiple Myeloma
Leukemia, Myeloid; Myelodysplastic Syndromes
Multiple Myeloma
Multiple Myeloma
Anemia; Chronic Lymphocytic Leukemia; Prolymphocytic Leukemia; Recurrent Small Lymphocytic Lymphoma; Refractory Chronic Lymphocytic Leukemia; Thrombocytopenia
Myelodysplastic Syndromes; Acute Myelogenous Leukemia
Immunoglobulin G Subclass 4 Related Disease; IgG4-related Disease; Autoimmune Pancreatitis; IgG4-related Sclerosing Cholangitis; Retroperitoneal Fibrosis
Recurrent B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma; Recurrent Burkitt Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Grade 3a Follicular Lymphoma; Recurrent Grade 3b Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mediastinal Lymphoma; Recurrent Non-Hodgkin Lymphoma; Recurrent Small Lymphocytic Lymphoma; Refractory B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma; Refractory Burkitt Lymphoma; Refractory Diffuse Large B-Cell Lymphoma; Refractory Follicular Lymphoma; Refractory Grade 1 Follicular Lymphoma; Refractory Grade 2 Follicular Lymphoma; Refractory Grade 3 Follicular Lymphoma; Refractory Grade 3a Follicular Lymphoma; Refractory Mantle Cell Lymphoma; Refractory Marginal Zone Lymphoma; Refractory Mediastinal Lymphoma; Refractory Non-Hodgkin Lymphoma; Refractory Small Lymphocytic Lymphoma
Recurrent Neuroblastoma; Refractory Neuroblastoma
Adult Non-Hodgkin Lymphoma; Adult Grade III Lymphomatoid Granulomatosis; Contiguous Stage II Adult Burkitt Lymphoma; Contiguous Stage II Adult Diffuse Large Cell Lymphoma; Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma; Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma; Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma; Contiguous Stage II Adult Lymphoblastic Lymphoma; Contiguous Stage II Grade 1 Follicular Lymphoma; Contiguous Stage II Grade 2 Follicular Lymphoma; Contiguous Stage II Grade 3 Follicular Lymphoma; Contiguous Stage II Mantle Cell Lymphoma; Contiguous Stage II Marginal Zone Lymphoma; Contiguous Stage II Small Lymphocytic Lymphoma; Cutaneous B-cell Non-Hodgkin Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Nodal Marginal Zone B-cell Lymphoma; Noncontiguous Stage II Adult Burkitt Lymphoma; Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma; Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma; Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma; Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma; Noncontiguous Stage II Adult Lymphoblastic Lymphoma; Noncontiguous Stage II Grade 1 Follicular Lymphoma; Noncontiguous Stage II Grade 2 Follicular Lymphoma; Noncontiguous Stage II Grade 3 Follicular Lymphoma; Noncontiguous Stage II Mantle Cell Lymphoma; Noncontiguous Stage II Marginal Zone Lymphoma; Noncontiguous Stage II Small Lymphocytic Lymphoma; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Small Lymphocytic Lymphoma; Splenic Marginal Zone Lymphoma; Stage I Adult Burkitt Lymphoma; Stage I Adult Diffuse Large Cell Lymphoma; Stage I Adult Diffuse Mixed Cell Lymphoma; Stage I Adult Diffuse Small Cleaved Cell Lymphoma; Stage I Adult Immunoblastic Large Cell Lymphoma; Stage I Adult Lymphoblastic Lymphoma; Stage I Grade 1 Follicular Lymphoma; Stage I Grade 2 Follicular Lymphoma; Stage I Grade 3 Follicular Lymphoma; Stage I Mantle Cell Lymphoma; Stage I Marginal Zone Lymphoma; Stage I Small Lymphocytic Lymphoma; Stage III Adult Burkitt Lymphoma; Stage III Adult Diffuse Large Cell Lymphoma; Stage III Adult Diffuse Mixed Cell Lymphoma; Stage III Adult Diffuse Small Cleaved Cell Lymphoma; Stage III Adult Immunoblastic Large Cell Lymphoma; Stage III Adult Lymphoblastic Lymphoma; Stage III Grade 1 Follicular Lymphoma; Stage III Grade 2 Follicular Lymphoma; Stage III Grade 3 Follicular Lymphoma; Stage III Mantle Cell Lymphoma; Stage III Marginal Zone Lymphoma; Stage III Small Lymphocytic Lymphoma; Stage IV Adult Burkitt Lymphoma; Stage IV Adult Diffuse Large Cell Lymphoma; Stage IV Adult Diffuse Mixed Cell Lymphoma; Stage IV Adult Diffuse Small Cleaved Cell Lymphoma; Stage IV Adult Immunoblastic Large Cell Lymphoma; Stage IV Adult Lymphoblastic Lymphoma; Stage IV Grade 1 Follicular Lymphoma; Stage IV Grade 2 Follicular Lymphoma; Stage IV Grade 3 Follicular Lymphoma; Stage IV Mantle Cell Lymphoma; Stage IV Marginal Zone Lymphoma; Stage IV Small Lymphocytic Lymphoma; Waldenstrom Macroglobulinemia
Prostate Cancer
Multiple Myeloma
Myelodysplastic Syndrome; Previously Treated Myelodysplastic Syndrome; Refractory High Risk Myelodysplastic Syndrome; Secondary Myelodysplastic Syndrome; Therapy-Related Myelodysplastic Syndrome
Multiple Myeloma
Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma
Advanced Solid Tumors
Colon Cancer; Rectal Cancer
Relapsed or Refractory Multiple Myeloma
Unspecified Adult Solid Tumor, Protocol Specific
Recurrent Central Nervous System Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; Refractory Central Nervous System Lymphoma; Refractory Diffuse Large B-Cell Lymphoma
Myeloma
Relapsed/Refractory Mantle Cell Lymphoma
Ovarian Cancer; Epithelial Ovarian Cancer; Fallopian Tube Carcinoma; Primary Peritoneal Carcinoma
Unspecified Adult Solid Tumor, Protocol Specific
Central Nervous System Lymphoma; Diffuse Large B-Cell Lymphoma
Multiple Myeloma; Lymphoma
Multiple Myeloma
Prostate Cancer
Indolent Plasma Cell Myeloma; Plasma Cell Myeloma; Smoldering Plasma Cell Myeloma
Healthy, Male
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Acute Myeloid Leukemia
Myeloma
Advanced Cancers
B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma; Grade 1 Follicular Lymphoma; Grade 2 Follicular Lymphoma; Grade 3a Follicular Lymphoma; Recurrent Burkitt Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Follicular Lymphoma; Recurrent Marginal Zone Lymphoma; Refractory Burkitt Lymphoma; Refractory Diffuse Large B-Cell Lymphoma; Refractory Follicular Lymphoma; Transformed Recurrent Non-Hodgkin Lymphoma
Solid Tumors
Leukemia Lymphocytic Chronic B-Cell
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Acute Biphenotypic Leukemia; Acute Lymphoblastic Leukemia in Remission; Acute Myeloid Leukemia in Remission; Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; DS Stage II Plasma Cell Myeloma; DS Stage III Plasma Cell Myeloma; High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; ISS Stage II Plasma Cell Myeloma; ISS Stage III Plasma Cell Myeloma; Myelodysplastic Syndrome; Recurrent Acute Lymphoblastic Leukemia; Recurrent Acute Myeloid Leukemia; Recurrent Chronic Lymphocytic Leukemia; Recurrent Hodgkin Lymphoma; Recurrent Non-Hodgkin Lymphoma; Recurrent Small Lymphocytic Lymphoma; Refractory Acute Lymphoblastic Leukemia; Refractory Chronic Lymphocytic Leukemia; Refractory Hodgkin Lymphoma; Refractory Non-Hodgkin Lymphoma; Refractory Small Lymphocytic Lymphoma; Secondary Acute Myeloid Leukemia; Therapy-Related Acute Myeloid Leukemia; Therapy-Related Myelodysplastic Syndrome
Anemia; Leukemia; Acute Myeloid Leukemia (AML); Myelodysplastic Syndromes (MDS)
Myelodysplastic Syndrome; Acute Myeloid Leukemia
Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Refractory Multiple Myeloma; Relapsed Multiple Myeloma; Multiple Myeloma
Solid Tumors
Multiple Myeloma
Multiple Myeloma
Lymphoma; Non-Hodgkin Lymphoma; Diffuse Large B-Cell Lymphoma; Burkitt Lymphoma
Chronic Lymphocytic Leukemia; Non-Hodgkin's Lymphoma
Primary Central Nervous System Lymphoma (PCNSL); Secondary Central Nervous System Lymphoma (SCNSL)
Multiple Myeloma
Multiple Myeloma
B-cell Chronic Lymphocytic Leukemia
Myeloma, Multiple
Healthy Volunteers
Neoplasms
Smoldering Multiple Myeloma
Malignant Gliomas
Richter's Syndrome; CLL
Recurrent B-Cell Non-Hodgkin Lymphoma; Recurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue; Recurrent Follicular Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3a Follicular Lymphoma; Recurrent Lymphoplasmacytic Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Nodal Marginal Zone Lymphoma; Recurrent Splenic Marginal Zone Lymphoma; Recurrent Waldenstrom Macroglobulinemia; Refractory B-Cell Non-Hodgkin Lymphoma; Refractory Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue; Refractory Follicular Lymphoma; Refractory Grade 1 Follicular Lymphoma; Refractory Grade 2 Follicular Lymphoma; Refractory Grade 3a Follicular Lymphoma; Refractory Lymphoplasmacytic Lymphoma; Refractory Mantle Cell Lymphoma; Refractory Marginal Zone Lymphoma; Refractory Nodal Marginal Zone Lymphoma; Refractory Splenic Marginal Zone Lymphoma; Refractory Waldenstrom Macroglobulinemia
Relapsed or Refractory Follicular Lymphoma, Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Demyelinating Sensorimotor Neuropathy
Multiple Myeloma
Multiple Myeloma
Recurrent B-Cell Prolymphocytic Leukemia; Recurrent Chronic Lymphocytic Leukemia; Recurrent Small Lymphocytic Lymphoma; Refractory B-Cell Prolymphocytic Leukemia; Refractory Chronic Lymphocytic Leukemia; Refractory Small Lymphocytic Lymphoma
Multiple Myeloma
Multiple Myeloma
Adult Nasal Type Extranodal NK/T-cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Cutaneous B-cell Non-Hodgkin Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Hepatosplenic T-cell Lymphoma; Intraocular Lymphoma; Nodal Marginal Zone B-cell Lymphoma; Peripheral T-Cell Lymphoma; Post-transplant Lymphoproliferative Disorder; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Adult T-cell Leukemia/Lymphoma; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Recurrent Small Lymphocytic Lymphoma; Small Intestine Lymphoma; Splenic Marginal Zone Lymphoma; Testicular Lymphoma; Waldenstrom Macroglobulinemia
Refractory Multiple Myeloma; Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma
Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Follicular Lymphoma; Recurrent Lymphoplasmacytic Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Refractory Diffuse Large B-Cell Lymphoma; Refractory Follicular Lymphoma; Refractory Lymphoplasmacytic Lymphoma; Refractory Mantle Cell Lymphoma
Relapsed and/or Refractory Multiple Myeloma
Myeloma
Hepatocellular Carcinoma
Multiple Myeloma
Relapsed/Refractory B-cell Lymphoma
Myelodysplasia
Lymphoma, Large B-Cell, Diffuse
Acute Myelogenous Leukemia
Smoldering Multiple Myeloma
Recurrent/Refractory CNS; Intraocular Lymphoma
Non-Small Cell Lung Cancer
Myelodysplastic Syndrome
Leukemia
Recurrent B-Cell Non-Hodgkin Lymphoma; Recurrent Follicular Lymphoma; Recurrent Indolent Adult Non-Hodgkin Lymphoma; Recurrent Marginal Zone Lymphoma; Refractory B-Cell Non-Hodgkin Lymphoma; Refractory Follicular Lymphoma; Refractory Indolent Adult Non-Hodgkin Lymphoma; Refractory Marginal Zone Lymphoma
Central Nervous System Tumors
Multiple Myeloma
Plasmacytoma; Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma
Multiple Myeloma
Recurrent Colon Carcinoma; Recurrent Hypopharyngeal Squamous Cell Carcinoma; Recurrent Laryngeal Squamous Cell Carcinoma; Recurrent Laryngeal Verrucous Carcinoma; Recurrent Lip and Oral Cavity Squamous Cell Carcinoma; Recurrent Metastatic Squamous Cell Carcinoma in the Neck With Occult Primary; Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma; Recurrent Nasopharyngeal Keratinizing Squamous Cell Carcinoma; Recurrent Oral Cavity Verrucous Carcinoma; Recurrent Oropharyngeal Squamous Cell Carcinoma; Recurrent Rectal Carcinoma; Recurrent Salivary Gland Carcinoma; Salivary Gland Squamous Cell Carcinoma; Squamous Cell Carcinoma Metastatic in the Neck With Occult Primary; Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7; Stage IV Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7; Stage IVA Colon Cancer AJCC v7; Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7; Stage IVA Laryngeal Verrucous Carcinoma AJCC v7; Stage IVA Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7; Stage IVA Major Salivary Gland Cancer AJCC v7; Stage IVA Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7; Stage IVA Oral Cavity Cancer AJCC v6 and v7; Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7; Stage IVA Rectal Cancer AJCC v7; Stage IVB Colon Cancer AJCC v7; Stage IVB Laryngeal Squamous Cell Carcinoma AJCC v7; Stage IVB Laryngeal Verrucous Carcinoma AJCC v7; Stage IVB Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7; Stage IVB Major Salivary Gland Cancer AJCC v7; Stage IVB Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7; Stage IVB Oral Cavity Cancer AJCC v6 and v7; Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7; Stage IVB Rectal Cancer AJCC v7; Stage IVC Laryngeal Squamous Cell Carcinoma AJCC v7; Stage IVC Laryngeal Verrucous Carcinoma AJCC v7; Stage IVC Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7; Stage IVC Major Salivary Gland Cancer AJCC v7; Stage IVC Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7; Stage IVC Oral Cavity Cancer AJCC v6 and v7; Stage IVC Oropharyngeal Squamous Cell Carcinoma AJCC v7; Tongue Carcinoma
Multiple Myeloma
Leukemia, Lymphocytic, Chronic, B-Cell; Chronic Lymphocytic Leukemia; Lymphoma, Small Lymphocytic
Multiple Myeloma
Acute Adult T-Cell Leukemia/Lymphoma; Adult T-Cell Leukemia/Lymphoma; Chronic Adult T-Cell Leukemia/Lymphoma; HTLV-1 Infection
Multiple Myeloma
Mantle Cell Lymphoma
Urethral Neoplasms; Neoplasms, Urethral; Cancer of the Urethra; Urethral Cancer
Partial Response of Multiple Myeloma or Plasma Cell Leukemia; Plasma Cell Myeloma
Leukemia, Lymphocytic, Chronic, B-Cell
Advanced Cancer, Various, NOS
Adult Acute Megakaryoblastic Leukemia (M7); Adult Acute Minimally Differentiated Myeloid Leukemia (M0); Adult Acute Monoblastic Leukemia (M5a); Adult Acute Monocytic Leukemia (M5b); Adult Acute Myeloblastic Leukemia With Maturation (M2); Adult Acute Myeloblastic Leukemia Without Maturation (M1); Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Adult Acute Myelomonocytic Leukemia (M4); Adult Erythroleukemia (M6a); Adult Pure Erythroid Leukemia (M6b); Recurrent Adult Acute Myeloid Leukemia
Relapsed/Refractory T-cell Malignancies; Cutaneous T-Cell Lymphoma; Mature T-cell Malignancies; Peripheral T-Cell Lymphoma
Advanced Cancers
Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome; Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11; Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11; Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); RUNX1-RUNX1T1; Adult Acute Myeloid Leukemia With t(9;11)(p22;q23); MLLT3-MLL; Adult Acute Promyelocytic Leukemia With t(15;17)(q22;q12); PML-RARA; Alkylating Agent-Related Acute Myeloid Leukemia; de Novo Myelodysplastic Syndrome; Previously Treated Myelodysplastic Syndrome; Recurrent Adult Acute Myeloid Leukemia; Secondary Acute Myeloid Leukemia; Secondary Myelodysplastic Syndrome; Untreated Adult Acute Myeloid Leukemia
Multiple Myeloma; Plasma Cell Neoplasm
Melanoma
Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma; Ann Arbor Stage III Grade 1 Follicular Lymphoma; Ann Arbor Stage III Grade 2 Follicular Lymphoma; Ann Arbor Stage III Grade 3 Follicular Lymphoma; Ann Arbor Stage IV Grade 1 Follicular Lymphoma; Ann Arbor Stage IV Grade 2 Follicular Lymphoma; Ann Arbor Stage IV Grade 3 Follicular Lymphoma
Acute Leukemia
Chronic Lymphocytic Leukemia; Leukemia, B-Cell, Chronic
Lymphoma; Small Intestine Cancer; Unspecified Adult Solid Tumor, Protocol Specific
Plasma Cell Myeloma
Childhood Myelodysplastic Syndromes; de Novo Myelodysplastic Syndromes; Previously Treated Myelodysplastic Syndromes; Refractory Anemia; Refractory Anemia With Excess Blasts; Refractory Anemia With Ringed Sideroblasts; Refractory Cytopenia With Multilineage Dysplasia; Secondary Myelodysplastic Syndromes; Unspecified Childhood Solid Tumor, Protocol Specific
Multiple Myeloma
Plasma Cell Myeloma
Colorectal Neoplasms
Refractory Multiple Myeloma
Recurrent Plasma Cell Myeloma
Acute Myeloid Leukemia
Solid Organ Malignancies; Adenoidcystic Carcinoma; Neuroendocrine Tumors
Recurrent Follicular Lymphoma
Lymphoma; Non-Hodgkin Lymphoma; Diffuse Large B-Cell Lymphoma; Burkitt Lymphoma
Hodgkin's Lymphoma; Mature T-cell Lymphoma; Multiple Myeloma
Diffuse Intrinsic Pontine Glioma; Anaplastic Astrocytoma; High Grade Glioma
Hodgkin Lymphoma
Multiple Myeloma
Myeloma
Peripheral T-cell Lymphomas; Adult T-cell Leukemia; Adult T-cell Lymphoma; Peripheral T-cell Lymphoma Unspecified; Angioimmunoblastic T-cell Lymphoma; Anaplastic Large Cell Lymphoma; T/Null Cell Systemic Type; Cutaneous t-Cell Lymphoma With Nodal/Visceral Disease
Myelodysplasia
Relapsed Neuroblastoma
Multiple Myeloma
Multiple Myeloma
Mantle Cell Lymphoma
Cutaneous Lupus Erythematosus (CLE)
Diffuse Large B Cell Lymphoma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma; Minimal Residual Disease; High-Risk Cancer
Myelodysplastic Syndromes; Lymphoma, Mantle-Cell
B-cell Chronic Lymphocytic Leukemia; Chronic Lymphocytic Leukemia; Stage 0 Chronic Lymphocytic Leukemia; Stage I Chronic Lymphocytic Leukemia; Stage II Chronic Lymphocytic Leukemia
Myeloma
Multiple Myeloma
Relapsed and/or Refractory Multiple Myeloma
Diffuse Large B Cell Lymphoma
Multiple Myeloma
Relapsed/Refractory Multiple Myeloma
Lymphoma, Mantle-Cell
Patient Non-adherence
Myelodysplastic Syndrome
Multiple Myeloma; Myelodysplastic Syndromes
Multiple Myeloma
Multiple Myeloma
Leukemia; Amyloidosis
Angioimmunoblastic T-cell Lymphoma; Chemotherapy Effect; Chemotherapeutic Toxicity
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Leukemia; CLL
Myelodysplastic Syndromes; Leukemia, Myeloid, Acute
Multiple Myeloma
Myelodysplastic Syndrome
Multiple Myeloma
Acute Myeloid Leukemia; Myelodysplastic Syndromes
Acute Myeloid Leukemia or Myelodysplasic Syndrome
Multiple Myeloma and Plasma Cell Neoplasm
Multiple Myeloma
Myeloma
Non-hodgkin Lymphoma,B Cell
Multiple Myeloma
Relapsed and/or Refractory Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Non-Hodgkin Lymphoma
Multiple Myeloma in Relapse; Multiple Myeloma
Multiple Myeloma
Lymphoma
Lymphoma, Mantle-Cell
Multiple Myeloma
Study Phase
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Early Phase 1
Early Phase 1
Early Phase 1
Early Phase 1
Early Phase 1
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Recruitment Status
Recruiting
Completed
Completed
Recruiting
Recruiting
Terminated
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Not yet recruiting
Recruiting
Recruiting
Recruiting
Completed
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Completed
Completed
Completed
Completed
Recruiting
Completed
Completed
Not yet recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Completed
Recruiting
Completed
Completed
Completed
Completed
Recruiting
Active, not recruiting
Completed
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Completed
Completed
Not yet recruiting
Terminated
Completed
Completed
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Unknown status
Completed
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Terminated
Active, not recruiting
Completed
Active, not recruiting
Terminated
Completed
Completed
Active, not recruiting
Completed
Not yet recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Withdrawn
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Terminated
Recruiting
Recruiting
Active, not recruiting
Terminated
Active, not recruiting
Recruiting
Completed
Completed
Active, not recruiting
Completed
Recruiting
Completed
Recruiting
Completed
Recruiting
Active, not recruiting
Completed
Completed
Active, not recruiting
Active, not recruiting
Completed
Recruiting
Completed
Recruiting
Completed
Recruiting
Recruiting
Not yet recruiting
Recruiting
Active, not recruiting
Recruiting
Completed
Completed
Completed
Completed
Terminated
Completed
Terminated
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Not yet recruiting
Active, not recruiting
Terminated
Completed
Active, not recruiting
Unknown status
Completed
Completed
Recruiting
Completed
Terminated
Unknown status
Unknown status
Terminated
Not yet recruiting
Terminated
Recruiting
Recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Active, not recruiting
Withdrawn
Completed
Completed
Active, not recruiting
Unknown status
Active, not recruiting
Completed
Completed
Unknown status
Active, not recruiting
Terminated
Active, not recruiting
Completed
Withdrawn
Active, not recruiting
Completed
Active, not recruiting
Recruiting
Completed
Active, not recruiting
Terminated
Active, not recruiting
Completed
Terminated
Completed
Completed
Completed
Terminated
Active, not recruiting
Recruiting
Completed
Completed
Terminated
Completed
Recruiting
Completed
Completed
Recruiting
Completed
Active, not recruiting
Active, not recruiting
Completed
Not yet recruiting
Completed
Completed
Terminated
Completed
Recruiting
Recruiting
Active, not recruiting
Recruiting
Terminated
Completed
Withdrawn
Completed
Withdrawn
Completed
Recruiting
Active, not recruiting
Completed
Active, not recruiting
Recruiting
Completed
Completed
Recruiting
Active, not recruiting
Unknown status
Completed
Unknown status
Completed
Completed
Active, not recruiting
Completed
Completed
Completed
Terminated
Active, not recruiting
Completed
Recruiting
Completed
Recruiting
Completed
Active, not recruiting
Active, not recruiting
Terminated
Completed
Active, not recruiting
Active, not recruiting
Active, not recruiting
Unknown status
Completed
Terminated
Terminated
Completed
Recruiting
Terminated
Active, not recruiting
Completed
Terminated
Active, not recruiting
Active, not recruiting
Completed
Active, not recruiting
Completed
Recruiting
Terminated
Recruiting
Recruiting
Recruiting
Completed
Active, not recruiting
Recruiting
Recruiting
Completed
Not yet recruiting
Enrolling by invitation
Terminated
Terminated
Recruiting
Active, not recruiting
Completed
Terminated
Recruiting
Completed
Active, not recruiting
Terminated
Suspended
Withdrawn
Completed
Completed
Active, not recruiting
Recruiting
Completed
Active, not recruiting
Completed
Withdrawn
Recruiting
Completed
Completed
Withdrawn
Completed
Completed
Recruiting
Active, not recruiting
Unknown status
Withdrawn
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Recruiting
Completed
Recruiting
Recruiting
Completed
Active, not recruiting
Recruiting
Completed
Terminated
Completed
Active, not recruiting
Completed
Recruiting
Recruiting
Completed
Completed
Completed
Active, not recruiting
Completed
Active, not recruiting
Completed
Completed
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Completed
Active, not recruiting
Completed
Unknown status
Completed
Recruiting
Terminated
Unknown status
Completed
Recruiting
Unknown status
Recruiting
Active, not recruiting
Terminated
Not yet recruiting
Recruiting
Not yet recruiting
Completed
Recruiting
Completed
Recruiting
Active, not recruiting
Completed
Terminated
Unknown status
Completed
Active, not recruiting
Completed
Completed
Terminated
Completed
Active, not recruiting
Completed
Active, not recruiting
Active, not recruiting
Terminated
Completed
Completed
Completed
Not yet recruiting
Terminated
Completed
Terminated
Active, not recruiting
Terminated
Active, not recruiting
Completed
Completed
Completed
Recruiting
Completed
Terminated
Recruiting
Active, not recruiting
Completed
Completed
Recruiting
Completed
Completed
Completed
Terminated
Completed
Active, not recruiting
Completed
Terminated
Completed
Unknown status
Completed
Completed
Recruiting
Completed
Completed
Recruiting
Completed
Active, not recruiting
Recruiting
Active, not recruiting
Completed
Terminated
Recruiting
Active, not recruiting
Active, not recruiting
Completed
Not yet recruiting
Recruiting
Completed
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Completed
Completed
Terminated
Unknown status
Completed
Completed
Completed
Completed
Not yet recruiting
Active, not recruiting
Active, not recruiting
Terminated
Active, not recruiting
Completed
Unknown status
Completed
Terminated
Completed
Not yet recruiting
Active, not recruiting
Completed
Completed
Active, not recruiting
Withdrawn
Withdrawn
Completed
Recruiting
Terminated
Completed
Active, not recruiting
Withdrawn
Active, not recruiting
Completed
Completed
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Completed
Active, not recruiting
Completed
Recruiting
Completed
Withdrawn
Completed
Active, not recruiting
Completed
Active, not recruiting
Completed
Completed
Terminated
Active, not recruiting
Completed
Terminated
Withdrawn
Active, not recruiting
Terminated
Recruiting
Terminated
Recruiting
Unknown status
Recruiting
Completed
Recruiting
Active, not recruiting
Completed
Withdrawn
Recruiting
Recruiting
Terminated
Recruiting
Completed
Terminated
Recruiting
Withdrawn
Completed
Active, not recruiting
Completed
Completed
Recruiting
Suspended
Completed
Completed
Completed
Not yet recruiting
Unknown status
Completed
Completed
Terminated
Unknown status
Completed
Terminated
Active, not recruiting
Withdrawn
Completed
Recruiting
Completed
Unknown status
Terminated
Completed
Unknown status
Active, not recruiting
Terminated
Active, not recruiting
Active, not recruiting
Completed
Completed
Active, not recruiting
Completed
Completed
Terminated
Unknown status
Suspended
Completed
Active, not recruiting
Completed
Completed
Terminated
Completed
Recruiting
Completed
Withdrawn
Terminated
Withdrawn
Terminated
Terminated
Completed
Terminated
Recruiting
Completed
Recruiting
Completed
Active, not recruiting
Terminated
Completed
Active, not recruiting
Terminated
Completed
Withdrawn
Terminated
Terminated
Completed
Withdrawn
Completed
Active, not recruiting
Recruiting
Completed
Active, not recruiting
Completed
Withdrawn
Completed
Completed
Completed
Completed
Active, not recruiting
Completed
Completed
Withdrawn
Terminated
Completed
Active, not recruiting
Recruiting
Active, not recruiting
Completed
Unknown status
Completed
Recruiting
Completed
Completed
Terminated
Completed
Completed
Completed
Active, not recruiting
Active, not recruiting
Terminated
Completed
Recruiting
Active, not recruiting
Recruiting
Completed
Active, not recruiting
Completed
Completed
Completed
Unknown status
Terminated
Completed
Active, not recruiting
Recruiting
Completed
Completed
Completed
Active, not recruiting
Terminated
Completed
Active, not recruiting
Recruiting
Recruiting
Recruiting
Completed
Completed
Completed
Active, not recruiting
Completed
Completed
Terminated
Completed
Completed
Recruiting
Unknown status
Recruiting
Unknown status
Completed
Completed
Completed
Recruiting
Completed
Terminated
Completed
Active, not recruiting
Terminated
Completed
Withdrawn
Recruiting
Completed
Completed
Completed
Recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Withdrawn
Terminated
Completed
Completed
Completed
Completed
Active, not recruiting
Completed
Terminated
Completed
Terminated
Terminated
Completed
Completed
Recruiting
Withdrawn
Completed
Active, not recruiting
Active, not recruiting
Completed
Active, not recruiting
Recruiting
Terminated
Recruiting
Terminated
Withdrawn
Completed
Recruiting
Active, not recruiting
Terminated
Active, not recruiting
Recruiting
Recruiting
Terminated
Terminated
Completed
Completed
Terminated
Completed
Recruiting
Active, not recruiting
Terminated
Completed
Completed
Recruiting
Completed
Terminated
Unknown status
Terminated
Completed
Completed
Terminated
Completed
Completed
Terminated
Completed
Recruiting
Terminated
Completed
Terminated
Completed
Completed
Active, not recruiting
Active, not recruiting
Completed
Terminated
Completed
Terminated
Recruiting
Completed
Completed
Active, not recruiting
Terminated
Active, not recruiting
Recruiting
Completed
Completed
Recruiting
Completed
Recruiting
Completed
Recruiting
Completed
Active, not recruiting
Terminated
Recruiting
Completed
Completed
Recruiting
Terminated
Recruiting
Not yet recruiting
Active, not recruiting
Recruiting
Completed
Active, not recruiting
Active, not recruiting
Recruiting
Completed
Terminated
Terminated
Active, not recruiting
Terminated
Completed
Terminated
Active, not recruiting
Completed
Completed
Active, not recruiting
Completed
Completed
Completed
Terminated
Completed
Completed
Completed
Recruiting
Suspended
Completed
Recruiting
Active, not recruiting
Completed
Active, not recruiting
Terminated
Completed
Recruiting
Completed
Active, not recruiting
Completed
Recruiting
Completed
Completed
Terminated
Recruiting
Completed
Completed
Completed
Completed
Active, not recruiting
Terminated
Completed
Completed
Active, not recruiting
Completed
Completed
Active, not recruiting
Not yet recruiting
Recruiting
Active, not recruiting
Completed
Completed
Completed
Not yet recruiting
Terminated
Completed
Completed
Terminated
Completed
Terminated
Unknown status
Recruiting
Active, not recruiting
Available
Recruiting
Completed
Recruiting
Completed
Completed
Active, not recruiting
Not yet recruiting
Terminated
Terminated
Completed
Active, not recruiting
Recruiting
Active, not recruiting
Completed
Completed
Unknown status
Completed
Active, not recruiting
Active, not recruiting
Completed
Completed
Recruiting
Approved for marketing
Recruiting
Active, not recruiting
Completed
Active, not recruiting
Recruiting
Active, not recruiting
Completed
Active, not recruiting
Completed
Completed
Active, not recruiting
Completed
Recruiting
Completed
Not yet recruiting
Terminated
Completed
Active, not recruiting
No longer available
Recruiting
Recruiting
Recruiting
Active, not recruiting
Certolizumab pegol
PHA-738144, CDP-870, CZP
Approved
Ucb
Infertility, Male, Arthritis, Rheumatoid, Spondylarthropathies, Spondylarthritis, Spondylitis, Ankylosing, Multiple Sclerosis, Psoriasis, Arthritis, Psoriatic, Osteoarthritis, Spine, Crohn Disease, Plaque psoriasis
NCT Number
NCT01500278
NCT01443364
NCT02714634
NCT01255761
NCT02466581
NCT02451748
NCT01024647
NCT02353780
NCT00580840
NCT02597829
NCT01602302
NCT03020992
NCT00993668
NCT02242474
NCT01295151
NCT01696942
NCT01491815
NCT01548768
NCT01147341
NCT00308581
NCT00851318
NCT00356408
NCT00358683
NCT03357471
NCT00152386
NCT01235598
NCT00674362
NCT00160602
NCT01817972
NCT03368664
NCT00160641
NCT02326298
NCT00993317
NCT01521923
NCT00552058
NCT00753454
NCT02505542
NCT00333788
NCT02151851
NCT00717236
NCT01197066
NCT01292265
NCT01374971
NCT01213017
NCT01864265
NCT00552344
NCT00160524
NCT00850343
NCT02586246
NCT00160693
NCT00152490
NCT00160706
NCT00307931
NCT00297648
NCT00354367
NCT02346240
NCT01550003
NCT01451203
NCT04610476
NCT01590966
NCT00544154
NCT00791921
NCT02552212
NCT04123795
NCT01087788
NCT00152425
NCT04643483
NCT02319642
NCT02497976
NCT00175877
NCT00548834
NCT02326272
NCT00349752
NCT01087762
NCT01519791
NCT00843778
NCT00791999
NCT03051217
NCT01090154
NCT00329303
NCT00329420
NCT01190410
NCT00245765
NCT00329550
NCT03215277
NCT02293590
NCT02430909
NCT00291668
NCT00899678
NCT03152058
NCT00813774
NCT04740814
NCT02806219
NCT00845663
NCT02120807
NCT02365948
NCT02154425
NCT01091220
NCT02019602
NCT04163016
NCT01288287
NCT00844285
NCT01773681
NCT03062865
NCT03559686
NCT04053881
NCT04378621
NCT01053559
NCT02714881
NCT01797224
NCT03559660
NCT03016260
NCT01764321
NCT02073526
NCT02619552
NCT01098201
NCT02775656
NCT01577264
NCT02354105
NCT01069419
NCT01582568
NCT03955861
NCT02620189
NCT01095393
NCT04569890
NCT03266471
NCT01625650
NCT01489384
NCT01691014
NCT01526434
NCT04725422
Intervention Type
Biological, Drug
Biological
Drug
Biological
Biological, Drug
Other, Drug
Biological
Drug
Other, Drug
Drug
Drug
Drug
Other, Biological
Drug
Biological, Drug
Drug
Biological, Drug
Drug
Drug
Other, Biological
Drug
Biological
Drug
Drug
Drug
Other, Biological
Biological
Drug
Biological, Drug
Drug
Biological
Other, Biological
Drug
Biological
Other, Biological
Drug
Other, Biological
Biological
Other, Biological, Drug
Other, Drug
Drug
Biological
Procedure, Drug
Drug
Drug
Biological
Biological
Drug
Drug
Biological
Drug
Biological
Biological
Biological
Drug
Other, Biological
Drug
Drug
Drug
Drug
Drug
Drug
Other, Biological
Drug
Other, Biological
Drug
Drug
Drug
Biological, Drug
Biological
Drug
Other, Biological
Other, Biological
Other, Biological
Other, Biological
Biological
Drug
Other, Drug
Drug
Drug
Biological
Drug
Other, Drug
Biological
Other, Drug
Drug
Other, Biological
Other, Biological
Drug
Drug
Biological
Drug
Device
Drug
Drug
Other, Biological
Procedure, Biological
Biological
Procedure, Biological
Drug
Drug
Drug, Device
Other
Drug
Drug
Other, Drug
Drug
Radiation, Drug
Drug
Biological
Drug
Drug
Drug
Drug
Biological
Drug
Drug
Diagnostic Test, Other
Other
Drug
Indications
Rheumatoid Arthritis
Rheumatoid Arthritis
Rheumatoid Arthritis; Insufficient Response to Methotrexate.
Rheumatoid Arthritis
Rheumatoid Arthritis
Rheumatoid Arthritis
Crohn's Disease
Rheumatoid Arthritis (RA)
Rheumatoid Arthritis
Crohn's Disease
Rheumatoid Arthritis
Axial Spondyloarthritis (axSpA); Anterior Uveitis (AU)
Rheumatoid Arthritis
Rheumatoid Arthritis
Rheumatoid Arthritis
Crohn's Disease
Rheumatoid Arthritis
Rheumatoid Arthritis
Rheumatoid Arthritis
Crohn's Disease
Rheumatoid Arthritis
Crohn's Disease
Crohn's Disease
Moderate and Severe Active Rheumatoid Arthritis; Active Psoriatic Arthritis; Active Ankylosing Spondylitis; Moderately to Severely Active Crohn's Disease
Rheumatoid Arthritis
Rheumatoid Arthritis
Rheumatoid Arthritis
Rheumatoid Arthritis
Crohn's Disease
Multiple Sclerosis
Rheumatoid Arthritis
Psoriasis; Plaque Psoriasis
Rheumatoid Arthritis
Rheumatoid Arthritis
Crohn Disease
Rheumatoid Arthritis
Axial Spondyloarthrithis; Ankylosing Spondylitis
Crohn's Disease
Rheumatoid Arthritis
Rheumatoid Arthritis
Rheumatoid Arthritis
Rheumatoid Arthritis
Rheumatoid Arthritis
Rheumatoid Arthritis
Rheumatoid Arthritis
Crohn Disease
Crohn's Disease
Rheumatoid Arthritis
Active Rheumatoid Arthritis
Rheumatoid Arthritis
Crohn's Disease
Crohn's Disease
Crohn's Disease
Crohn's Disease
Crohn Disease
Psoriasis; Plaque Psoriasis
Polyarticular-course Juvenile Idiopathic Arthritis (JIA)
Rheumatoid Arthritis
Psoriatic Arthritis; Withdrawal; Reduction
Axial and Peripheral Spondyloarthritis; Rheumatoid Arthritis
Arthritis, Rheumatoid
Rheumatoid Arthritis
Axial Spondyloarthritis; Nonradiographic Axial Spondyloarthritis; Nr-axSpA
Moderate Chronic Plaque Psoriasis; Severe Chronic Plaque Psoriasis; Mixed Guttate/Plaque Psoriasis
Arthritis, Psoriatic
Crohn's Disease
Crohn's Disease
Rheumatoid Arthritis
Cystitis, Interstitial
Rheumatoid Arthritis
Rheumatoid Arthritis
Psoriasis; Plaque Psoriasis
Crohn's Disease
Spondyloarthropathies
Rheumatoid Arthritis
Rheumatoid Arthritis
Rheumatoid Arthritis
Moderate to Severe Psoriasis; Generalized Pustular Psoriasis and Erythrodermic Psoriasis
Ulcerative Colitis
Psoriasis
Crohn's Disease
Crohn's Disease
Chronic Plaque Psoriasis
Crohn's Disease
Ankylosing Spondylitis
Rheumatoid Arthritis
Rheumatoid Arthritis
Crohn's Disease
Crohn's Disease
High Risk Pregnancy; Pregnancy Complications; Antiphospholipid Syndrome in Pregnancy; Lupus Anticoagulant Disorder
Bioavailability Study on Healthy Volunteers
Rheumatoid Arthritis
Healthy
Healthy
Stage IV Lung Adenocarcinoma
Healthy Subjects
Axial Spondyloarthritis (AxSpA); Non-radiographic Evidence-AxSpA; Ankylosing Spondylitis; Crohn's Disease; Psoriatic Arthritis; Rheumatoid Arthritis
Sperm Quality
Axial Spondyloarthritis (AxSpA); Non-radiographic Evidence-AxSpA; Ankylosing Spondylitis; Crohn's Disease; Psoriatic Arthritis; Rheumatoid Arthritis
Rheumatoid Arthritis; Psoriatic Arthritis; Crohn's Disease; Axial Spondyloarthritis; Plaque Psoriasis
Arthritis,Rheumatoid
Crohn's Disease
Rheumatoid Arthritis
RheumatoId Arthritis
Rheumatoid Arthritis
Plaque Psoriasis
Rheumatoid Arthritis; Pain; Fatigue; Cognitive Decline; Depression; Brain Diseases; Hand Rheumatism
Crohn's Disease
Rheumatoid Arthritis; Cardiovascular Disease
Crohn's Disease; Rheumatoid Arthritis; Ankylosing Spondylitis; Psoriatic Arthritis; Psoriasis
Crohn's Disease
RheumatoId Arthritis
Rheumatoid Arthritis
Inflammatory Bowel Disease; Crohn's Disease; Ulcerative Colitis
Crohn's Disease; IBD
Rheumatoid Arthritis
Rheumatoid Arthritis (RA); Crohn's Disease (CD); Psoriatic Arthritis (PsA); Axial Spondyloarthritis and Ankylosing Spondylitis
Rheumatoid Arthritis; Crohn's Disease
Axial Spondyloarthritis
Rheumatoid Arthritis
Crohns Disease
Psoriatic Arthritis; Psoriasis; Enthesitis
Rheumatoid Arthritis
Rheumatoid Arthritis
Rheumatoid Arthritis; Pregnancy Related
Inflammatory Bowel Diseases
Rheumatoid Arthritis
Rheumatoid Arthritis
Rheumatoid Arthritis (RA)
Rheumatoid Arthritis
Chronic Nonbacterial Osteomyelitis; Chronic Recurrent Multifocal Osteomyelitis
Study Phase
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Recruitment Status
Completed
Completed
Unknown status
Completed
Active, not recruiting
Completed
Unknown status
Terminated
Completed
Unknown status
Terminated
Completed
Completed
Unknown status
Completed
Terminated
Active, not recruiting
Completed
Completed
Completed
Completed
Completed
Withdrawn
Completed
Completed
Completed
Completed
Completed
Unknown status
Active, not recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Terminated
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Terminated
Completed
Withdrawn
Completed
Recruiting
Completed
Not yet recruiting
Completed
Completed
Completed
Completed
Recruiting
Completed
Completed
Not yet recruiting
Completed
Completed
Completed
Completed
Completed
Terminated
Completed
Completed
Completed
Completed
Completed
Active, not recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Terminated
Recruiting
Completed
Not yet recruiting
Completed
Completed
Active, not recruiting
Completed
Completed
Completed
Completed
Recruiting
Completed
Completed
Completed
Recruiting
Available
Recruiting
Not yet recruiting
Completed
Active, not recruiting
Recruiting
Available
Terminated
Completed
Completed
Completed
Completed
Terminated
Terminated
Completed
Completed
Terminated
Recruiting
Unknown status
Completed
Not yet recruiting
Active, not recruiting
Completed
Unknown status
Terminated
Completed
Recruiting
Infliximab (ABDA)
SB-2
Approved
Samsung Bioepis, Merck & Co Inc
Spondylitis, Ankylosing, Arthritis, Rheumatoid, Psoriasis, Arthritis, Psoriatic, Colitis, Ulcerative, Crohn Disease
NCT Number
NCT01936181
NCT04305145
NCT01922336
NCT03662919
NCT04378621
NCT03016260
Intervention Type
Drug
Drug
Biological
Drug
Other, Drug
Biological
Indications
Rheumatoid Arthritis
Melanoma Stage III; Melanoma Stage IV; Side Effect of Drug; Colitis
Healthy
Arthritis, Rheumatoid; Spondylitis, Ankylosing; Arthritis, Psoriatic; Crohn's Disease; Colitis, Ulcerative
Rheumatoid Arthritis; Pain; Fatigue; Cognitive Decline; Depression; Brain Diseases; Hand Rheumatism
RheumatoId Arthritis
Study Phase
Phase 3
Phase 2
Phase 1
N/A
N/A
N/A
Recruitment Status
Completed
Recruiting
Completed
Recruiting
Not yet recruiting
Terminated
Etanercept biosimilar (Mycenax Biotech/TSH Biopharm)
ENIA-11, E-11
Approved
Mycenax Biotech Inc, Tsh Biopharm
Spondylitis, Ankylosing, Arthritis, Rheumatoid
NCT Number
NCT01787149
NCT01709760
NCT02685904
Intervention Type
Drug
Drug
Biological
Indications
Combination With DMARDs
Rheumatoid Arthritis
Ankylosing Spondylitis
Study Phase
Phase 3
Phase 3
Phase 3
Recruitment Status
Unknown status
Unknown status
Terminated
PG-201
PG-201
Approved
Viromed
Osteoarthritis, Knee, Osteoarthritis
NCT Number
NCT02049606
NCT01768468
NCT01576419
NCT01122485
Intervention Type
Drug
Drug
Drug
Other
Indications
Osteoarthritis of the Knee
Osteoarthritis of the Knee
Osteoarthritis of the Knee
Osteoarthritis of the Knee
Study Phase
Phase 4
Phase 4
Phase 3
Phase 2
Recruitment Status
Completed
Completed
Completed
Completed
Adalimumab
D2E7, ABT-D2E7, LU-200134
Approved
Abbvie Inc
Pyoderma Gangrenosum, Coronavirus Disease 2019 (COVID-19), Arthritis, Rheumatoid, Spondylitis, Ankylosing, Arthritis, Juvenile, Psoriasis, Colitis, Ulcerative, Arthritis, Psoriatic, Asthma, Osteoarthritis, Knee, Hidradenitis Suppurativa, Uveitis, Arthritis, Crohn Disease, Plaque psoriasis
NCT Number
NCT01270035
NCT02634541
NCT02808975
NCT02489760
NCT01500278
NCT04300686
NCT00761514
NCT03220841
NCT01185288
NCT02897115
NCT02242474
NCT01716039
NCT00216177
NCT00233558
NCT01602302
NCT01270087
NCT00940862
NCT00234234
NCT04086745
NCT01609205
NCT00932113
NCT01866592
NCT03619876
NCT01548768
NCT02132234
NCT02374021
NCT00420927
NCT00133315
NCT00837434
NCT02852694
NCT02198651
NCT00972218
NCT02994836
NCT00234897
NCT03917303
NCT02492217
NCT00735787
NCT01722214
NCT01644396
NCT01405326
NCT04132388
NCT00477893
NCT03505008
NCT02256462
NCT03059849
NCT04131322
NCT01553058
NCT01382160
NCT01556672
NCT01893996
NCT00649922
NCT03737708
NCT02814175
NCT03221621
NCT00480272
NCT01072058
NCT01465438
NCT02056184
NCT01265823
NCT01793519
NCT04194827
NCT01181570
NCT00796705
NCT02148718
NCT00808509
NCT04045782
NCT01295151
NCT01895764
NCT01698307
NCT01162421
NCT02035800
NCT01604629
NCT00291915
NCT02878161
NCT03739853
NCT04646187
NCT02764762
NCT01174186
NCT00517296
NCT01088165
NCT01029847
NCT00853099
NCT04610476
NCT00385736
NCT00686374
NCT00348283
NCT00566722
NCT00775437
NCT02722044
NCT01243671
NCT00195663
NCT03172325
NCT00048542
NCT01646073
NCT00235872
NCT00427921
NCT02629159
NCT04705844
NCT03311464
NCT01870284
NCT01064856
NCT00338650
NCT04115748
NCT04088409
NCT00409617
NCT02332356
NCT02016105
NCT00667355
NCT00448383
NCT02499783
NCT02016482
NCT00427362
NCT00049751
NCT00647270
NCT01138657
NCT00195819
NCT00927069
NCT02150473
NCT00646178
NCT01468207
NCT01468233
NCT02185014
NCT00660647
NCT00077779
NCT00603993
NCT02632175
NCT01494857
NCT01166282
NCT03104400
NCT00195702
NCT00195650
NCT01986127
NCT01185301
NCT04404517
NCT03816397
NCT02019472
NCT00513370
NCT00939003
NCT00736983
NCT00478660
NCT00305539
NCT00235885
NCT01764997
NCT00237887
NCT02065570
NCT04527380
NCT00234936
NCT00870467
NCT00085644
NCT00929864
NCT01674413
NCT01629628
NCT01497717
NCT01550965
NCT01148225
NCT00409682
NCT04230213
NCT04798755
NCT01670240
NCT02065622
NCT01562951
NCT00055497
NCT00690573
NCT01251614
NCT01808118
NCT03849404
NCT01635764
NCT01124838
NCT02196701
NCT02497469
NCT02065557
NCT00573794
NCT01231321
NCT01295814
NCT00235859
NCT00233571
NCT03828019
NCT02207231
NCT02889796
NCT02533375
NCT01235689
NCT03906136
NCT00235820
NCT01114880
NCT03789292
NCT02840175
NCT00195715
NCT01958827
NCT03412747
NCT02904902
NCT00195676
NCT00574249
NCT02207244
NCT00105300
NCT00234845
NCT00647920
NCT00408629
NCT00445432
NCT00538902
NCT00647491
NCT00445939
NCT03759288
NCT00647400
NCT03217734
NCT00348153
NCT00235105
NCT00470509
NCT01136252
NCT00645814
NCT01163617
NCT02833350
NCT02015793
NCT00690911
NCT02456363
NCT00235833
NCT03248531
NCT02862574
NCT00690846
NCT02706704
NCT01225393
NCT00512863
NCT00645905
NCT03823391
NCT00055523
NCT03180957
NCT04655807
NCT00730717
NCT00731757
NCT00827996
NCT04154852
NCT01502423
NCT01752855
NCT03651518
NCT01561313
NCT00274352
NCT00814255
NCT02349451
NCT02113904
NCT00646386
NCT00185562
NCT00298272
NCT02141997
NCT00514982
NCT02471118
NCT00645892
NCT00646191
NCT00918255
NCT00525902
NCT04009668
NCT00311246
NCT04588818
NCT01704599
NCT00686439
NCT03153319
NCT03607903
NCT02437253
NCT03849313
NCT00650156
NCT03254810
NCT00855608
NCT00421642
NCT02516774
NCT04439929
NCT03273192
NCT02675023
NCT02144714
NCT00193648
NCT04514796
NCT01101555
NCT02927353
NCT03983876
NCT02252809
NCT04131504
NCT00649545
NCT02963402
NCT01078571
NCT04089514
NCT03261102
NCT01592292
NCT01078610
NCT01012570
NCT02739828
NCT01736189
NCT00650390
NCT01613963
NCT00963313
NCT03016260
NCT02376478
NCT03561649
NCT01812954
NCT01971970
NCT01197144
NCT00234884
NCT00724672
NCT00814866
NCT03681652
NCT00783510
NCT00650026
NCT02330380
NCT02450513
NCT04808739
NCT03775824
NCT01610947
NCT01356758
NCT00497614
NCT04378621
NCT02878083
NCT03043677
NCT04449224
NCT01029613
NCT03955861
NCT02539849
NCT01706692
NCT04752748
NCT03496831
NCT04725422
Intervention Type
Drug
Other, Drug
Drug
Biological
Biological, Drug
Biological
Drug
Procedure, Drug
Biological, Drug
Other, Biological
Drug
Drug
Drug
Drug
Drug
Drug
Other, Biological, Device
Drug
Drug
Biological
Drug
Drug
Drug
Drug
Drug
Drug
Biological, Drug
Drug
Drug
Drug
Other, Biological
Biological
Biological, Drug
Drug
Drug
Drug
Biological
Other, Biological
Biological
Biological
Other, Drug
Drug
Drug
Drug
Drug
Drug
Other, Drug
Biological
Drug, Device
Drug
Biological
Biological, Drug
Biological, Drug
Procedure, Drug
Drug
Drug
Drug
Drug
Biological
Drug
Diagnostic Test, Drug
Drug
Drug
Biological
Biological, Drug
Drug
Biological, Drug
Drug
Other
Biological, Drug
Drug
Drug
Drug
Biological, Drug
Drug
Biological
Drug
Drug
Procedure, Drug
Other, Drug
Drug
Biological, Drug
Drug
Biological
Biological
Biological
Biological
Drug
Biological, Device
Biological
Biological, Drug
Drug
Biological, Drug
Biological
Biological
Biological
Drug
Drug
Drug
Drug
Biological
Drug
Drug
Drug
Biological
Drug
Drug
Biological
Biological
Other, Biological
Other, Biological
Drug
Drug
Drug
Biological, Drug
Biological
Drug
Drug
Drug
Biological
Biological
Drug
Drug
Drug
Biological
Biological
Drug
Biological
Drug
Biological, Drug
Biological
Drug
Biological, Drug
Drug
Other, Biological
Biological, Drug
Biological
Biological
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological, Drug
Biological
Drug
Drug
Drug
Drug
Biological
Drug
Biological
Drug
Drug
Drug
Other, Drug
Drug
Biological
Biological
Biological, Drug
Biological
Biological
Biological
Drug
Drug
Drug
Biological
Biological
Drug
Other, Drug
Drug
Biological
Biological, Drug
Drug
Drug
Drug
Biological, Drug
Other, Biological
Drug
Other, Biological
Biological
Drug
Biological
Biological
Other, Drug
Drug
Drug
Biological, Drug
Drug
Drug
Drug
Biological
Biological
Other, Biological
Biological
Biological
Biological
Drug
Biological
Biological, Drug
Drug
Drug
Drug
Drug
Drug
Device
Drug
Biological
Drug
Biological, Drug
Biological
Other, Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological
Biological
Drug
Biological
Drug
Drug
Biological
Drug
Drug
Drug
Biological, Drug, Dietary Supplement
Biological
Drug
Drug
Drug
Drug
Biological, Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other, Biological
Other, Drug
Drug
Biological
Biological
Drug
Drug
Drug
Biological
Drug
Biological
Biological
Drug
Drug
Other, Drug
Drug
Drug
Drug
Drug
Biological
Drug
Biological
Drug
Biological
Drug
Biological
Drug
Biological
Drug
Biological
Drug
Drug
Biological
Other, Drug
Drug
Drug
Biological
Drug
Biological
Drug
Drug
Drug
Biological, Drug
Biological
Other, Drug
Drug
Biological
Drug
Drug
Drug
Drug
Other, Drug
Drug
Biological
Drug
Drug
Biological
Drug, Dietary Supplement
Biological, Drug
Drug
Drug
Drug
Indications
Rheumatoid Arthritis
Ankylosing Spondyloarthritis
Hidradenitis Suppurativa (HS)
Ankylosing Spondylitis
Rheumatoid Arthritis
Takayasu Arteritis; Tocilizumab; Adalimumab; Treatment
Rheumatoid Arthritis
Crohn Disease; Inflammatory Bowel Diseases; Stricture; Bowel
Rheumatoid Arthritis
Axial Spondyloarthritis
Rheumatoid Arthritis
Ulcerative Colitis
Rheumatoid Arthritis
Rheumatoid Arthritis
Rheumatoid Arthritis
Rheumatoid Arthritis
Psoriasis; Vascular Inflammation; Coronary Atherosclerosis
Rheumatoid Arthritis
Rheumatoid Arthritis
Rheumatoid Arthritis
Psoriasis
Psoriasis; Cardiovascular Disease
Rheumatoid Arthritis; Myocardial Inflammation
Rheumatoid Arthritis
Rheumatoid Arthritis; Psoriatic Arthritis; Ankylosing Spondylitis; Hypertension
Arthritis, Rheumatoid
Rheumatoid Arthritis
Spondylarthropathies; Ankylosing Spondylitis; Psoriatic Arthritis
Rheumatoid Arthritis
Crohn's Disease
Rheumatoid Arthritis; Musculoskeletal and Connective Tissue Diseases
Spondyloarthritis; Crohn's Disease
Crohn's Disease; Inflammatory Bowel Disease; Ulcerative Colitis
Rheumatoid Arthritis
Crohn Disease; Inflammatory Bowel Diseases
Ankylosing Spondylitis
Psoriasis
Psoriasis; Vascular Inflammation; Coronary Atherosclerosis
Moderate to Severe Plaque Psoriasis
Rheumatoid Arthritis
Hidradenitis Suppurativa
Spondyloarthritis
Rheumatoid Arthritis
Crohn's Disease
Crohn Disease; Ulcerative Colitis
Crohn Disease; Ulcerative Colitis
Psoriasis; Cardiovascular Disease
Rheumatoid Arthritis
Plaque Psoriasis; Crohn's Disease
Rheumatoid Arthritis; Cardiovascular Disease
Rheumatoid Arthritis
Rheumatoid Arthritis (RA)
Psoriatic Arthritis
Hidradenitis Suppurativa
Rheumatoid Arthritis
Arthritis, Rheumatoid; Spondylitis, Ankylosing
Psoriatic Arthritis
Rheumatoid Arthritis; Targeted Ultrasound
Psoriasis
Rheumatoid Arthritis
Rheumatoid Arthritis
Psoriasis; Sleep Apnea, Obstructive
Rheumatoid Arthritis
Moderate to Severe Crohn's Disease
Arthritis, Rheumatoid
Inflammatory Bowel Diseases
Rheumatoid Arthritis
Ankylosing Spondylitis
Crohn's Disease
Rheumatoid Arthritis
RheumatoId Arthritis
Spondylarthropathies
Rheumatoid Arthritis; Arthritis
Rheumatoid Arthritis
Psoriatic Arthritis
Crohn Disease
Spondyloarthritis; Enterocolitis
Crohn Disease; Rectal Fistula
Psoriasis; Cardiovascular Diseases; Diabetes Mellitus, Type 2
Spondyloarthritis
Ulcerative Colitis
Psoriatic Arthritis; Withdrawal; Reduction
Ulcerative Colitis
Crohn's Disease
Crohn's Disease
Psoriasis
Juvenile Idiopathic Arthritis
Rheumatoid Arthritis
Intestinal Behçet's Disease
Early Rheumatoid Arthritis
Active Rheumatoid Arthritis
Arthritis, Juvenile Idiopathic
Plaque Psoriasis
Rheumatoid Arthritis
Crohn's Disease
Rheumatoid Arthritis
Mild to Moderate COVID-19
Pyoderma Gangrenosum
Spondylitis, Ankylosing
Peripheral Spondyloarthritis
Crohn's Disease
Psoriatic Arthritis
Uveitis
Crohn's Disease
Crohn Disease
Plaque Type Psoriasis
Ankylosing Spondylitis
Rheumatoid Arthritis
Crohn's Disease
Nail Psoriasis; Plaque Psoriasis
Psoriatic Arthritis
Rheumatoid Arthritis
Rheumatoid Arthritis
Uveitis
Ankylosing Spondylitis
Plaque Psoriasis
Rheumatoid Arthritis
Arthritis; Psoriatic
Hidradenitis Suppurativa (HS)
Hidradenitis Suppurativa (HS)
Crohn's Disease
Arthritis, Rheumatoid
Crohn's Disease
Rheumatoid Arthritis
Ulcerative Colitis
Ulcerative Colitis
Enthesitis Related Arthritis (ERA)
Psoriatic Arthritis
Rheumatoid Arthritis
Rheumatoid Arthritis
Crohn's Disease
Early Rheumatoid Arthritis
Inflammatory Bowel Diseases
Uveitis; JIA
Arthritis, Rheumatoid
Psoriasis
Axial Spondyloarthritis
Crohn's Disease With Perianal Fistulas
Ankylosing Spondylitis
Giant Cell Arteritis
Psoriatic Arthritis
Rheumatoid Arthritis
Psoriasis
Crohn's Disease
Juvenile Psoriatic Arthritis; Enthesitis Related Arthritis
Rheumatoid Arthritis
Rheumatoid Arthritis
Ankylosing Spondylitis
Rheumatoid Arthritis
Crohn's Disease
Crohn Disease
Arthritis; Behcet
Ulcerative Colitis
Uveitis
Crohn's Disease
Rheumatoid Arthritis
Ulcerative Colitis; Pouchitis
Ulcerative Colitis (UC)
Crohn's Disease; Mucosal Inflammation
Crohn's Disease
Juvenile Rheumatoid Arthritis
Plaque Psoriasis
Axial Spondyloarthritis
Plaque Psoriasis
Hidradenitis Suppurativa
Uveitis
Psoriasis
Colitis, Ulcerative
Ulcerative Colitis
Ulcerative Colitis
Rheumatoid Arthritis
Interstitial Cystitis
Rheumatoid Arthritis
Rheumatoid Arthritis
Uveitis
Psoriasis
Rheumatoid Arthritis
Generalized Pustular Psoriasis (GPP); Adalimumab; Japanese
Crohn's Disease
Axial Spondyloarthritis
Psoriasis
Ankylosing Spondylitis
Rheumatoid Arthritis
Juvenile Idiopathic Arthritis
Crohn's Disease
Crohn's Disease
Chronic Plaque Psoriasis; Moderate to Severe Plaque Psoriasis
Hidradenitis Suppurativa
Psoriasis
Chronic Plaque Psoriasis
Psoriasis
Crohn's Disease
Rheumatoid Arthritis
Rheumatoid Arthritis
Ulcerative Colitis
Crohn's Disease
Rheumatoid Arthritis
Rheumatoid Arthritis
Crohn's Disease
Crohn's Disease; IBD
Psoriasis
Psoriasis
Uveitis
Ankylosing Spondylitis
Sciatica
Age-Related Macular Degeneration; Choroidal Neovascularization
Psoriasis
Rheumatoid Arthritis
Rheumatoid Arthritis
Crohn's Disease
Sarcoidosis
Ankylosing Spondylitis
Rheumatoid Arthritis
Hidradenitis Suppurativa
Rheumatoid Arthritis
Pyoderma Gangrenosum
Uveitis; Non-Infectious Uveitis
Rheumatoid Arthritis
Asthma
Psoriasis
Rheumatoid Arthritis (RA)
Crohn's Disease
Dupuytren's Disease
Pyoderma Gangrenosum
Sarcoidosis; Cutaneous Sarcoidosis
Hidradenitis Suppurativa
Oligoarthritis
Rheumatoid Arthritis
Rheumatoid Arthritis
Inflammatory Disease; Autoimmune Diseases
Rheumatoid Arthritis
Sarcoidosis
Focal Segmental Glomerulosclerosis
Psoriatic Arthritis
Netherton Syndrome
Arthritis; Psoriatic
Osteoarthritis
Rheumatoid Arthritis
Rheumatoid Arthritis
Hermanski-Pudlak Syndrome; Colitis; Cytokines; Lymphocytes; Drug Evaluation
Osteoarthritis, Knee
Psoriasis
Psoriasis
Hidradenitis Suppurativa
Uveitis
FSGS; MCD; Focal Segmental Glomerulosclerosis; Minimal Change Disease
Sarcoidosis
Uveitis
Psoriasis
Osteoarthritis
Mucopolysaccharidosis I; Mucopolysaccharidosis II
Pain; Injection Site
Mucopolysaccharidosis Type I; Mucopolysaccharidosis Type II; Mucopolysaccharidosis Type VI
Healthy Volunteers
Rheumatoid Arthritis
Arthritis, Rheumatoid
Uveitis; Diabetic Retinopathy; Choroidal Neovascularization
Ulcerative Colitis
Anaplastic Thyroid Cancers
Healthy Participants
Bioequivalence; Phase 1
Healthy
Healthy
Focal Glomerulosclerosis
Healthy
Arthritis, Rheumatoid
Healthy Volunteer
Plaque Psoriasis
Innate Immunity
Crohn's Disease; IBD
Rheumatoid Arthritis
Arthritis,Rheumatoid
Rheumatoid Arthritis
Arthritis, Rheumatoid (RA); Axial Spondyloarthritis (axSpA); Arthritis, Psoriatic (PsA); Crohn's Disease (CD); Colitis, Ulcerative (UC)
Crohn Disease; Drug Monitoring; Inflammatory Bowel Diseases
Rheumatoid Arthritis
Psoriatic Arthritis
Crohn's Disease
Hidradenitis Suppurativa
Rheumatoid Arthritis
Rheumatoid Arthritis
Uveitis; Scleritis
Psoriatic Arthritis
RheumatoId Arthritis
Psoriasis; Inflammatory Bowel Diseases
Psoriasis
Inflammatory Bowel Diseases
Arthritis, Rheumatoid; Pain; Fatigue
Rheumatoid Arthritis
Rheumatoid Arthritis
Rheumatoid Arthritis
Crohn Disease
Juvenile Idiopathic Arthritis; JIA
Rheumatoid Arthritis
Psoriasis; Inflammation
Crohn's Disease
Psoriasis
Rheumatoid Arthritis
Spondyloarthritis
Psoriasis; Atopic Dermatitis; Atherosclerosis
Rheumatoid Arthritis
Rheumatoid Arthritis; Pain; Fatigue; Cognitive Decline; Depression; Brain Diseases; Hand Rheumatism
ULCERATIVE COLITIS
Inflammatory Bowel Disease
Rheumatoid Arthritis
Rheumatoid Arthritis
Psoriatic Arthritis; Psoriasis; Enthesitis
Crohn Disease
Psoriasis
Early Rheumatoid Arthritis
Rheumatoid Arthritis; Spondyloarthritis; Psoriatic Arthritis
Chronic Nonbacterial Osteomyelitis; Chronic Recurrent Multifocal Osteomyelitis
Study Phase
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Early Phase 1
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Recruitment Status
Unknown status
Unknown status
Completed
Unknown status
Completed
Recruiting
Terminated
Active, not recruiting
Completed
Terminated
Unknown status
Active, not recruiting
Unknown status
Terminated
Terminated
Completed
Completed
Completed
Recruiting
Completed
Completed
Completed
Recruiting
Completed
Unknown status
Recruiting
Completed
Completed
Completed
Recruiting
Completed
Withdrawn
Active, not recruiting
Completed
Recruiting
Completed
Completed
Completed
Completed
Unknown status
Not yet recruiting
Unknown status
Active, not recruiting
Completed
Withdrawn
Terminated
Completed
Completed
Completed
Unknown status
Completed
Completed
Completed
Recruiting
Completed
Unknown status
Completed
Completed
Completed
Recruiting
Recruiting
Completed
Terminated
Completed
Completed
Recruiting
Completed
Completed
Completed
Completed
Unknown status
Completed
Unknown status
Unknown status
Recruiting
Recruiting
Active, not recruiting
Completed
Completed
Unknown status
Completed
Completed
Not yet recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Active, not recruiting
Not yet recruiting
Completed
Withdrawn
Completed
Completed
Active, not recruiting
Recruiting
Completed
Recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Terminated
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Active, not recruiting
Unknown status
Completed
Active, not recruiting
Completed
Completed
Terminated
Completed
Recruiting
Recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Terminated
Completed
Completed
Not yet recruiting
Completed
Completed
Completed
Completed
Withdrawn
Unknown status
Completed
Completed
Completed
Completed
Recruiting
Not yet recruiting
Completed
Completed
Terminated
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Recruiting
Completed
Completed
Completed
Completed
Recruiting
Completed
Completed
Active, not recruiting
Active, not recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Active, not recruiting
Completed
Completed
Unknown status
Unknown status
Completed
Completed
Completed
Completed
Completed
Completed
Withdrawn
Unknown status
Completed
Completed
Terminated
Withdrawn
Unknown status
Completed
Withdrawn
Completed
Completed
Completed
Active, not recruiting
Recruiting
Withdrawn
Withdrawn
Completed
Completed
Completed
Completed
Recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Terminated
Completed
Withdrawn
Recruiting
Completed
Completed
Completed
Completed
Recruiting
Terminated
Recruiting
Terminated
Completed
Recruiting
Active, not recruiting
Completed
Completed
Completed
Completed
Unknown status
Completed
Withdrawn
Completed
Completed
Completed
Completed
Completed
Recruiting
Completed
Completed
Completed
Completed
Recruiting
Approved for marketing
Completed
Completed
Active, not recruiting
Recruiting
Completed
Withdrawn
Terminated
Completed
Completed
Approved for marketing
Unknown status
Completed
Terminated
Completed
Completed
Completed
Completed
Completed
Completed
Withdrawn
Completed
Recruiting
Active, not recruiting
Approved for marketing
Completed
Unknown status
Completed
Completed
Completed
Completed
Completed
Not yet recruiting
Terminated
Completed
Recruiting
Completed
Recruiting
Completed
Recruiting
Completed
Completed
Recruiting
Pomalidomide
CDC-394, CC-4047, IMiD-1, IMID-4047
Approved
Celgene Corp
Medulloblastoma, Solid tumours, Bone Marrow Neoplasms, Lymphoma, B-Cell, Scleroderma, Systemic, Hodgkin Disease, Lymphoma, Large B-Cell, Diffuse, Multiple Myeloma, Lung Diseases, Interstitial, Central Nervous System Neoplasms, Sarcoma, Prostatic Neoplasms, Lymphoma, Follicular, Primary Myelofibrosis, Lymphoma, Non-Hodgkin, Neoplasm Metastasis, Leukemia, Lymphocytic, Chronic, B-Cell, Sarcoma, Kaposi, Anemia, Sickle Cell
NCT Number
NCT03143049
NCT02576977
NCT01178281
NCT03151811
NCT02990338
NCT01712789
NCT02726581
NCT01311687
NCT03180736
NCT01324947
NCT03651128
NCT03440411
NCT02916420
NCT04181827
NCT01734928
NCT01243944
NCT03539744
NCT04484623
NCT02158702
NCT03227432
NCT02612779
NCT00558896
NCT03567616
NCT02188368
NCT04577755
NCT02294357
NCT00717522
NCT03242460
NCT02718833
NCT03959358
NCT03601624
NCT02011113
NCT04508790
NCT01688466
NCT01053949
NCT01319422
NCT04700176
NCT04191616
NCT01159574
NCT04305444
NCT01946477
NCT00946270
NCT02807454
NCT00072722
NCT03590652
NCT03202628
NCT03756896
NCT00463385
NCT02654132
NCT00770757
NCT02046915
NCT01135199
NCT02244125
NCT04302324
NCT01510613
NCT03030261
NCT02176213
NCT03841565
NCT03113942
NCT04176718
NCT01177735
NCT04287855
NCT01745640
NCT02547662
NCT01745588
NCT04124497
NCT03520985
NCT00949364
NCT01559129
NCT03910244
NCT03683277
NCT04270175
NCT03257631
NCT02406222
NCT03601806
NCT04584307
NCT03713294
NCT02045017
NCT03170882
NCT03104270
NCT02578121
NCT04661137
NCT04790474
NCT03215524
NCT01794039
NCT01570387
NCT01541332
NCT00833833
NCT00669578
NCT01665794
NCT02185820
NCT01997840
NCT02542657
NCT01946152
NCT02289222
NCT01638936
NCT02661022
NCT01495598
NCT03715478
NCT02119468
NCT02265510
NCT04094961
NCT02384083
NCT01432600
NCT01212952
NCT02548962
NCT01166113
NCT04643002
NCT02004275
NCT01592370
NCT01644110
NCT04150965
NCT04762745
NCT02206425
NCT01421186
NCT01522872
NCT00537511
NCT01979276
NCT01464034
NCT02228512
NCT04764942
NCT00540579
NCT02343042
NCT01754402
NCT01562405
NCT02415153
NCT01807286
NCT02431208
NCT03798314
NCT04392648
NCT01568294
NCT04667663
NCT03424928
NCT03657420
NCT03015922
NCT01522547
NCT04722146
NCT02287558
NCT02189343
NCT03143985
NCT02939183
NCT01707407
NCT01986894
NCT02569320
NCT01474330
NCT02900716
NCT01835561
NCT02659930
NCT00482521
NCT01722305
NCT03023527
NCT04355039
NCT02616640
NCT01497093
NCT02283775
NCT04045795
NCT02400242
NCT01728259
NCT02168205
NCT01078974
NCT01889420
NCT01198067
NCT03605719
NCT01999335
NCT02029950
NCT02462525
NCT01575925
NCT01998971
NCT02103335
NCT01537861
NCT01632826
NCT03288974
NCT03723096
NCT02902900
NCT02555839
NCT02921828
NCT03353545
NCT02164955
NCT02075996
Intervention Type
Drug
Biological, Drug
Drug
Drug
Drug
Drug
Biological, Drug
Drug
Drug
Drug
Biological, Drug
Drug
Drug
Drug
Drug
Other, Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Procedure, Other, Drug
Drug
Drug
Drug
Drug
Drug
Drug
Procedure, Drug
Drug
Drug
Drug
Drug
Biological, Drug
Drug
Drug
Drug
Drug
Drug
Other, Drug
Procedure, Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other, Drug
Drug
Biological, Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other, Biological, Drug
Drug
Drug
Drug
Drug
Drug
Other, Drug
Drug
Drug
Drug
Drug
Other, Drug
Drug
Drug
Drug
Drug
Biological, Drug
Drug
Drug
Drug
Drug, Dietary Supplement
Drug
Drug
Drug
Drug
Drug
Drug
Other, Drug
Drug
Drug
Drug
Drug
Other, Drug
Drug, Behavioral
Drug
Biological, Drug
Drug
Drug
Drug
Drug
Drug
Biological, Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other, Drug
Drug
Drug
Drug
Drug
Drug
Other, Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other, Drug
Other, Drug
Drug
Drug
Drug
Biological, Drug
Drug
Other, Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Indications
Relapse Multiple Myeloma
Multiple Myeloma
Primary Myelofibrosis; MPN-associated Myelofibrosis
Multiple Myeloma
Plasma Cell Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Polycythemia Vera
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma; Relapse After Use of Lenalidomide and Bortezomib
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma and Plasma Cell Neoplasm
Multiple Myeloma
Multiple Myeloma
Skin Kaposi Sarcoma
Multiple Myeloma
Soft Tissue Sarcoma
Relapsed and/or refractorY Multiple Myeloma
Multiple Myeloma
Multiple Myeloma; Amyloidosis
Multiple Myeloma in Relapse; Multiple Myeloma Progression; Refractory Multiple Myeloma
Multiple Myeloma
Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma
Graft vs Host Disease; Graft-Versus-Host Disease
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Relapsed or Refractory Multiple Myeloma
Multiple Myeloma
Relapsed Chronic Lymphocytic Leukemia; Refractory Chronic Lymphocytic Leukemia; Diffuse Large B Cell Lymphoma; Follicular Lymphoma; Richter's Transformation
Multiple Myeloma
Polycythemia Vera; Thrombocythemia
Multiple Myeloma
Prostate Cancer
Relapsed/Refractory Multiple Myeloma
Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma
Plasma Cell Myeloma
Myelofibrosis With Myeloid Metaplasia; Myeloid Metaplasia; Myelofibrosis
Multiple Myeloma
Graft vs Host Disease
Relapsed or Refractory Multiple Myeloma
Pulmonary Fibrosis
Multiple Myeloma; First Relapse
Multiple Myeloma; Refractory Multiple Myeloma; Relapse Multiple Myeloma
Primary Amyloidosis of Light Chain Type
Multiple Myeloma in Relapse
Multiple Myeloma in Relapse; Multiple Myeloma, Refractory
Recurrent Plasma Cell Myeloma
High Grade Squamous Intra-epithelial Lesion (HSIL)
Multiple Myeloma; Refractory Multiple Myeloma; Multiple Myeloma in Relapse; Relapse
Multiple Myeloma
Multiple Myeloma in Relapse; Multiple Myeloma, Refractory
Multiple Myeloma
Plasma Cell Leukemia; Plasma Cell Myeloma; Plasmacytoma
Multiple Myeloma
Multiple Myeloma; Deletion 17P Syndrome
Refractory Multiple Myeloma
Myeloproliferative Neoplasms
Scleroderma, Systemic; Sclerosis, Systemic; Systemic Scleroderma; Systemic Sclerosis; Interstitial Lung Disease
Telangiectasia, Hereditary Hemorrhagic
Multiple Myeloma; Relapsed and Refractory Multiple Myeloma; Genetic Condition
Amyloid; AL Amyloidosis; Refractory AL Amyloidosis
Central Nervous System Neoplasms; Medulloblastoma
Multiple Myeloma
Human Immunodeficiency Virus 1 Positive; Skin Kaposi Sarcoma
Multiple Myeloma
Refractory Plasma Cell Myeloma
Multiple Myeloma
Relapsed and/or Refractory Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma in Relapse; Refractory Multiple Myeloma
Multiple Myeloma
Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma
AL Amyloidosis
Multiple Myeloma
Multiple Myeloma
Chronic Myeloproliferative Disorders; Secondary Myelofibrosis
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Myeloma
Multiple Myeloma-Light Chain Only; Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Kaposi Sarcoma; Sarcoma, Kaposi
Relapsed and/or Refractory Multiple Myeloma
Refractory Plasma Cell Myeloma; Recurrent Plasma Cell Myeloma
Solid Tumors; Advanced Malignancies; Metastatic Cancer
Multiple Myeloma; Multiple Myeloma in Relapse
Multiple Myeloma
Myeloma
Refractory Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Plasma Cell Myeloma Refractory
Multiple Myeloma in Relapse
Non-Hodgkin's Lymphoma; Hodgkin Lymphoma; Multiple Myeloma
Primary Myelofibrosis; Secondary Myelofibrosis; PMF; SMF; Post-PV MF; Post-ET MF
Multiple Myeloma; Relapsed Refractory Multiple Myeloma
Relapsed, Refractory, Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Carcinoma, Small Cell
Multiple Myeloma
Multiple Myeloma
Large Cell Lymphoma Arising in KSHV-associated Multicentric Castleman Disease; Primary Effusion Lymphoma
Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma
Pancreatic Cancer
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Neurofibromatosis Type 1; Recurrent Childhood Brain Stem Glioma; Recurrent Childhood Visual Pathway Glioma; Recurrent Primary Central Nervous System Neoplasm; Refractory Primary Central Nervous System Neoplasm
Myeloma
Multiple Myeloma
Recurrent Nervous System Lymphoma; Recurrent Primary Vitreoretinal DLBCL; Refractory Nervous System Lymphoma; Refractory Primary Vitreoretinal DLBCL
Relapsed and/or Refractory Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Bioequivalence
Multiple Myeloma
Multiple Myeloma
Anemia, Sickle Cell
Multiple Myeloma
Hereditary Hemorrhagic Telangiectasia; Idiopathic Vascular Ectasia
Multiple Myeloma
Multiple Myeloma
Relapsed or Refractory Multiple Myeloma
Pharmacology, Clinical; Healthy
Clinical Pharmacology, Healthy Volunteer Study
Recurrent Plasma Cell Myeloma
Healthy
Chronic Lymphocytic Leukemia; B-Cell Lymphoma
Clinical Pharmacology, Healthy Volunteer Study
Kaposi Sarcoma
Unspecified Adult Solid Tumor, Protocol Specific
B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma; Central Nervous System Lymphoma; Intraocular Lymphoma; Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System; Recurrent Adult Diffuse Large Cell Lymphoma; Retinal Lymphoma
Multiple Myeloma
Refractory Multiple Myeloma; Relapse Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Plasma Cell Myeloma
Multiple Myeloma
Multiple Myeloma
Light Chain Deposition Disease; Primary Systemic Amyloidosis
Healthy Volunteers
Waldenstrom's Macroglobulinemia
Multiple Myeloma in Relapse
Recurrent Waldenstrom Macroglobulinemia; Refractory Waldenstrom Macroglobulinemia
Recurrent Plasma Cell Myeloma
Multiple Myeloma
Acute Myeloid Leukemia; Chronic Myelomonocytic Leukemia-2; High Risk Myelodysplastic Syndrome; Myeloproliferative Neoplasm
Multiple Myeloma
Multiple Myeloma; Renal Impairment
Multiple Myeloma
Multiple Myeloma in Relapse; Refractory Multiple Myeloma; Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Relapse/Refractory Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Study Phase
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Early Phase 1
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Recruitment Status
Recruiting
Terminated
Completed
Active, not recruiting
Active, not recruiting
Completed
Active, not recruiting
Completed
Active, not recruiting
Completed
Recruiting
Terminated
Unknown status
Recruiting
Active, not recruiting
Completed
Recruiting
Recruiting
Unknown status
Withdrawn
Completed
Completed
Completed
Active, not recruiting
Not yet recruiting
Active, not recruiting
Terminated
Completed
Active, not recruiting
Recruiting
Recruiting
Completed
Recruiting
Completed
Completed
Completed
Not yet recruiting
Recruiting
Completed
Recruiting
Recruiting
Completed
Active, not recruiting
Completed
Recruiting
Active, not recruiting
Recruiting
Completed
Active, not recruiting
Completed
Completed
Withdrawn
Active, not recruiting
Not yet recruiting
Completed
Recruiting
Completed
Recruiting
Active, not recruiting
Recruiting
Completed
Recruiting
Completed
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Completed
Terminated
Recruiting
Not yet recruiting
Not yet recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Not yet recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Withdrawn
Not yet recruiting
Recruiting
Active, not recruiting
Completed
Completed
Unknown status
Completed
Completed
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Terminated
Terminated
Completed
Completed
Active, not recruiting
Recruiting
Unknown status
Terminated
Recruiting
Completed
Completed
Completed
Terminated
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
Not yet recruiting
Active, not recruiting
Completed
Unknown status
Terminated
Terminated
Completed
Withdrawn
Not yet recruiting
Completed
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Terminated
Active, not recruiting
Active, not recruiting
Withdrawn
Completed
Not yet recruiting
Completed
Withdrawn
Active, not recruiting
Completed
Recruiting
Completed
Completed
Recruiting
Active, not recruiting
Completed
Completed
Suspended
Completed
Completed
Completed
Recruiting
Completed
Completed
Terminated
Withdrawn
Active, not recruiting
Completed
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Completed
Terminated
Terminated
Active, not recruiting
Recruiting
Completed
Completed
Terminated
Active, not recruiting
Active, not recruiting
Completed
Terminated
Approved for marketing
Recruiting
No longer available
Active, not recruiting
Recruiting
Active, not recruiting
Completed
Active, not recruiting
Completed
Infliximab biosimilar (Reliance Life Sciences)
BOW-015, R-TPR-015
Approved
Epirus Biopharmaceuticals
Arthritis, Rheumatoid
NCT Number
NCT02683564
Intervention Type
Drug
Indications
Rheumatoid Arthritis
Study Phase
Phase 3
Recruitment Status
Unknown status
Adalimumab biosimilar (Fresenius Kabi)
MSB-11022
Approved
Merck Serono, Fresenius Kabi Ag
Spondylitis, Ankylosing, Arthritis, Rheumatoid, Arthritis, Juvenile, Psoriasis, Arthritis, Psoriatic, Colitis, Ulcerative, Uveitis, Hidradenitis Suppurativa, Crohn Disease
NCT Number
NCT03052322
NCT02660580
NCT03014947
NCT04018599
Intervention Type
Drug
Drug
Drug
Drug
Indications
Moderate to Severe Rheumatoid Arthritis
Psoriasis; Plaque Type Psoriasis; Moderate to Severe Plaque Psoriasis
Healthy Subjects
Rheumatoid Arthritis; Polyarticular Juvenile Idiopathic Arthritis; Psoriatic Arthritis; Ankylosing Spondylitis; Crohn Disease; Ulcerative Colitis; Plaque Psoriasis; Pediatric Plaque Psoriasis; Pediatric Crohns Disease; Hidradenitis Suppurativa; Non-infectious Uveitis
Study Phase
Phase 3
Phase 3
Phase 1
Phase 1
Recruitment Status
Completed
Completed
Completed
Completed
Etanercept
TNR-001
Approved
Pfizer Pharmaceuticals Ltd (China), Amgen Inc
Arthritis, Rheumatoid, Spondylitis, Ankylosing, Arthritis, Juvenile, Pulmonary Fibrosis, Psoriasis, Asthma, Arthritis, Psoriatic, Arthritis, Inflammation, Plaque psoriasis
NCT Number
NCT00132418
NCT00858780
NCT00111124
NCT02915354
NCT00259610
NCT00161655
NCT00252668
NCT04086745
NCT00420303
NCT00458185
NCT01578850
NCT00581165
NCT01009879
NCT01927757
NCT01793519
NCT01313208
NCT02144857
NCT00791765
NCT02092467
NCT02353780
NCT00992394
NCT00099554
NCT00444340
NCT00837434
NCT01053819
NCT02364479
NCT00115219
NCT00581100
NCT00247962
NCT03504072
NCT00833729
NCT01783015
NCT00523692
NCT02489760
NCT01295151
NCT00688103
NCT01548768
NCT02242474
NCT00094341
NCT03649061
NCT00768053
NCT00654368
NCT01303874
NCT00936065
NCT02713997
NCT01132235
NCT00127842
NCT02374021
NCT00195507
NCT00581555
NCT04485325
NCT00420238
NCT02638896
NCT00410046
NCT00565409
NCT01543204
NCT00245960
NCT01298531
NCT00832364
NCT00546533
NCT00873730
NCT00796705
NCT00663052
NCT00910273
NCT01875991
NCT03636373
NCT00133315
NCT03976245
NCT02433184
NCT01604629
NCT02509026
NCT00848354
NCT01602302
NCT01934933
NCT00913458
NCT02878161
NCT01072058
NCT01971346
NCT02132234
NCT00967538
NCT01372930
NCT00706797
NCT00432406
NCT02749370
NCT00640393
NCT00783536
NCT00195494
NCT00110981
NCT02373813
NCT01729754
NCT03781375
NCT01936688
NCT00393471
NCT01001208
NCT01421069
NCT00468117
NCT00445770
NCT00116181
NCT00524381
NCT02346240
NCT00418717
NCT00111436
NCT01258738
NCT00434811
NCT00434044
NCT00726375
NCT03451851
NCT01313221
NCT01270997
NCT02840175
NCT03728478
NCT00421980
NCT01690299
NCT00357903
NCT00078819
NCT00078806
NCT04079374
NCT00333034
NCT00353119
NCT00111449
NCT00012506
NCT02986139
NCT00421915
NCT00413452
NCT00111111
NCT00962741
NCT00249041
NCT00484237
NCT00356590
NCT01764997
NCT00141921
NCT00121615
NCT03332719
NCT00443950
NCT02115750
NCT00418548
NCT00317499
NCT01235442
NCT00356356
NCT00110903
NCT02987257
NCT04610476
NCT01901185
NCT00421174
NCT02378506
NCT00005007
NCT00127387
NCT00789997
NCT01030120
NCT00111956
NCT00035958
NCT03780959
NCT00298272
NCT01989689
NCT00031551
NCT00520572
NCT01289730
NCT02656082
NCT00107991
NCT00329823
NCT00309907
NCT00001893
NCT00639717
NCT00001901
NCT00006070
NCT03193957
NCT02464033
NCT00841789
NCT00141713
NCT00001955
NCT00509600
NCT00224393
NCT01289743
NCT00789308
NCT00063869
NCT00797784
NCT00034060
NCT00048373
NCT00001862
NCT00224874
NCT00141791
NCT02862574
NCT00285779
NCT00001954
NCT00434850
NCT00293202
NCT00141739
NCT02464878
NCT00447265
NCT02456363
NCT01730495
NCT00135720
NCT01068353
NCT00134368
NCT00678782
NCT04066348
NCT00141726
NCT00888628
NCT00093366
NCT00730392
NCT03160001
NCT02586831
NCT02821026
NCT03182426
NCT00201838
NCT00201682
NCT00118287
NCT00201812
NCT00502879
NCT01716637
NCT04255498
NCT01276847
NCT02799498
NCT03273088
NCT04585711
NCT03193203
NCT01145950
NCT01865630
NCT04559412
NCT01894412
NCT01725620
NCT00112385
NCT00705042
NCT00091741
NCT01294397
NCT04254627
NCT00361634
NCT00802815
NCT00965666
NCT02766439
NCT01170715
NCT04428411
NCT03016260
NCT00825344
NCT01706692
NCT04398732
NCT03729674
NCT02486302
NCT01623752
NCT02031211
NCT02202837
NCT04449224
NCT00195403
NCT01100034
NCT01613963
NCT01558089
NCT04507776
NCT03955861
NCT04507763
NCT03178955
NCT01421303
NCT03775824
NCT01356758
NCT00116272
NCT00195416
NCT01592292
NCT00322439
NCT02376478
NCT00195377
NCT01557322
NCT00477191
NCT04378621
NCT04725422
NCT00405275
NCT00078793
NCT01610947
NCT00409318
NCT01793285
NCT00293722
NCT02258282
NCT04428502
NCT02330380
NCT04428424
NCT02202850
NCT00949546
NCT00683384
NCT00116727
NCT02722811
NCT01646385
NCT00544557
NCT00245934
NCT01812954
NCT01411215
NCT01932372
NCT03496831
NCT00503139
NCT00708708
NCT04267614
NCT03100734
NCT01276314
NCT00195338
NCT00503503
NCT00931957
NCT00121056
NCT04582084
NCT03327454
NCT01145352
NCT00488475
NCT00293709
NCT00413400
NCT02722772
NCT01230177
NCT00195364
NCT00484809
NCT00276029
NCT02322580
NCT01432249
NCT01188655
Intervention Type
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other, Drug
Drug
Drug
Drug
Drug
Biological, Drug
Drug
Drug
Drug
Biological
Biological, Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological
Biological, Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological, Drug
Drug
Drug
Drug
Biological
Drug
Drug
Drug
Other, Drug
Biological, Drug
Other, Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological, Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological
Biological, Drug
Drug
Drug
Drug
Biological, Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug, Device
Drug
Drug
Drug, Device
Drug, Dietary Supplement
Drug
Drug
Drug
Drug
Drug
Drug
Procedure, Biological
Drug
Drug
Drug
Other, Biological
Drug
Drug
Other, Biological, Drug
Procedure, Biological, Drug
Drug
Drug
Drug
Biological, Drug
Biological
Drug
Drug
Drug
Drug
Biological
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological
Drug
Drug
Drug
Biological, Drug
Drug
Drug
Drug
Other, Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological, Drug, Dietary Supplement
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological, Drug
Drug
Procedure, Drug
Drug
Drug
Drug, Device
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological, Drug
Drug
Drug
Procedure, Drug
Drug
Biological, Drug
Drug
Drug
Other, Biological
Drug
Drug
Other, Biological
Drug
Biological, Drug
Biological, Drug
Drug
Drug
Drug
Procedure, Drug
Drug
Drug
Drug
Biological, Drug
Drug
Drug
Biological, Dietary Supplement
Drug
Drug
Other, Drug, Device
Drug
Drug
Drug
Drug
Drug
Drug, Device
Biological
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological
Drug
Biological, Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other, Drug
Drug
Biological, Drug
Drug
Other, Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other, Drug
Drug
Drug
Drug
Drug
Drug
Other, Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological
Drug
Drug
Drug
Drug
Drug
Drug
Biological
Drug
Drug
Drug
Drug
Other, Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Indications
Rheumatoid Arthritis
Rheumatoid Arthritis
Psoriasis
Spondylitis, Ankylosing; Recurrence
Rheumatoid Arthritis
Psoriasis; Arthritis, Psoriatic
Rheumatoid Arthritis
Rheumatoid Arthritis
Spondylarthropathies, Enthesitis
Ankylosing Spondylitis
Rheumatoid Arthritis
Psoriasis
Rheumatoid Arthritis
Moderate to Severe Rheumatoid Arthritis
Rheumatoid Arthritis
Rheumatoid Arthritis
Psoriasis
Psoriasis
Arthritis, Rheumatoid
Rheumatoid Arthritis (RA)
Psoriasis
Rheumatoid Arthritis
Ankylosing Spondylitis
Rheumatoid Arthritis
Psoriasis; Melanoma; Non-melanoma Skin Cancer
Spondyloarthritis
Rheumatoid Arthritis
Nail Psoriasis; Plaque Psoriasis
Ankylosing Spondylitis
Spondyloarthritis
Plaque Psoriasis
Rheumatoid Arthritis
Rheumatoid Arthritis
Ankylosing Spondylitis
Rheumatoid Arthritis
Rheumatoid Arthritis
Rheumatoid Arthritis
Rheumatoid Arthritis
Rheumatoid Arthritis
Arthritis, Rheumatoid
Rheumatoid Arthritis
Rheumatoid Arthritis
Rheumatoid Arthritis; Inflammatory Arthritis
Moderate to Severe Psoriasis
Pancreatitis, Chronic; Diabetes; Transplant
Psoriasis
Psoriatic Arthritis
Arthritis, Rheumatoid
Psoriasis
Psoriasis
Rheumatic Arthritis
Ankylosing Spondylitis
Ankylosing Spondylitis
Ankylosing Spondylitis
Arthritis, Rheumatoid
Psoriasis
Psoriatic Arthritis
Axial Spondyloarthritis
Plaque Psoriasis
Rheumatoid Arthritis
Ankylosing Spondylitis
Rheumatoid Arthritis
Plaque Psoriasis; Psoriasis
Ankylosing Spondylitis
Rheumatoid Arthritis; Plaque Psoriasis
Gout Attack
Spondylarthropathies; Ankylosing Spondylitis; Psoriatic Arthritis
Rheumatoid Arthritis
Rheumatoid Arthritis
Spondylarthropathies
Spondylitis, Ankylosing
Rheumatoid Arthritis
Rheumatoid Arthritis
Ankylosing Spondylitis
Active Rheumatoid Arthritis; Arthritis, Rheumatoid; Rheumatoid Arthritis
Rheumatoid Arthritis
Arthritis, Rheumatoid; Spondylitis, Ankylosing
Psoriasis
Rheumatoid Arthritis; Psoriatic Arthritis; Ankylosing Spondylitis; Hypertension
Psoriasis
Myocardial Infarction
Rheumatoid Arthritis
Psoriatic Arthritis
Plaque Psoriasis
Psoriasis Vulgaris
Rheumatoid Arthritis
Rheumatoid Arthritis
Psoriasis
Rheumatoid Arthritis
Plaque Psoriasis
Juvenile Rheumatoid Arthritis
Plaque-type Psoriasis
Active Rheumatoid Arthritis
Psoriasis
Juvenile Idiopahtic Arthritis
Type 1 Diabetes Mellitus
Arthritis, Rheumatoid
Psoriasis
Polymyalgia Rheumatica
Psoriasis; Plaque Psoriasis
Arthritis, Rheumatoid
Psoriasis
Spondylitis, Ankylosing
Type 1 Diabetes Mellitus
Ankylosing Spondylitis
Acute Graft Versus Host Disease
Psoriasis
Rheumatoid Arthritis
Juvenile Idiopathic Arthritis
Oligoarthritis, Juvenile; Polyarthritis, Juvenile, Rheumatoid Factor Negative
Ankylosing Spondylitis
Psoriasis; Psoriatic Arthritis
Rheumatoid Arthritis
Psoriasis
Juvenile Rheumatoid Arthritis
Rheumatoid Arthritis
Psoriasis
Palmoplantaris Pustulosis
Psoriasis
Uveitis; Arthritis, Juvenile Rheumatoid
Arthritis, Rheumatoid; Arthritis, Psoriatic
Ankylosing Spondylitis
Rheumatoid Arthritis
Psoriasis
Arthritis, Juvenile Idiopathic
Rheumatoid Arthritis
Rheumatoid Arthritis
Rheumatoid Arthritis
Rheumatoid Arthritis
Pediatric Plaque Psoriasis
Inflammation; Psoriasis
Rheumatoid Arthritis
Arthritis, Rheumatoid
Rheumatoid Arthritis
Ankylosing Spondylitis
Psoriatic Arthritis; Psoriasis
Psoriasis
Ankylosing Spondylitis
Rheumatoid Arthritis
Stevens-Johnson Syndrome; Toxic Epidermal Necrolyses
Psoriatic Arthritis; Withdrawal; Reduction
Rheumatoid Arthritis; Psoriatic Arthritis
Pneumonia; Idiopathic Pneumonia Syndrome
Arthritis, Rheumatoid
Wegener's Granulomatosis
Lung Cancer; Prostate Cancer; Neoplasm Metastasis; Bone Cancer
COPD Exacerbation
Chronic Idiopathic Urticaria
Metabolic Syndrome X
Dermatomyositis
Juvenile Rheumatoid Arthritis
Rheumatoid Arthritis
PSORIASIS
Stomatitis
Rheumatoid Arthritis
Spondyloarthritis
Lupus Erythematosus, Discoid; Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Chronic Cutaneous
Hidradenitis Suppurativa
Hidradenitis Suppurativa
Accelerated Phase Chronic Myelogenous Leukemia; Blastic Phase Chronic Myelogenous Leukemia; Childhood Acute Lymphoblastic Leukemia in Remission; Childhood Acute Myeloid Leukemia in Remission; Childhood Chronic Myelogenous Leukemia; Childhood Myelodysplastic Syndromes; Chronic Phase Chronic Myelogenous Leukemia; de Novo Myelodysplastic Syndromes; Disseminated Neuroblastoma; Juvenile Myelomonocytic Leukemia; Previously Treated Childhood Rhabdomyosarcoma; Previously Treated Myelodysplastic Syndromes; Pulmonary Complications; Recurrent Childhood Acute Lymphoblastic Leukemia; Recurrent Childhood Acute Myeloid Leukemia; Recurrent Childhood Large Cell Lymphoma; Recurrent Childhood Lymphoblastic Lymphoma; Recurrent Childhood Rhabdomyosarcoma; Recurrent Childhood Small Noncleaved Cell Lymphoma; Recurrent Neuroblastoma; Recurrent Wilms Tumor and Other Childhood Kidney Tumors; Recurrent/Refractory Childhood Hodgkin Lymphoma; Relapsing Chronic Myelogenous Leukemia; Secondary Acute Myeloid Leukemia; Secondary Myelodysplastic Syndromes
Asthma
Graft Versus Host Disease
Vasculitis; Wegener's Granulomatosis
Healthy; Inflammation
Rheumatoid Arthritis
Diabetes Mellitus, Type 1
Mucocutaneous Lymph Node Syndrome; Kawasaki Disease
Graft-Versus-Host Disease
Temporomandibular Joint Disorder
Leukemia
Primary Systemic Amyloidosis
Ankylosing Spondylitis
Diabetes Mellitus, Type I
Pulmonary Fibrosis
Discoid Lupus Erythematosus (DLE)
Rheumatoid Arthritis; Healthy
Histiocytosis, Langerhans-Cell
Juvenile Rheumatoid Arthritis; Uveitis
Graft vs Host Disease; Immune System Disorders
Asthma
Rheumatoid Arthritis
Lichen Planus
Sjogren's Syndrome
Diabetes Mellitus, Type 1
End Stage Renal Disease
Graft-Versus-Host Disease
Kidney Transplant; Type 1 Diabetes
Lupus Nephritis
Ankylosing Spondylitis
Chronic Fatigue Syndrome; Myalgic Encephalomyelitis
Pemphigus Vulgaris
Alzheimer's Disease
Vitiligo
Persistent Knee Joint Synovitis
Tinnitus, Noise Induced
Lung Injury, Acute; Respiratory Distress Syndrome, Adult; Bronchiolitis Obliterans
Diabetes Mellitus, Type I
Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
Type 1 Diabetes
Rheumatoid Arthritis (RA)
Diabetes Mellitus, Type 1; Hypoglycemia; Autoimmune Diseases; Diabetes Mellitus
Type 1 Diabetes
Diabetes Mellitus, Type 1
Pancreatic Neoplasms; Adenocarcinoma
Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma
de Novo Myelodysplastic Syndromes; Previously Treated Myelodysplastic Syndromes; Secondary Myelodysplastic Syndromes
Tumors
Healthy
Alzheimer's Disease
Gulf War Illness; Persian Gulf Syndrome; Occupational Diseases
Psoriasis
Healthy Men and Women
Phase 1; Bioequivalence
Juvenile Idiopathic Arthritis; Rheumatoid Arthritis; Obesity
Healthy
Healthy
Subarachnoid Hemorrhage, Aneurysmal
Rheumatoid Arthritis
Healthy
Healthy
Dermatomyositis
Healthy Subjects
HIV Infection
Postmenopausal; Osteopenia; Rheumatoid Arthritis; Osteoporosis
Gulf War Illness
Rheumatoid Arthritis
Inclusion Body Myositis
Fanconi Anemia
Rhupus Syndrome, Etanercept
Psoriasis
Plaque Psoriasis
RheumatoId Arthritis
Inguinal Hernia; Postoperative Pain
Psoriasis
Plaque Psoriasis
Rheumatoid Arthritis; Ankylosing Spondylitis; Ulcerative Colitis; Crohn's Disease
Rheumatoid Arthritis; Psoriatic Arthritis; Axial Spondyloarthritis; Plaque Psoriasis
Rheumatoid Arthritis; Psoriasis Arthritis
CRPS; Chronic Regional Pain Syndrome
Rheumatoid Arthritis
Rheumatoid Arthritis
Rheumatoid Arthritis
Psoriasis
Uveitis; Scleritis
Rheumatoid Arthritis
Spondyloarthrosis
Psoriatic Arthritis; Psoriasis; Enthesitis
Ankylosing Spondylitis
Rheumatoid Arthritis
Ankylosing Spondylitis
Rheumatoid Arthritis
Psoriasis; Atopic Dermatitis; Atherosclerosis
Pregnancy
Ankylosing Spondylitis
Rheumatoid Arthritis
Psoriasis
Psoriasis; Inflammatory Bowel Diseases
Arthritis, Psoriatic; Arthritis, Rheumatoid
Rheumatoid Arthritis
Psoriasis; Metabolic Syndrome; Hyperlipidemia; Obesity; Hypertension
Rheumatoid Arthritis; Pain; Fatigue; Cognitive Decline; Depression; Brain Diseases; Hand Rheumatism
Chronic Nonbacterial Osteomyelitis; Chronic Recurrent Multifocal Osteomyelitis
Rheumatoid Arthritis
Juvenile Rheumatoid Arthritis
Spondyloarthritis
Metabolic Syndrome
Ankylosing Spondylitis
Arthritis, Psoriatic; Psoriasis; Skin Diseases, Papulosquamous
Psoriasis
Psoriatic Arthritis
Psoriasis; Inflammation
Arthritis, Rheumatoid
Ankylosing Spondylitis
Hidradenitis Suppurativa
Arthritis, Psoriatic
Rheumatoid Arthritis
Osteoarthritis Of Knee
Rheumatoid Arthritis
Ankylosing Spondylitis
Rheumatoid Arthritis
Psoriasis
Rheumatoid Arthritis; Ankylosing Spondylitis
Rheumatoid Arthritis
Rheumatoid Arthritis; Spondyloarthritis; Psoriatic Arthritis
Rheumatoid Arthritis
Psoriasis
Arthritis Rheumatoid
Rheumatoid Arthritis; Axial Spondyloarthritis
Drug Hypersensitivity
Rheumatoid Arthritis
Rheumatoid Arthritis
Behcet Syndrome; Uveal Disease
Rheumatoid Arthritis
Rheumatoid Arthritis; Ankylosing Spondylitis; Psoriatic Arthritis
Rheumatoid Arthritis; Spondyloarthropathies
Juvenile Idiopathic Arthritis
Rheumatoid Arthritis
Arthritis, Psoriatic; Psoriasis; Skin Diseases, Papulosquamous
Metabolic Syndrome
Osteoarthritis of Knee
Arthritis; Rheumatoid
Rheumatoid Arthritis; Inflammation
Rheumatoid Arthritis
Asthma
Psoriasis
Pediatric Psoriasis
Spondylitis, Ankylosing
Study Phase
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Early Phase 1
Early Phase 1
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Recruitment Status
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Recruiting
Completed
Completed
Completed
Completed
Withdrawn
Terminated
Recruiting
Completed
Recruiting
Completed
Completed
Terminated
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Unknown status
Completed
Terminated
Unknown status
Unknown status
Completed
Completed
Completed
Unknown status
Completed
Active, not recruiting
Completed
Completed
Completed
Completed
Active, not recruiting
Unknown status
Completed
Recruiting
Completed
Completed
Recruiting
Completed
Unknown status
Completed
Completed
Terminated
Completed
Completed
Withdrawn
Completed
Completed
Terminated
Completed
Terminated
Completed
Suspended
Completed
Recruiting
Completed
Completed
Completed
Completed
Terminated
Completed
Completed
Unknown status
Unknown status
Completed
Unknown status
Completed
Unknown status
Terminated
Completed
Completed
Completed
Withdrawn
Completed
Completed
Completed
Active, not recruiting
Terminated
Withdrawn
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Recruiting
Completed
Completed
Active, not recruiting
Recruiting
Completed
Completed
Completed
Completed
Terminated
Recruiting
Completed
Completed
Completed
Unknown status
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Terminated
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Not yet recruiting
Not yet recruiting
Completed
Completed
Completed
Completed
Terminated
Completed
Withdrawn
Completed
Terminated
Completed
Terminated
Completed
Terminated
Completed
Unknown status
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Unknown status
Completed
Completed
Terminated
Suspended
Unknown status
Completed
Completed
Unknown status
Completed
Completed
Completed
Completed
Completed
Terminated
Terminated
Completed
Completed
Terminated
Completed
Recruiting
Terminated
Unknown status
Terminated
Completed
Completed
Completed
Completed
Not yet recruiting
Completed
Completed
Completed
Completed
Completed
Not yet recruiting
Completed
Recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Recruiting
Completed
Completed
Completed
Not yet recruiting
Completed
Completed
Withdrawn
Recruiting
Completed
Completed
Completed
Completed
Completed
Terminated
Recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Terminated
Completed
Recruiting
Completed
Recruiting
Completed
Completed
Withdrawn
Completed
Recruiting
Completed
Completed
Unknown status
Completed
Completed
Recruiting
Completed
Withdrawn
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Terminated
Not yet recruiting
Recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Active, not recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Unknown status
Completed
Completed
Completed
Completed
Terminated
Active, not recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Unknown status
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Unknown status
Completed
Completed
Completed
Completed
Completed
Withdrawn
Completed
Etanercept biosimilar (Samsung Bioepis)
SB-4
Approved
Samsung Bioepis
Arthritis, Rheumatoid, Spondylitis, Ankylosing, Arthritis, Juvenile, Psoriasis, Arthritis, Psoriatic
NCT Number
NCT03813771
NCT01895309
NCT03193957
NCT01865552
NCT03100734
NCT03327454
Intervention Type
Drug
Drug
Drug, Device
Biological
Biological
Biological
Indications
Rheumatoid Arthritis
Rheumatoid Arthritis
Rheumatoid Arthritis
Healthy
Rheumatoid Arthritis; Axial Spondyloarthritis
Rheumatoid Arthritis; Spondyloarthropathies
Study Phase
Phase 4
Phase 3
Phase 2
Phase 1
N/A
N/A
Recruitment Status
Not yet recruiting
Completed
Completed
Completed
Completed
Completed
Anti-tumour necrosis factor-alpha antibody
Approved
Materia Medica Holding Research And Production Company
Arthritis, Rheumatoid, Osteoarthritis
Etanercept biosimilar (PROBIOMED)
Approved
Probiomed
Arthritis, Rheumatoid
Etanercept-szzs
GP-2015
Approved
Clariant Produkte (Schweiz) Ag
Arthritis, Rheumatoid, Spondylitis, Ankylosing, Arthritis, Juvenile, Psoriasis, Arthritis, Psoriatic
NCT Number
NCT02638259
NCT03729674
Intervention Type
Drug
Drug
Indications
Rheumatoid Arthritis
Rheumatoid Arthritis; Ankylosing Spondylitis; Ulcerative Colitis; Crohn's Disease
Study Phase
Phase 3
N/A
Recruitment Status
Completed
Recruiting
Infliximab biosimilar (AXXO)
Approved
Axxo
Autoimmune Diseases, Crohn Disease
Etanercept biosimilar (Nanogen Biopharmaceutical)
Approved
Nanogen Biopharmaceutical Co
Arthritis, Rheumatoid, Psoriasis
Infliximab biosimilar (Shanghai Biomabs)
CMAB-008, STI-002
NDA/BLA
Shanghai Biomabs Pharmaceuticals Co Ltd
Arthritis, Rheumatoid
Recombinant chimeric anti-TNFα antibody (Hisun Pharma)
HS-626
NDA/BLA
Zhejiang Hisun Pharmaceutical Co Ltd
Psoriasis
Adalimumab biosimilar (Jiangsu Zhonghe)
UBP-1211
NDA/BLA
Shanghai Junshi Biosciences Co Ltd, Jiangsu Zhonghe Pharmaceutical Technology Co Ltd
Arthritis, Rheumatoid
Etanercept biosimilar (Qilu Pharmaceutical)
QL-0902
NDA/BLA
Qilu Pharmaceutical Co Ltd
Arthritis, Rheumatoid, Spondylitis, Ankylosing
Etanercept biosimilar (Shanghai Fudan-Zhangjiang Bio-Pharmaceutical)
NDA/BLA
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
Arthritis, Rheumatoid
Adalimumab biosimilar (CTTQ Pharma)
NDA/BLA
Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd
Arthritis, Rheumatoid
Infliximab biobetter (Mabtech/Sorrento)
STI-002
Phase 3 Clinical
Taizhou Maibo Taike Biotechnology Co Ltd, Sorrento Therapeutics
Arthritis, Rheumatoid
Adalimumab biosimilar (Oncobiologics)
ONS-3010
Phase 3 Clinical
Outlook Therapeutics
Psoriasis
Adalimumab biosimilar (Tonghua Dongbao Pharmaceutical)
Phase 3 Clinical
Tonghua Dongbao Pharmaceutical Co Ltd
Arthritis, Rheumatoid, Psoriasis, Plaque psoriasis
Adalimumab biosimilar (Hualan Biological Engineering)
Phase 3 Clinical
Hualan Genetic Engineering Co Ltd
Arthritis, Rheumatoid, Spondylitis, Ankylosing, Psoriasis, Arthritis
Adalimumab biosimilar (Hetero Drugs)
Phase 3 Clinical
Hetero Drugs
Arthritis, Rheumatoid
CD24-Fc
HAS-CD24, CD24-Fc-IgG, MK-7110, MK7110, CD24-Fc
Phase 3 Clinical
Oncoimmune
HIV Infections, Leukemia, Coronavirus Disease 2019 (COVID-19), Graft vs Host Disease, Myelodysplastic Syndromes, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Dyslipidemias, Leukemia, Myeloid, Acute, Melanoma
NCT Number
NCT04317040
NCT04095858
NCT02663622
NCT03960541
NCT04060407
NCT04552704
NCT02650895
Intervention Type
Drug
Drug
Drug
Drug
Drug
Biological, Drug
Biological, Drug
Indications
Covid19
Hematopoietic Stem Cell Transplantation; Acute Graft Versus Host Disease; Acute Myeloid Leukemia; Acute Lymphoblastic Leukemia; Myelodysplastic Syndromes
Graft Versus Host Disease; Hematopoietic Stem Cell Transplantation; Leukemia
HIV Infections; Dyslipidemias
Metastatic Melanoma
Advanced Malignant Solid Neoplasm
Healthy Volunteers
Study Phase
Phase 3
Phase 3
Phase 2
Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1
Recruitment Status
Completed
Recruiting
Completed
Active, not recruiting
Not yet recruiting
Recruiting
Completed
Recombinant human TNF-α monoclonal antibody (Sinocelltech)
SCT-630
Phase 3 Clinical
Shenzhou Cell Engineering Co Ltd
Psoriasis, Plaque psoriasis
NCT Number
NCT03927352
NCT03917628
Intervention Type
Biological
Drug
Indications
Psoriasis
Healthy
Study Phase
Phase 3
Phase 1
Recruitment Status
Active, not recruiting
Completed
Adalimumab biosimilar (CinnaGen)
Phase 3 Clinical
Cinnagen
Arthritis, Rheumatoid
Golimumab biosimilar (Bio-thera)
BAT-2506
Phase 3 Clinical
Bio-Thera Solutions Ltd
Spondylitis, Ankylosing, Arthritis, Rheumatoid, Psoriasis, Arthritis, Psoriatic, Arthritis
NCT Number
NCT04152759
Intervention Type
Drug
Indications
Psoriatic Arthritis
Study Phase
Phase 1
Recruitment Status
Recruiting
Adalimumab biosimilar (LG Life Sciences)
LBAL
Phase 3 Clinical
Mochida Pharmaceutical Co Ltd, Lg Chemical Ltd
Arthritis, Rheumatoid
NCT Number
NCT02746380
NCT02206867
Intervention Type
Drug
Biological
Indications
Arthritis, Rheumatoid
Healthy Subjects
Study Phase
Phase 3
Phase 1
Recruitment Status
Completed
Completed
Thykamine
PUR-0110, PCT-233
Phase 3 Clinical
Purgenesis Technologies
Dermatitis, Colitis, Ulcerative, Proctocolitis
NCT Number
NCT01149707
NCT01149694
Intervention Type
Drug
Drug
Indications
Left-Sided Ulcerative Colitis; Proctosigmoiditis
Ulcerative Colitis
Study Phase
Phase 2
Phase 1
Recruitment Status
Completed
Completed
Tanfanercept
HBM-9036, HL-036
Phase 3 Clinical
Hanall
Dry Eye Syndromes, Xerophthalmia
NCT Number
NCT03846453
NCT04633213
NCT03334539
NCT04092907
NCT02717208
Intervention Type
Biological
Drug
Other, Biological
Drug
Biological
Indications
Dry Eye
Dry Eye
Dry Eye
Dry Eye
Dry Eye
Study Phase
Phase 3
Phase 3
Phase 2
Phase 2
Phase 1
Recruitment Status
Recruiting
Recruiting
Completed
Completed
Completed
Etanercept biosimilar (Clover Biopharmaceuticals)
SCB-808
Phase 3 Clinical
Sichuan Sanyecao Bio-Pharmaceutical Co Ltd
Spondylitis, Ankylosing, Arthritis, Rheumatoid
Etanercept biosimilar (Coherus Biosciences)
CHS-0214, BAX-2200
Phase 3 Clinical
Coherus Biosciences
Arthritis, Rheumatoid, Psoriasis
NCT Number
NCT02115750
NCT02486939
NCT02134210
Intervention Type
Drug
Drug
Drug
Indications
Rheumatoid Arthritis
Rheumatoid Arthritis; Plaque Psoriasis
Plaque Psoriasis
Study Phase
Phase 3
Phase 3
Phase 3
Recruitment Status
Completed
Completed
Completed
HMPL-004 (Hutchison Medipharma)
HMPL-004
Phase 3 Clinical
Hutchison Medipharma Ltd
Lupus Erythematosus, Systemic, Colitis, Ulcerative, Crohn Disease
NCT Number
NCT01882764
NCT01805791
Intervention Type
Drug
Drug
Indications
Ulcerative Colitis
Ulcerative Colitis
Study Phase
Phase 3
Phase 3
Recruitment Status
Terminated
Terminated
Adalimumab biosimilar (Alvotech)
AVT-02 (Alvotech)
Phase 3 Clinical
Alvotech
Autoimmune Diseases, Psoriasis
NCT Number
NCT04453137
NCT03579823
Intervention Type
Biological
Drug
Indications
Plaque Psoriasis
Healthy Volunteers
Study Phase
Phase 3
Phase 1
Recruitment Status
Active, not recruiting
Completed
Adalimumab biosimilar (Danhong Pharma)
BC-002
Phase 3 Clinical
Shandong Danhong Pharmaceutical Co Ltd
Spondylitis, Ankylosing, Arthritis, Rheumatoid
Infliximab biosimilar (Genor Biopharma)
GB-242
Phase 3 Clinical
Genor Biopharma Co Ltd
Arthritis, Rheumatoid
NCT Number
NCT04178850
Intervention Type
Biological
Indications
Rheumatoid Arthritis
Study Phase
Phase 3
Recruitment Status
Recruiting
Infliximab biosimilar (Biocad)
BCD-055
Phase 3 Clinical
Biocad
Spondylitis, Ankylosing, Arthritis, Rheumatoid
NCT Number
NCT02762812
NCT02762838
NCT02359903
Intervention Type
Biological
Biological, Drug
Drug
Indications
Ankylosing Spondylitis
Rheumatoid Arthritis
Ankylosing Spondylitis
Study Phase
Phase 3
Phase 3
Phase 1
Recruitment Status
Completed
Completed
Completed
Ozoralizumab
TS-152, ATN-103, PF-5230896, PF-05230896
Phase 3 Clinical
Ablynx
Arthritis, Rheumatoid
NCT Number
NCT04077567
NCT01063803
NCT01007175
NCT00959036
NCT00916110
Intervention Type
Drug
Drug
Biological
Drug
Drug
Indications
Rheumatoid Arthritis
Rheumatoid Arthritis
Rheumatoid Arthritis
Active Rheumatoid Arthritis
Healthy
Study Phase
Phase 3
Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1
Recruitment Status
Active, not recruiting
Completed
Completed
Completed
Completed
Recombinant anti-TNFα monoclonal antibody (Wuhan Institute of Biological Products)
Phase 3 Clinical
Wuhan Institute Of Biological Products Co Ltd
Spondylitis, Ankylosing, Arthritis, Rheumatoid, Psoriasis, Plaque psoriasis
Adalimumab biosimilar (Coherus BioSciences)
CHS-1420
Phase 3 Clinical
Coherus Biosciences
Psoriasis
NCT Number
NCT02489227
Intervention Type
Drug
Indications
Plaque Psoriasis
Study Phase
Phase 3
Recruitment Status
Completed
EYS-606
EYS-606
Phase 2 Clinical
Eyevensys
Uveitis
NCT Number
NCT03308045
Intervention Type
Biological
Indications
Non-infectious Uveitis
Study Phase
Phase 1/Phase 2
Recruitment Status
Recruiting
CC-10015
CC-10015
Phase 2 Clinical
Celgene Corp
Sarcoidosis, Multiple Myeloma, Lupus Erythematosus, Systemic
NCT Number
NCT02185040
NCT02192489
NCT03161483
NCT02773030
NCT01733875
NCT03294603
NCT03135509
NCT02034773
NCT02820935
Intervention Type
Drug
Drug
Other, Drug
Drug
Drug
Radiation, Drug
Drug
Drug
Drug
Indications
Systemic Lupus Erythematosus
Sarcoidosis
Lupus Erythematosus, Systemic
Multiple Myeloma
Healthy
Healthy Volunteer
Healthy Volunteers
Healthy Volunteers
Pharmacokinetics
Study Phase
Phase 2
Phase 2
Phase 2
Phase 1/Phase 2
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Recruitment Status
Completed
Withdrawn
Active, not recruiting
Recruiting
Completed
Completed
Completed
Completed
Completed
OCS-02
OCS-02, ESBA-1622, LME-636
Phase 2 Clinical
Oculis Pharma
Dry Eye Syndromes, Uveitis, Anterior, Xerophthalmia
NCT Number
NCT02482129
NCT02365519
Intervention Type
Drug
Biological
Indications
Acute Anterior Uveitis
Dry Eye
Study Phase
Phase 2
Phase 2
Recruitment Status
Completed
Completed
Adalimumab biosimilar (Genor Biopharma)
GB-232, BCD-100
Phase 2 Clinical
Genor Biopharma Co Ltd
Carcinoma, Renal Cell, Arthritis, Rheumatoid, Lung Neoplasms, Melanoma
NCT Number
NCT03269565
NCT03050047
Intervention Type
Biological
Biological
Indications
Melanoma
Melanoma; Lung Cancer; Renal Cell Carcinoma
Study Phase
Phase 2
Phase 1
Recruitment Status
Active, not recruiting
Unknown status
ABT-122
ABT-122, D2E7-GS10-B6-17
Phase 2 Clinical
Abbvie Inc
Arthritis, Rheumatoid, Rheumatic Diseases, Arthritis, Psoriatic
NCT Number
NCT02429895
NCT02141997
NCT02433340
NCT02349451
NCT01853033
Intervention Type
Drug
Biological
Drug
Biological
Biological
Indications
Psoriatic Arthritis
Rheumatoid Arthritis
Rheumatoid Arthritis
Psoriatic Arthritis
Rheumatoid Arthritis
Study Phase
Phase 2
Phase 2
Phase 2
Phase 2
Phase 1
Recruitment Status
Terminated
Completed
Completed
Completed
Completed
Recombinant anti-TNFα monoclonal antibody (Livzon Group)
AT-132, LZM-001
Phase 2 Clinical
Livzon Pharmaceutical Group Inc
Arthritis, Rheumatoid
Hemay-005
Hemay-005
Phase 2 Clinical
Hainan Hailing Chemipharma Corporation Ltd, Tianjin Hemei Pharmaceutical Technology Co Ltd
Spondylitis, Ankylosing, Psoriasis, Arthritis, Psoriatic, Behcet Syndrome, Dermatitis, Atopic, Plaque psoriasis
NCT Number
NCT04609397
NCT04102241
NCT03577626
NCT03007810
NCT03570346
Intervention Type
Other, Drug
Drug
Drug
Drug
Drug
Indications
Behçet Disease
Psoriasis
Psoriasis
Psoriasis
Psoriasis
Study Phase
Phase 2
Phase 2
Phase 1
Phase 1
Phase 1
Recruitment Status
Recruiting
Active, not recruiting
Unknown status
Completed
Unknown status
Hemay007
Hemay-007
Phase 2 Clinical
Tianjin Hemei Biological Technology Co Ltd
Inflammatory Bowel Diseases, Arthritis, Rheumatoid, Colitis, Ulcerative
NCT Number
NCT03977480
NCT02603185
Intervention Type
Drug
Drug
Indications
Ulcerative Colitis
Inflammatory Bowel Disease
Study Phase
Phase 2
Phase 1
Recruitment Status
Recruiting
Unknown status
Etanercept biosimilar (Suzhou Genemen Biotech)
BF-02, GM-02
Phase 2 Clinical
Suzhou Genemen Biotech. Co Ltd
Spondylitis, Ankylosing, Arthritis, Rheumatoid, Psoriasis
LP-0058
LP-0058, LEO-32731
Phase 2 Clinical
Leo Pharma Inc
Drug-Related Side Effects and Adverse Reactions, Psoriasis, Dermatitis, Atopic
NCT Number
NCT02888236
NCT03126578
NCT02514694
NCT02753218
NCT02496546
NCT01310049
NCT03812198
NCT02126371
NCT03231124
Intervention Type
Drug
Drug
Other, Drug
Drug
Drug
Drug
Other, Drug
Drug
Drug
Indications
Psoriasis Vulgaris
Drug Interaction Potentiation
Psoriasis Vulgaris
Psoriasis Vulgaris
Atopic Dermatitis
Healthy Subjects
Healthy
Psoriasis Vulgaris
Psoriasis Vulgaris
Study Phase
Phase 2
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Recruitment Status
Completed
Completed
Completed
Terminated
Completed
Completed
Completed
Completed
Completed
COVA-322
COVA-322
Phase 2 Clinical
Covagen
Psoriasis
NCT Number
NCT02243787
Intervention Type
Other, Drug
Indications
Plaque Psoriasis
Study Phase
Phase 1/Phase 2
Recruitment Status
Terminated
V-565
V-565
Phase 2 Clinical
Vhsquared
Colitis, Ulcerative, Crohn Disease
NCT Number
NCT02976129
NCT03705117
Intervention Type
Drug
Biological
Indications
Crohn's Disease
Ulcerative Colitis
Study Phase
Phase 2
Phase 1
Recruitment Status
Recruiting
Completed
LY-3114062
LY3114062, LY-3114062
Phase 1 Clinical
Eli Lilly And Company
Arthritis
NCT Number
NCT02144272
Intervention Type
Drug
Indications
Inflammatory Arthritis
Study Phase
Phase 1
Recruitment Status
Completed
Adalimumab biosimilar (Prestige BioPharma)
PBP-1502
Phase 1 Clinical
Prestige Biopharma
Arthritis
Recombinant human monoclonal antibody specific for human tumor necrosis factor (North China Pharmaceutical)
Phase 1 Clinical
North China Pharmaceutical Company Ltd
Spondylitis, Ankylosing, Arthritis, Rheumatoid, Autoimmune Diseases, Psoriasis
Human anti-TNFα monoclonal antibody (DZM Biotech)
Phase 1 Clinical
Daqing Dongzhuming Biotechnology Co Ltd
Arthritis, Rheumatoid
Recombinant anti-TNFα antibody (Shanghai Xiesheng Medicine)
Phase 1 Clinical
Shanghai Harmony Pharmaceutical Technology Co Ltd
Certolizumab (Intrexon)
AG-014
Phase 1 Clinical
Intrexon Co
Inflammatory Bowel Diseases
AVX-470
AVX-470, AVX-1350, AVX-470h
Phase 1 Clinical
Avaxia Biologics
Colitis, Ulcerative
NCT Number
NCT01759056
Intervention Type
Drug
Indications
Ulcerative Colitis
Study Phase
Phase 1
Recruitment Status
Completed
Wogonin
Phase 1 Clinical
Shandong Buchang Pharmaceuticals Co Ltd, Hefei Cosource Medicine Technology, Daewoong Pharmaceutical Co Ltd, China Pharmaceutical University
Respiratory Tract Infections, Neoplasms
Adalimumab biosimilar (Eastern Biotech)
JY-026
Phase 1 Clinical
Beijing Eastern Biotech Co Ltd
Arthritis, Rheumatoid, Spondylitis, Ankylosing, Arthritis, Juvenile, Psoriasis, Crohn Disease
Recombinant human anti-TNFα monoclonal antibody (Qilu Pharmaceutical)
Phase 1 Clinical
Qilu Pharmaceutical Co Ltd
Arthritis, Rheumatoid, Spondylitis, Ankylosing
JNJ-63823539
JNJ-63823539
Phase 1 Clinical
Janssen Global Services Llc
Arthritis, Rheumatoid
Recombinant human anti-TNFα monoclonal antibody (Huaota Biopharma)
Phase 1 Clinical
Shanghai Huaao Tai Biopharma Co Ltd
Spondylitis, Ankylosing, Psoriasis, Arthritis
Adalimumab biosimilar (Beijing Luzhu Biotechnology)
Phase 1 Clinical
Beijing Lvzhu Biological Technology Co Ltd
Spondylitis, Ankylosing, Arthritis, Rheumatoid, Psoriasis, Arthritis
Recombinant human anti-TNFα monoclonal antibody (Weimingdamu Biotech)
Phase 1 Clinical
Anhui Weiming Damu Biomedicine Co Ltd
Arthritis, Rheumatoid
Anti-tumour necrosis factor alpha (Livzon)
Phase 1 Clinical
Livzon Pharmaceutical Group Inc
Autoimmune Diseases
Etanercept (Neurokine Pharmaceuticals)
NP-1, NK-001
Clinical
Pivot Pharmaceuticals
Cognition Disorders
IBPM005IX (Inbiopro Solutions)
Clinical
Inbiopro Solutions
Spondylitis, Ankylosing, Arthritis, Rheumatoid, Arthritis, Juvenile, Arthritis, Psoriatic, Crohn Disease
Adalimumab biosimilar (AXXO)
Clinical
Axxo
Arthritis, Rheumatoid, Arthritis, Psoriatic
Infliximab (Hisun Biopharmaceutical)
IND
Hisun Biopharmaceutical Co Ltd
Adalimumab biosimilar (HEC Pharma)
IND
Guangdong Dongyangguang Pharmaceutical Co Ltd
Arthritis, Rheumatoid
Recombinant human TNF-α monoclonal antibody(SL Pharma/Combio)
KM113
IND
Beijing Sl Pharmaceutical Co Ltd, Beijing Kangming Bio New Drug Development Co Ltd
Autoimmune Diseases
Recombinant human tumor necrosis factor-α (hTNF-α) monoclonal antibody (Shanghai Humanized Bio-tech)
IND
Shanghai Humanized Bio-tech Ltd
CMAB815
CMAB815
IND
Shanghai Biomabs Pharmaceuticals Co Ltd, Sinomab Bioscience Ltd
Arthritis, Rheumatoid
LQ-026
LQ-026, LQ026
Preclinical
Arthritis, Rheumatoid, Spondylitis, Ankylosing
Adalimumab (Beijing Science Sun)
K-3, K3
Preclinical
Arthritis, Rheumatoid, Spondylitis, Ankylosing, Colitis, Ulcerative, Plaque psoriasis
LQ-024
LQ-024, LQ024
Preclinical
Arthritis, Rheumatoid
SCT-640A
SCT-640A, SCT640A
Preclinical
Shenzhou Cell Engineering Co Ltd
Arthritis, Rheumatoid, Psoriasis
Recombinant human anti-TNFα monoclonal antibody (Taizhou Mabtech)
Pending
Taizhou Maibo Taike Biotechnology Co Ltd
YHB-1411-2
YHB-14112, YHB1411-2, YHB-1411-2, MAb YHB1411-2
Pending
Yuhan Corp
Arthritis, Rheumatoid
Etanercept biosimilar (Zenotech Laboratories)
Pending
Zenotech Laboratories
Arthritis, Rheumatoid
INDUS-83030
INDUS-83030
Pending
Indus Biotech Pvt Ltd
Arthritis, Rheumatoid
Recombinant anti-TNFα human monoclonal antibody (Jilin Kanghui Biotech)
Pending
Alphamab Jilin Co Ltd
PMI-001
PMI-001
Pending
Phytomedics
Lupus Vulgaris, Arthritis, Rheumatoid, Multiple Sclerosis, Psoriasis
NCT Number
NCT00062465
Intervention Type
Drug
Indications
Rheumatoid Arthritis
Study Phase
Phase 2
Recruitment Status
Completed
Adalimumab biosimilar (Bionovis/The Instituto Vital Brazil)
Pending
Bionovis, The Instituto Vital Brazil
Arthritis, Rheumatoid, Spondylitis, Ankylosing, Psoriasis, Colitis, Ulcerative, Arthritis, Psoriatic, Crohn Disease
BLX-1002
BLX-1002
Pending
Orchid
Diabetes Mellitus, Type 2
MM-A01-01
MM-A01-01
Pending
Myungmoon Pharm
Arthritis, Rheumatoid
tgAAC 94
Pending
Armata Pharmaceuticals
Arthritis, Rheumatoid, Periodontal Diseases
Adalimumab biosimilar (Alphamab)
KN-002
Pending
Suzhou Alphamab Co Ltd
Arthritis, Rheumatoid
OCT-B201
BT-201, OCT-B201
Pending
Oscotec
Osteoarthritis
Recombinant mutant human tumor necrosis factor alpha (State Key Laboratory of Cancer Biology)
Pending
State Key Laboratory Of Cancer Biology
Head and Neck Neoplasms, Stomach Neoplasms, Carcinoma, Renal Cell, Colorectal Neoplasms, Lung Neoplasms
PF-5230905
ATN-192, PF-5230905, PF-05230905
Pending
Ablynx
Arthritis, Rheumatoid
GSK-2800528
GSK-2800528
Pending
Glaxosmithkline Plc
Psoriasis, Inflammation
NCT Number
NCT01899755
Intervention Type
Drug
Indications
Psoriasis
Study Phase
Phase 1
Recruitment Status
Completed
BIRB-1017
BIRB-1017
Pending
Boehringer Ingelheim Gmbh
Arthritis, Rheumatoid, Psoriasis
NV-52
NV-52, NV-07β
Pending
Novogen
Inflammatory Bowel Diseases, Colitis, Ulcerative, Crohn Disease
QR-449
QR-440, QR-443, QR-449
Pending
Prophase Labs
Pain, Metabolic Diseases, Cachexia
Etanercept biosimilar (AvesthaGen)
Pending
Avesthagen
Arthritis, Rheumatoid
KOB-03
KOB-03
Pending
Rhinitis, Allergic
Etanercept biosimilar (Bionovis/The Instituto Vital Brazil)
Pending
The Instituto Vital Brazil, Bionovis
Spondylitis, Ankylosing, Arthritis, Rheumatoid, Psoriasis, Arthritis, Psoriatic
Etanercept biosimilar (Biotrion)
BT-D001
Pending
Biotrion
Arthritis, Rheumatoid
AN-0128
AN-0128, CRM-0005, ONT-0001
Pending
Anacor Pharmaceuticals
Dental Plaque, Dermatitis, Atopic
NCT Number
NCT00762151
Intervention Type
Other, Drug
Indications
Dental Plaque
Study Phase
Phase 1
Recruitment Status
Completed
BCD-121
BCD-121
Pending
Biocad
Arthritis, Rheumatoid
NCT Number
NCT03103451
Intervention Type
Other, Drug
Indications
Healthy
Study Phase
Phase 1
Recruitment Status
Completed
Adalimumab biosimilar (Shanghai Maitaiyabo Biotech)
Pending
Shanghai Maitai Yabo Biotechnology Co Ltd
Arthritis, Rheumatoid
MCT-475
MCT-475, MCT-485
Pending
Multicell Technologies
Hepatitis, Chronic, Liver Neoplasms
Anti-TNFalpha polyclonal antibody (Verigen)
Pending
Genzyme Corp
Arthritis, Rheumatoid, Crohn Disease
Adalimumab biosimilar (Dong-A ST/Meiji Seika Pharma)
DA-3113, DMB-3113
Pending
Dong-A Pharmaceutical Co Ltd, Meiji Seika Pharma Co Ltd
Arthritis, Rheumatoid
NCT Number
NCT02927353
Intervention Type
Drug
Indications
Healthy Volunteer
Study Phase
Phase 1
Recruitment Status
Completed
Tumour necrosis factor alpha kinoid
TNF-K, TNF-K005
Pending
Neovacs
Arthritis, Rheumatoid, Crohn Disease
NCT Number
NCT01291810
NCT01040715
NCT01911234
Intervention Type
Biological
Biological
Other, Biological
Indications
Crohn's Disease
Rheumatoid Arthritis
Rheumatoid Arthritis
Study Phase
Phase 2
Phase 2
Phase 2
Recruitment Status
Completed
Completed
Completed
YS-IL6
YS-IL6, YSIL-6, YSIL6-O-RA, YSIL6-T-PS
Pending
Y'S Therapeutics
Arthritis, Rheumatoid
ONO-4007
ONO-4007
Discontinued
Ono Pharmaceutical Co Ltd
Neoplasms
Doramapimod
BIBR-796, BIRB-796, BIRB-0796, BIRB-796-BS
Discontinued
C.H. Boehringer Sohn Ag & Co. Kg
Arthritis, Rheumatoid, Psoriasis
NCT Number
NCT02214888
NCT02209753
NCT02209779
NCT02211144
NCT02208856
NCT02211885
NCT02211157
NCT02209805
Intervention Type
Drug
Drug
Drug
Drug
Other, Drug
Drug
Other, Drug
Drug
Indications
Arthritis, Rheumatoid
Psoriasis
Arthritis, Rheumatoid
Healthy
Healthy
Healthy
Healthy
Healthy
Study Phase
Phase 2
Phase 2
Phase 2
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Recruitment Status
Terminated
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Adalimumab biosimilar (Synermore Biologics)
SYN-060
Discontinued
Lonn Ryonn Pharma Ltd, Xingmeng Biotechnology (Beijing) Co Ltd
Arthritis, Rheumatoid
NCT Number
NCT03254810
Intervention Type
Biological
Indications
Arthritis, Rheumatoid
Study Phase
Phase 1
Recruitment Status
Completed
AZD-9773 (BTG)
Discontinued
Btg Plc
Shock, Septic, Sepsis
DOM-0215
DOM-0215
Discontinued
Glaxosmithkline Plc
Arthritis, Rheumatoid
Placulumab
ART-621, PN-0621, Dom-0200, CEP-37247
Discontinued
Domantis, Peptech Uk
Arthritis, Rheumatoid, Sciatica, Psoriasis, Inflammation
NCT Number
NCT00928317
NCT00854685
NCT01240876
Intervention Type
Drug
Drug
Drug
Indications
Rheumatoid Arthritis
Rheumatoid Arthritis
Sciatica
Study Phase
Phase 2
Phase 2
Phase 1/Phase 2
Recruitment Status
Terminated
Completed
Completed
Infliximab biosimilar (Shanghai CP Guojian)
Discontinued
Shanghai Cp Guojian Pharmaceutical Co Ltd
Arthritis, Rheumatoid
Ro-327315
Ro-327315, Ro-32-7315
Discontinued
F. Hoffmann-La Roche Ltd
Arthritis, Rheumatoid
NPH-30907
NPH-30907
Discontinued
Piramal Phytocare
Mycoses
MGN-1404
MGN-1404
Discontinued
Mologen
Melanoma
AMG-548
AMG-548
Discontinued
Amgen Inc
Arthritis, Rheumatoid, Arthritis
AME-527
AME-527
Discontinued
Applied Molecular Evolution
Arthritis, Rheumatoid
CDP-571
CDP-571, cb-0010, BAY-10-3356
Discontinued
Celltech
Shock, Septic, Diabetes Mellitus, Type 2, Arthritis, Rheumatoid, Crohn Disease
Recombinant humanized anti-TNFα monoclonal antibody (Shenzhen Main Luck Pharmaceuticals)
Discontinued
Shenzhen Main Luck Pharmaceuticals Inc
Spondylitis, Ankylosing, Arthritis, Rheumatoid
Lenercept
RO-452081, NFR55-IgG1, TNFR55-Ig1, p55TNFR-Ig
Discontinued
F. Hoffmann-La Roche Ltd
Shock, Septic, Arthritis, Rheumatoid
CYT 007 TNFQb
Discontinued
Cytos
Arthritis, Rheumatoid, Psoriasis
CC-11050
CC-11050
Discontinued
Celgene Corp
Lupus Erythematosus, Cutaneous
NCT Number
NCT02968927
NCT03807362
NCT01300208
NCT02652546
NCT04139226
Intervention Type
Drug
Drug
Other, Drug
Drug
Drug
Indications
Tuberculosis
Erythema Nodosum Leprosum; Leprosy
Cutaneous Lupus Erythematosus
HIV, Inflammation
Healthy Volunteers
Study Phase
Phase 2
Phase 2
Phase 2
Phase 1
Phase 1
Recruitment Status
Active, not recruiting
Recruiting
Completed
Completed
Completed
Azacitidine/Lenalidomide
Discontinued
Celgene Corp
Leukemia, Myeloid, Acute
ENMD-0995
S-3APG, ENMD-0995
Discontinued
Boston Children'S Hospital, Celgene Corp
Multiple Myeloma
ISIS-104838
ISIS 104838
Discontinued
Ionis
Arthritis, Rheumatoid, Psoriasis, Inflammation, Crohn Disease
NCT Number
NCT00048321
Intervention Type
Drug
Indications
Rheumatoid Arthritis
Study Phase
Phase 2
Recruitment Status
Completed
Adalimumab biosimilar (Momenta Pharmaceuticals)
M-923, BAX-923, BAX-2923
Discontinued
Momenta
Arthritis, Rheumatoid, Autoimmune Diseases, Psoriasis, Inflammation
NCT Number
NCT02722044
NCT02581345
NCT02675023
Intervention Type
Biological, Device
Biological
Biological
Indications
Rheumatoid Arthritis
Chronic Plaque Psoriasis; Psoriasis
Healthy
Study Phase
Phase 3
Phase 3
Phase 1
Recruitment Status
Completed
Completed
Completed
MNX-160
LMP-160, MNX-160
Discontinued
Nonindustrial Source
Arthritis, Rheumatoid, Multiple Sclerosis, Respiratory Distress Syndrome, Adult, Psoriasis, Asthma, Cachexia, Diabetes Mellitus
Recombinant anti-TNFα antibody (Sailemin Biotech)
Discontinued
Hainan Selemin Biological Technology Co Ltd
Spondylitis, Ankylosing, Arthritis, Rheumatoid
Genz-29155
Genz-29155
Discontinued
Sanofi
Multiple Sclerosis, Rejection of organ transplantation
REN-1654
CPI-1189, REN-1189, REN-1654
Discontinued
Evotec
Intervertebral Disc Displacement, Peripheral Nervous System Diseases, HIV Infections, Neuralgia, Postherpetic, Sciatica, Radiculopathy, AIDS Dementia Complex, Neuralgia, Herpes Zoster
NCT Number
NCT00107055
NCT00002414
NCT00099528
NCT00002209
Intervention Type
Drug
Drug
Drug
Drug
Indications
Sciatica; Herniated Disc; Radiculopathy
HIV Infections
Neuralgia; Shingles; Peripheral Nervous System Disease
AIDS Dementia Complex; HIV Infections
Study Phase
Phase 2
Phase 2
Phase 2
Phase 1
Recruitment Status
Unknown status
Unknown status
Unknown status
Completed
BB-2275
BB-2275
Discontinued
Vernalis
Cachexia
DLX-105
DLX-105, ESBA-105
Discontinued
Esbatech
Dry Eye Syndromes, Psoriasis, Uveitis, Anterior, Osteoarthritis, Xerophthalmia, Uveitis, Crohn Disease
NCT Number
NCT01936337
NCT01624376
NCT00823173
NCT01338610
NCT00819572
NCT01595997
NCT00671619
Intervention Type
Drug
Drug
Biological
Other, Biological
Biological, Drug
Drug
Drug
Indications
Psoriasis Vulgaris
Fistulizing Crohn's Disease
Anterior Uveitis
Eyes Dry Chronic
Osteoarthritis
Mild-to-moderate Psoriasis Vulgaris
Healthy
Study Phase
Phase 2
Phase 2
Phase 2
Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1
Recruitment Status
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Golnerminogene pradenovec
ADgvEGR.TNF.11D
Discontinued
Asahi Kasei Corp
Head and Neck Neoplasms, Rectal Neoplasms, Pancreatic Neoplasms, Melanoma
NCT Number
NCT00868114
NCT00261404
NCT00137878
NCT00496535
NCT00496236
Intervention Type
Biological
Drug
Drug
Drug
Drug
Indications
Metastatic Pancreatic Cancer
Melanoma
Rectal Cancer
Head and Neck Cancer; Head and Neck Neoplasms
Head and Neck Cancer; Head and Neck Neoplasms
Study Phase
Phase 2
Phase 2
Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Recruitment Status
Terminated
Completed
Completed
Completed
Completed
HP-228
HP-228, ILP-228
Discontinued
Sygnis
Diabetes Mellitus, Type 2, Pain, Postoperative, Obesity, Inflammation
Human TNF-α monoclonal antibody( Simcere Pharmaceutical)
Discontinued
Nanjing Simcere Dongyuan Pharmaceutical Co Ltd, Shandong Simcere Bio-Pharmaceutical Co Ltd, Jiangsu Xiansheng Pharmaceutical Co Ltd
K-832
K-832
Discontinued
Kowa
Arthritis, Rheumatoid
ABBV-257
DVD-1, ABBV-257, DVD-Ig-1
Discontinued
Abbott Laoratories
Arthritis, Rheumatoid
NCT Number
NCT02531178
Intervention Type
Biological
Indications
Rheumatoid Arthritis
Study Phase
Phase 1
Recruitment Status
Completed
Adalimumab with ENHANZE technology (Abbvie)
Discontinued
Abbvie Inc
ABX-0401
ABX-0401
Discontinued
Sanofi
Inflammatory Bowel Diseases, Arthritis, Rheumatoid, Inflammation
SA-13353
DE-096, SA-13353
Discontinued
Santen Pharmaceutical Co Ltd
Arthritis, Rheumatoid, Diabetic macular oedema
References
Title
Authors
Source
Tandem arrangement of genes coding for tumor necrosis factor (TNF-alpha) and lymphotoxin (TNF-beta) in the human genome
Nedospasov S.A., Shakhov A.N., Turetskaya R.L., Mett V.A., Azizov M.M., Georgiev G.P., Korobko V.G., Dobrynin V.N., Filippov S.A., Bystrov N.S., Boldyreva E.F., Chuvpilo S.A., Chumakov A.M., Shingarova L.N., Ovchinnikov Y.A.,
Cold Spring Harb. Symp. Quant. Biol. 51:611-624(1986)
Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin
Pennica D., Nedwin G.E., Hayflick J.S., Seeburg P.H., Derynck R., Palladino M.A., Kohr W.J., Aggarwal B.B., Goeddel D.V.,
Nature 312:724-729(1984)
Cloning and expression in Escherichia coli of the gene for human tumour necrosis factor
Shirai T., Yamaguchi H., Ito H., Todd C.W., Wallace R.B.,
Nature 313:803-806(1985)
Human lymphotoxin and tumor necrosis factor genes: structure, homology and chromosomal localization
Nedwin G.E., Naylor S.L., Sakaguchi A.Y., Smith D.H., Jarrett-Nedwin J., Pennica D., Goeddel D.V., Gray P.W.,
Nucleic Acids Res. 13:6361-6373(1985)
Molecular cloning of the complementary DNA for human tumor necrosis factor
Wang A.M., Creasey A.A., Ladner M.B., Lin L.S., Strickler J., van Arsdell J.N., Yamamoto R., Mark D.F.,
Science 228:149-154(1985)
Molecular cloning and expression of human tumor necrosis factor and comparison with mouse tumor necrosis factor
Marmenout A., Fransen L., Tavernier J., van der Heyden J., Tizard R., Kawashima E., Shaw A., Johnson M.J., Semon D., Mueller R., Ruysschaert M.-R., van Vliet A., Fiers W.,
Eur. J. Biochem. 152:515-522(1985)
Dense Alu clustering and a potential new member of the NF kappa B family within a 90 kilobase HLA class III segment
Iris F.J.M., Bougueleret L., Prieur S., Caterina D., Primas G., Perrot V., Jurka J., Rodriguez-Tome P., Claverie J.-M., Dausset J., Cohen D.,
Nat. Genet. 3:137-145(1993)
A new member of the Ig superfamily and a V-ATPase G subunit are among the predicted products of novel genes close to the TNF locus in the human MHC
Neville M.J., Campbell R.D.,
J. Immunol. 162:4745-4754(1999)
Analysis of the gene-dense major histocompatibility complex class III region and its comparison to mouse
Xie T., Rowen L., Aguado B., Ahearn M.E., Madan A., Qin S., Campbell R.D., Hood L.,
Genome Res. 13:2621-2636(2003)
Association of TNF-alpha promoter polymorphisms with the clearance of hepatitis B virus infection
Kim Y.J., Lee H.-S., Yoon J.-H., Kim C.Y., Park M.H., Kim L.H., Park B.L., Shin H.D.,
Hum. Mol. Genet. 12:2541-2546(2003)
Smac mimetic enables the anticancer action of BCG-stimulated neutrophils through TNF-alpha but not through TRAIL and FasL
Jinesh G.G., Chunduru S., Kamat A.M.,
J. Leukoc. Biol. 92:233-244(2012)
Phosphorylation of FOXP3 controls regulatory T cell function and is inhibited by TNF-alpha in rheumatoid arthritis
Nie H., Zheng Y., Li R., Guo T.B., He D., Fang L., Liu X., Xiao L., Chen X., Wan B., Chin Y.E., Zhang J.Z.,
Nat. Med. 19:322-328(2013)
Structure of tumour necrosis factor
Jones E.Y., Stuart D.I., Walker N.P.,
Nature 338:225-228(1989)
The structure of tumour necrosis factor -- implications for biological function
Jones E.Y., Stuart D.I., Walker N.P.,
J. Cell Sci. Suppl. 13:11-18(1990)
The structure of tumor necrosis factor-alpha at 2.6-A resolution. Implications for receptor binding
Eck M.J., Sprang S.R.,
J. Biol. Chem. 264:17595-17605(1989)
Crystal structure of TNF-alpha mutant R31D with greater affinity for receptor R1 compared with R2
Reed C., Fu Z.Q., Wu J., Xue Y.N., Harrison R.W., Chen M.J., Weber I.T.,
Protein Eng. 10:1101-1107(1997)
High resolution crystal structure of a human tumor necrosis factor-alpha mutant with low systemic toxicity
Cha S.S., Kim J.S., Cho H.S., Shin N.K., Jeong W., Shin H.C., Kim Y.J., Hahn J.H., Oh B.H.,
J. Biol. Chem. 273:2153-2160(1998)
Cytokine gene polymorphisms: association with psoriatic arthritis susceptibility and severity
Balding J., Kane D., Livingstone W., Mynett-Johnson L., Bresnihan B., Smith O., FitzGerald O.,
Arthritis Rheum. 48:1408-1413(2003)
The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)
The MGC Project Team,
Genome Res. 14:2121-2127(2004)
O-glycosylated species of natural human tumor-necrosis factor-alpha
Takakura-Yamamoto R., Yamamoto S., Fukuda S., Kurimoto M.,
Eur. J. Biochem. 235:431-437(1996)
Phosphorylation of the 26 kDa TNF precursor in monocytic cells and in transfected HeLa cells
Pocsik E., Duda E., Wallach D.,
J. Inflamm. 45:152-160(1995)
A casein kinase I motif present in the cytoplasmic domain of members of the tumour necrosis factor ligand family is implicated in 'reverse signalling'
Watts A.D., Hunt N.H., Wanigasekara Y., Bloomfield G., Wallach D., Roufogalis B.D., Chaudhri G.,
EMBO J. 18:2119-2126(1999)
Localization of the active site of human tumour necrosis factor (hTNF) by mutational analysis
Ostade X.V., Tavernier J., Prange T., Fiers W.,
EMBO J. 10:827-836(1991)
Myristyl acylation of the tumor necrosis factor alpha precursor on specific lysine residues
Stevenson F.T., Bursten S.L., Locksley R.M., Lovett D.H.,
J. Exp. Med. 176:1053-1062(1992)
Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha
Moss M.L., Jin S.-L.C., Milla M.E., Burkhart W., Carter H.L., Chen W.-J., Clay W.C., Didsbury J.R., Hassler D., Hoffman C.R., Kost T.A., Lambert M.H., Leesnitzer M.A., McCauley P., McGeehan G., Mitchell J., Moyer M., Pahel G., Becherer J.D.,
Nature 385:733-736(1997)
A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria
Knight J.C., Udalova I., Hill A.V., Greenwood B.M., Peshu N., Marsh K., Kwiatkowski D.,
Nat. Genet. 22:145-150(1999)
Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis
Nakahara H., Song J., Sugimoto M., Hagihara K., Kishimoto T., Yoshizaki K., Nishimoto N.,
Arthritis Rheum. 48:1521-1529(2003)
SPPL2a and SPPL2b promote intramembrane proteolysis of TNFalpha in activated dendritic cells to trigger IL-12 production
Friedmann E., Hauben E., Maylandt K., Schleeger S., Vreugde S., Lichtenthaler S.F., Kuhn P.H., Stauffer D., Rovelli G., Martoglio B.,
Nat. Cell Biol. 8:843-848(2006)
A gamma-secretase-like intramembrane cleavage of TNFalpha by the GxGD aspartyl protease SPPL2b
Fluhrer R., Grammer G., Israel L., Condron M.M., Haffner C., Friedmann E., Bohland C., Imhof A., Martoglio B., Teplow D.B., Haass C.,
Nat. Cell Biol. 8:894-896(2006)